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Immune-Metabolic Regulation by the Transsulfuration Pathway 
 





 Pro-longevity interventions such as caloric restriction (CR) and methionine 
restriction (MR) can improve metabolic health. However, despite decades of extensive 
studies, the mechanisms that underlie the benefits of these dietary interventions are still 
being characterized. Particularly, the effect of these diets on immune cells in mediating 
their metabolic benefits has been largely unexplored. This work aimed to expand our 
understanding of how these dietary interventions may regulate immune responses and 
identify novel immunomodulatory pathways that could be harnessed during inflammatory 
and metabolic pathologies. 
In line with other studies in animal models, we identified that the transsulfuration 
pathway (TSP) was induced in humans with CR. The TSP controls the synthesis of cysteine 
from methionine, and produces byproducts such as hydrogen sulfide (H2S). We find that 
during MR, NLRP3 inflammasome-mediated inflammation can be inhibited by the 
induction of autophagy due to low availability of sulfur-containing amino acids (SAA). 
Additionally, the TSP can inhibit NLRP3 inflammasome through the production of H2S. 
This highlights SAA availability mediated by the TSP as an immunoregulatory checkpoint 
that may be harnessed to reduce inflammasome-mediated inflammation. However, MR 
failed to reduce white adipose tissue inflammation in mouse models of acute endotoxemia, 
 ii 
Muckle Wells Syndrome, and aging, suggesting that more direct interventions of specific 
TSP metabolites may need to be explored. 
In addition to regulation of inflammation, we have found that single amino acid 
deficiencies can drive extreme thermogenesis in mice, and pathways that protect critical 
amino acid levels such as the TSP can serve as important checkpoints to defend against 
unchecked thermogenesis. We find that cysteine deficiency in mice lacking the TSP leads 
to rapid loss of fat mass and robust adipose tissue browning. This is mediated by an increase 
in sympathetic signaling in the adipose tissue, in part through a reduction in the expression 
of catecholamine degrading enzymes in adipose tissue macrophages. 
Altogether, this work highlights that regulation of cysteine availability through the 
TSP serves as an important check point in metabolic and inflammatory homeostasis, and 
may underlie many of the metabolic benefits during CR. Manipulation of cysteine 
availability may thus potentiate novel therapeutic strategies for combating inflammatory 
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Chapter 1: Introduction 
 
Aging is associated with systemic low-grade inflammation in the absence of apparent 
infection, and is the single greatest risk factor for chronic diseases including cardiovascular 
disease, type II diabetes, cancer, and neurodegenerative diseases. With the exception of 
viral pandemics such as the current COVID-19 crisis, as the population of Americans over 
the age of 65 has increased, there has been a shift in the leading causes of death from 
infectious diseases and acute illness to non-communicable chronic diseases and 
degenerative illnesses. By 2030, people aged 65 and older are projected to account for 20 
percent of the total U.S. population, and by 2056, are projected to outnumber individuals 
under the age of 18 (Colby and Ortman, 2014). Over the next 20-30 years, the number of 
people over the age of 65 will double to ~80 million in the U.S. with healthcare costs 
projected to be 2 trillion dollars (Ortman et al., 2014). In the 2013 report from the Centers 
for Disease Control and Prevention, “The State of Aging in America 2013,” more than a 
quarter of all Americans suffered from multiple chronic conditions, such as heart disease, 
cancer, chronic lower respiratory diseases, Alzheimer’s disease, and diabetes, accounting 
for 66% of the national health care burden (CDC, 2013). Furthermore, these age-related 
conditions are also associated with high morbidity and mortality in the context of infectious 
diseases, putting the elderly at even higher risks. Particularly, studies of the 2009 H1N1 
pandemic, the MERS outbreak, and current COVID-19 pandemic have revealed that aging, 
obesity, and diabetes to be high risk factors for disease severity and mortality (Drucker, 
2020; Kulcsar et al., 2019; Pastor-Barriuso et al., 2020; Perez-Saez et al., 2020; Van 
Kerkhove et al., 2011).  It has thus become crucial to understand the process of aging and 
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develop therapeutic interventions to increase heatlhspan and delay the onset of age-
associated disease. 
 
Aging and Inflammation 
While many facets contribute to the decline in health during aging, inflammation is 
an important driver of most age-related diseases (Ferrucci et al., 2005; Franceschi and 
Campisi, 2014). One contributor of chronic inflammation is the accumulation of damaged 
macromolecules and cell debris that increase with age. These include damaged cellular 
organelle components, reactive species from oxidative stress, and cellular components 
indicative of dying cells such as extracellular ATP, ceramides, saturated fatty acids, urate 
and cholesterol crystals, amyloid fibrils, succinate, and advanced glycation end products, 
which act as danger associated molecular patterns (DAMPs); these DAMPs are sensed by 
innate sensors called pathogen recognition receptors (PRRs) (Goldberg and Dixit, 2015; 
Medzhitov, 2008). One such sensor of molecular DAMPs is the NACHT, LRR and PYD 
domains containing protein 3 (NLRP3) inflammasome. While the NLRP3 inflammasome 
normally plays an important role in defense against bacterial infections, sustained NLRP3 
activation becomes a major driver of age-related inflammation. Consistently, ablation of 
NLRP3 delays the onset of age associated diseases such as bone loss, thymic demise, 
insulin insensitivity, development of cataracts, and memory loss (Youm et al., 2013).  
Activation of the NLRP3 inflammasome is tightly regulated in a two-step process. 
The first priming step involves sensing of cytokines or pathogen associated molecular 
patterns (PAMPs) such as lipopolysaccharide (LPS) by PRRs, leading to NF-κB mediated 
transcription of the NLRP3 inflammasome complex, including NLRP3, IL-1β, and IL-18 
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(Franchi et al., 2009; Tschopp and Schroder, 2010). Once the inflammasome is primed, 
sensing of additional PAMPs or DAMPs such as extracellular ATP, microbial toxins, or 
crystalline structures by NLPR3 acts as the second signal that leads to the assembly and 
oligomerization of the inflammasome complex involving NLRP3, ASC, and caspase 1 (Cai 
et al., 2014; Kanneganti and Dixit, 2012; Lu et al., 2014; Mangan et al., 2018). This 
assembly initiates the proteolytic cleavage of pro-caspase 1 into its active form, which can 
further process pro-IL-1β and pro-IL-18 into their biologically active forms that are 
secreted out of the cell and mediate inflammation. Activation of the NLRP3 inflammasome 
further leads to the activation of gasdermin D which mediates pyroptotic cell death, a rapid 
inflammatory form of cell death (Aglietti et al., 2016; Shi et al., 2015). How the NLRP3 
inflammasome can uniquely sense and respond to such a plethora of PAMPs and DAMPs 
has been an outstanding question in the field. Studies have revealed that these stimuli 
commonly induce cellular stress responses which lead to intracellular signaling events such 
as potassium and chloride ion efflux, calcium ion influx, mitochondrial reactive oxygen 
species (ROS) and DNA release, and lysosomal disruption which then drive NLRP3 
inflammasome activation (Di et al., 2018; Domingo-Fernandez et al., 2017; Hornung et al., 
2008; Lee et al., 2012; Murakami et al., 2012; Zhang et al., 2010; Zhong et al., 2018; Zhou 
et al., 2011). However, exactly how NLRP3 senses these diverse intracellular signaling 
events is still unknown. 
Activation of NLRP3 is particularly increased in the adipose during aging and 
obesity (Vandanmagsar et al., 2011; Youm et al., 2013). Amongst myeloid cells, 
macrophages are important regulators of adipose tissue homeostasis through NLRP3 
inflammasome dependent regulation of insulin-action and lipolysis (Vandanmagsar et al., 
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2011). In healthy adipose tissue, macrophages are skewed towards an anti-inflammatory 
phenotype and play important roles in the removal of dying adipocytes, lipid processing 
and buffering, antigen presentation, modulating angiogenesis, and regulating sympathetic 
tone (Camell et al., 2017; Haka et al., 2016; Hill et al., 2018; Jaitin et al., 2019; Lee et al., 
2013; Odegaard et al., 2007; Silva et al., 2019; Xu et al., 2013). But with obesity, an 
increased infiltration of macrophages is accompanied by a switch towards a pro-
inflammatory phenotype, expressing TNF-α, iNOS, and IL-6 (Weisberg et al., 2003). 
Furthermore, NLRP3 activation by these inflammatory macrophages mediates subsequent 
insulin resistance in obesity (Vandanmagsar et al., 2011). With aging, known activators of 
the NLRP3 inflammasome such as reactive oxygen species, urate crystals, cholesterol 
crystals, and saturated fatty acids are increased (Dostert et al., 2008; Duewell et al., 2010; 
Martinon et al., 2006; Vandanmagsar et al., 2011). Transmission electron microscopy of 
macrophages in the thymus, where adiposity is increased with age, have revealed that aged 
macrophages accumulate these activators intracellularly in the form of large lipid droplets, 
crystals, protein aggregates, and electron dense materials in the lysosome (Youm et al., 
2016). As such, ablation of NLRP3 reverses the metabolic defects in glycemic control in 
aged mice (Youm et al., 2013). Conversely, growth hormone receptor knock out (GHRKO) 
mice that are notable for their longevity, are characterized by reduced levels of NLRP3 
activation (Spadaro et al., 2016). Importantly, analysis of multi-omics profiling of young 
and older adult peripheral blood samples from the Stanford-Ellison longitudinal aging 
study found an age-dependent increase in inflammasome gene modules; furthermore, 
follow up of the study found the high expression of inflammasome modules was associated 
with all-cause mortality (Furman et al., 2017). 
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More recent studies have found that activation of NLRP3 in adipose tissue 
macrophages drives the expression of catecholamine degradation enzymes, causing the 
lipolysis resistance that is characteristic of reduced metabolic function in age and obesity 
(Camell et al., 2017; Pirzgalska et al., 2017). Additionally, NLRP3 activation in 
macrophages further recruits and maintains B cells in tertiary lymphoid structures called 
fat associated lymphoid clusters, and drive metabolic dysfunction exhibited as lipolysis 
resistance and cold intolerance in aged animals (Camell et al., 2019). These with other 
studies have highlighted a tight network of interactions that link metabolic function with 
inflammatory processes. Further understanding of these interactions will allow for 
therapeutic strategies to improve metabolically driven chronic diseases that occur with age. 
This is particularly important because the prevalence of metabolic disorders such as obesity 
and diabetes in adults aged 65 and over has increased continuously between 1999 and 2010 
(Fakhouri et al., 2012).   
 
Dietary Interventions can Extend Lifespan and Restrain Age-related Inflammation  
One of the most successful interventions to delay aging and extend healthspan and 
lifespan has been caloric restriction (CR). Since the first studies by Osborne et al. and 
McCay et al. to show that decreasing food intake slowed growth and increased lifespan of 
rats (McCay et al., 1935; Osborne et al., 1915), subsequent studies have demonstrated that 
CR extends lifespan in many species including mice, yeast, fruit flies, nematodes, fish, 
hamsters, and monkeys (Masoro, 2005; Sanchez-Roman and Barja, 2013). In addition to 
increasing lifespan, CR has been shown to delay the onset of most age-associated diseases, 
such as neoplastic disease, cardiomyopathy, degenerative diseases, and metabolic disorders 
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(Mattison et al., 2017; Ravussin et al., 2015; Sanchez-Roman and Barja, 2013). Besides 
CR, other, more targeted dietary interventions such as restricting protein intake, or 
restricting specific amino acids can also increase lifespan (Lee et al., 2008; Orentreich et 
al., 1993; Richardson et al., 2021; Solon-Biet et al., 2014), suggesting the restriction of 
protein derived macronutrients may be an important factor for their health benefits. Indeed, 
protein quality and amino acid composition of diet have been more strongly associated 
with metabolic and age associated health (Solon-Biet et al., 2014). Independently of caloric 
intake, low protein and high carbohydrate diets were found to have the strongest extension 
of lifespan in mice (Solon-Biet et al., 2014). In addition to dietary protein restriction (PR), 
some studies suggest it is the restriction of essential amino acids (EAAs) that drive 
beneficial effects, as supplementing dietary restriction with EAAs but not non-essential 
amino acids were sufficient to reverse pro-longevity effects (Grandison et al., 2009; 
Yoshida et al., 2018). Diets restricting specific EAAs have been extensively characterized 
to increase metabolic homeostasis and promote healthy aging; these diets include the 
restriction of sulfur amino acids (SAAs), methionine and cysteine, also known as 
methionine restriction (MR), and restriction of the branched chain amino acids, leucine, 
isoleucine, and valine, also known as branched chain amino acid restriction (BCAAR) 
(Fontana et al., 2016; Lee et al., 2016; Solon-Biet et al., 2014). These dietary interventions 
commonly lead to reduced adiposity and inflammation, increased insulin sensitivity and 
lipolytic gene signatures, and reduction of lipogenesis in adipose tissue and liver (Kitada 
et al., 2019). Although much less characterized, restriction of tryptophan can also lead to 
increased lifespan and increases recovery to cold stress, suggesting an increase in 
thermogenic capacity (Segall and Timiras, 1975, 1976; Zapata et al., 2018). Surprisingly, 
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these studies indicate that deficiencies of specific essential amino acids drive 
reprogramming of metabolic tissues to promote health. Despite numerous studies 
investigating the mechanisms driving increased longevity during these dietary 
interventions, there have been a lack of studies investigating the alterations to the immune 
system and their role in tissue reprogramming.  
 
Autophagy and Inflammation 
One pathway that is increased during dietary protein and amino acid restriction is 
the integrated stress response-mediated autophagy. The integrated stress response allows 
for adaptive responses to various stresses such as starvation and ER stress. Stressors are 
sensed by four different sensors: general control nonderepressible 2 (GCN2), protein 
kinase R (PKR), heme-regulated inhibitor (HRI), and PKR like endoplasmic reticulum 
kinase (PERK) (Pakos-Zebrucka et al., 2016). GCN2 senses amino acid depletion by 
sensing the accumulation of uncharged tRNAs (Gallinetti et al., 2013). HRI recognizes 
heme deficiency, while PKR senses viral infection through activation by double stranded 
RNA (Pakos-Zebrucka et al., 2016). Finally, PERK is activated by ER stress (Pakos-
Zebrucka et al., 2016). Activation of these sensors are integrated by the activation and 
phosphorylation of eIF2ɑ leading to global translational arrest (Pakos-Zebrucka et al., 
2016). One central component of the integrated stress response is autophagy (Kroemer et 
al., 2010). Autophagy, which literally means “self-eating” in Greek, is a process that 
delivers cellular components such as organelles and proteins to lysosomes for degradation 
and recycling of amino acids. This process is mediated by a broad network of proteins, 
many of which are called autophagy related genes (ATGs) (Tsukada and Ohsumi, 1993). 
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The most well characterized initiator of autophagy is deprivation of amino acids. In 
addition to GCN2-sensing of uncharged tRNAs, depletion of EAAs leads to interaction of 
their specific sensors such as SAMTOR (SAM sensor), sestrin 2 (leucine sensor), and 
CASTOR (arginine sensor) with GATOR1 or GATOR2 to prevent mTORC1 activation 
(Kim and Guan, 2019). The inhibition of mTORC1 leads to the dissociation of ULK1 from 
mTORC1 (Hosokawa et al., 2009). ULK1 then proceeds to phosphorylate itself and other 
complex members such as ATG13 and FIP200, ultimately leading to the formation of the 
phagophore that undergoes further expansion, maturation and fusion with the lysosome 
(Dikic and Elazar, 2018).  
As an ancient, evolutionarily conserved pathway, autophagy has been adapted to 
mediate multiple critical functions. In addition to acting as a homeostatic process that is 
activated to replenish amino acids during starvation, autophagy was more recently 
discovered to play a cytoprotective role through the elimination of damaged and 
dysfunctional organelles such as mitochondria and protein aggregates in a process called 
selective autophagy (Rui et al., 2015). Selective autophagy is in part mediated by p62, 
which is also known as sequestosome 1 (SQSTM1); p62 acts as an adaptor between LC3 
and ubiquitin chains to allow for recruitment of specific targets that have been ubiquitinated 
for autophagy (Bjorkoy et al., 2005; Narendra et al., 2010). In addition to p62, NDP52 can 
also act as an adaptor protein that not only binds to ubiquitin chains, but also galectin-8, 
which marks damaged endosomes and lysosomes (Thurston et al., 2012).  
Autophagy can also act as a type of primitive immune response via another process 
of selective autophagy called xenophagy, through the capture and degradation of 
intracellular pathogens such as Mycobacterium tuberculosis, Shigella flexneri, and 
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Salmonella typhimurium (Levine 2005). Conversely, autophagy can also regulate immune 
function. Multiple groups have now shown that autophagy can inhibit inflammasome 
activity through several mechanisms. Initially, Saitoh et al, showed that depletion of 
autophagosome machinery such as ATG16L1, ATG7, or treatment with the autophagy 
inhibitor, 3-methyladenine (3-MA), lead to increased production of IL-1β in response to 
LPS (Saitoh et al., 2008), suggesting that autophagy negatively regulates inflammasome 
activation. Follow up studies have found that autophagy can promote the labeling of 
inflammasome components with ubiquitin by parkin for proteasomal degradation (Shi et 
al., 2012). Autophagy was also found to promote mitophagy in a p62 dependent manner to 
reduce mitochondrial ROS production and subsequent inflammasome activation (Zhong et 
al., 2016; Zhou et al., 2011). These studies underscore amino acid starvation induced 
autophagy as a potential mechanism to regulate inflammation to mediate the effects of 
protein restricting interventions. In a model of colitis, PR and BCAAR reduced 
inflammation through the inhibition of NLRP3 inflammasome and reduction of Th17 
differentiation in the gut. This response was dependent on amino acid sensing through 
GCN2 (Ravindran et al., 2016). Furthermore, treatment with halofuginone, which activates 
starvation responses by inhibiting prolyl tRNA charging, also inhibits differentiation of 
Th17 cells, which play pathogenic roles in a multitude of autoimmune diseases (Sundrud 
et al., 2009). These studies highlight the induction of amino acid starvation responses in 
immune cells as potential strategies against inflammation driven pathological states such 
as obesity, aging, and autoimmunity.  
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The Transsulfuration Pathway as a Novel Immunomodulatory Metabolic Pathway 
Another pathway that could potentially mediate the effects of these dietary 
interventions is the transsulfuration pathway (TSP). Recent studies from our lab have 
revealed that Cth expression, a gene that encodes for cystathionine-γ lyase (CSE) and is 
part of the TSP, is induced in the adipose tissue of humans that underwent 14% CR over 
two years (CALERIE II, Dixit lab, unpublished). The TSP involves the metabolism of 
sulfur amino acids (SAAs), beginning with the catabolism of methionine to generate 
intermediates such as the methyl donor S-adenosylmethionine (SAM), S-
adenosylhomocysteine (SAH), homocysteine, and cystathionine. Additionally, TSP also 
allows for the generation of cysteine through the action of CSE which can further provide 
important metabolites and byproducts such as glutathione, taurine, pyruvate, and hydrogen 
sulfide (H2S). Interestingly, recent studies have linked the TSP to longevity. The lifespan 
extension induced by CR in Drosophila was abolished when treated with the inhibitor of 
CSE, propargylglycine (PPG) (Kabil et al., 2011), and overexpression of another TSP 
enzyme, cystathionine β-synthase (CBS) increased median lifespan in C. elegans (Hine et 
al., 2015). Furthermore, a recent study evaluating the effects of CR across two different 
mouse strains, and sex, found that 20% and 40% CR induces increased production of H2S, 
one of the end products of the TSP (Mitchell et al., 2016). Finally, treatment of yeast with 
H2S donors, NaHS and GYY4137, is sufficient to extend median lifespan of yeast, i.e. 
delay replicative senescence (Hine et al., 2015). These studies suggest that TSP mediated 
H2S production is an important mediator of lifespan benefits. 
 H2S is a gas molecule that has recently gained attention as a physiologically 
relevant signaling molecule. While the role of H2S in controlling vasodilation by its action 
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on endothelial smooth muscle is the most established (Paul and Snyder, 2015), one study 
reports that H2S treatment can induce suspended animation in mice, leading to reduced 
metabolic rate and decreased body temperature (Blackstone et al., 2005). Other studies 
have begun to uncover a role for H2S in immune processes. In T cells, H2S is required for 
the differentiation of regulatory T cells by promoting demethylation at the Foxp3 locus by 
Tet1 and Tet2 (Yang et al., 2015). An anti-inflammatory role for H2S has been implicated 
by its action on NF-κB to augment its antiapoptotic transcriptional activity in macrophages 
(Sen et al., 2012), and its action on antioxidant gene regulation (Yang et al., 2013). Given 
that both regulatory T cells and anti-inflammatory macrophages play important roles in 
promoting metabolic homeostasis of adipose tissue, the increased localized production of 
H2S may play important roles in regulating immune cells to mediate the effects of dietary 
interventions.   
 
Harnessing Adaptive Thermogenesis  
One other effect of pro-longevity dietary interventions is the activation of adipose 
tissue thermogenesis (Kim et al., 2017; Wanders et al., 2017). Brown adipose tissue (BAT) 
along with skeletal muscle are the main thermogenic organs in the body. BAT can generate 
heat by inducing energy-consuming futile cycles. Brown adipocytes express high amounts 
of mitochondria and the uncoupling protein 1 (UCP1) which allows the uncoupling of 
mitochondrial oxidative phosphorylation (OXPHOS) to generate heat instead of ATP 
(Kozak and Harper, 2000). BAT is mainly activated in response to cold, where sensory 
neurons expressing transient receptor potential cation channel subfamily M member 8 
(TRPM8) sense the cooling of the skin and signal to the central nervous system (CNS) 
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(Bautista et al., 2007). Within the CNS, sensory signals are conveyed to the hypothalamus, 
which integrates these signals to activate sympathetic signaling that directs 
vasoconstriction of cutaneous blood vessels to reduce heat loss through the skin (Bini et 
al., 1980), and subsequent activation of thermogenic organs to increase energy expenditure 
and generate heat via non-shivering mechanisms (Nakamura and Morrison, 2007, 2008). 
During early cold exposure, when non-shivering thermogenic mechanisms are insufficient 
to maintain body temperature, shivering thermogenesis mediated by the involuntary 
contraction of muscle primarily generates heat (Israel and Pozos, 1989). When cold 
exposure becomes chronic, reliance on shivering mechanisms is reduced and an increase 
in non-shivering thermogenic capacity by BAT and white adipose tissue (WAT) occurs 
(Betz and Enerback, 2018; Foster and Frydman, 1979). Indeed, acclimatization to cold 
increases the density of noradrenergic fibers to increase response to sympathetic signaling 
in both BAT and WAT (Chi et al., 2018; Murano et al., 2009). Furthermore, recent studies 
have reminded the field that current standard housing conditions for mice at 20-22°C are 
lower than their thermoneutral temperatures (28-33°C), such that mice are constantly in a 
state of chronic cold stress and activate adaptive thermogenesis (Gaskill et al., 2009). 
Accordingly, housing mice at 30°C reduces the activation of non-shivering thermogenesis, 
and comparison of housing at 20°C vs. 30°C suggests that nearly half of the total energy 
expenditure of mice at 20°C is utilized to maintain core body temperature (Skop et al., 
2020). In this way, BAT and WAT acts as adaptive thermogenic organs that allows 
maintenance of core body temperature in response to environmental temperatures.  
BAT is highly innervated by sympathetic nerve fibers and highly vascularized, 
allowing for its rapid activation by the CNS and dispersion of heat throughout the body via 
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the circulation (Rosell and Belfrage, 1979). In contrast to white adipocytes, brown 
adipocytes store lipids in multiple smaller lipid droplets and harbor a large number of 
mitochondria. While in rodents, BAT is prominently found in the interscapular region, in 
response to long term or repeated cold exposure, additional brown-like adipocytes called 
‘beige adipocytes’ are induced in the WAT, particularly in subcutaneous white adipose 
tissues (SFAT) (Wu et al., 2012). This process where there is an increase in thermogenic 
capacity of the SFAT is called ‘browning’ or ‘beiging’. UCP1 is uniquely expressed within 
the inner mitochondrial membrane of brown and beige adipocytes, and forms a channel 
allowing protons to flow into the mitochondrial matrix from the cytosol (Kozak and 
Harper, 2000). This uncouples the proton gradient of the electron transport chain, allowing 
for uncoupling of OXPHOS from ATP generation, ultimately converting energy stored as 
triglycerides into heat (Kozak and Harper, 2000). Activation of UCP1 begins with the 
stimulation of β3-adrenergic receptors on adipocytes by catecholamines released by 
sympathetic nerves (Jimenez et al., 2003). This leads to the upregulation of the thermogenic 
program including UCP1, and mitochondrial biogenesis by induction of peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) in a p38 mitogen-
activated protein kinase (MAPK) dependent manner (Cao et al., 2001). β3-adrenergic 
signaling also activates lipolysis through the action of protein kinase A (PKA), a cyclic 
AMP activated protein kinase (Fricke et al., 2004). PKA phosphorylates perilipin A and 
hormone-sensitive lipase (HSL), where phosphorylated perilipin A dissociates with lipid 
droplets and acts as a scaffold for the phosphorylation of HSL, which is involved in the 
cleavage of stored triglycerides into fatty acids and glycerol. Another adipose tissue lipase, 
adipose tissue triglyceride lipase (ATGL) also induces lipolysis semi-independently of 
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PKA, through its interaction with CGI-58 and perilipin 5 (Lass et al., 2006; Wang et al., 
2011a). ATGL favors triglycerides as substrates as it catalyzes the first rate-limiting step 
of lipolysis, whereas HSL is thought to primarily function more downstream as a 
diacylglycerol lipase (Bezaire et al., 2009; Haemmerle et al., 2002; Holst et al., 1996; 
Zimmermann et al., 2004). The released free fatty acids (FFAs) are then utilized as fuels 
for beta oxidation and to increase flux through the electron transport chain. As UCP1 acts 
as a long chain fatty acid (LCFA)/proton symporter, the release of long chain fatty acid 
anions and their association with UCP1 drives stable uncoupling of the electron transport 
chain (Fedorenko et al., 2012). And in a futile cycle as ATP production becomes 
uncoupled, accumulation of ADP continues to drive the activation of OXPHOS, further 
increasing heat production (Wikstrom and Springett, 2020).  
While UCP1 was long thought to be the primary mediator of non-shivering 
thermogenesis, the discovery that Ucp1-/- mice are able to adapt to long term cold exposure 
uncovered the possibility of alternative thermogenic mechanisms independent of UCP1 
(Ukropec et al., 2006). One such mechanism is through creatine futile cycling. Utilizing 
Ucp1 deficient animals, Kazak and colleagues identified increased levels of mitochondrial 
creatine kinases, CKMT1 and CKMT2, upon acute cold exposure, specifically in the beige 
adipocytes of browning WAT (Kazak et al., 2015). Blocking the transport of creatine 
reduced oxygen consumption in both human and Ucp1-deficient beige adipocytes, 
suggesting that mobilization of creatine in and out of the mitochondria were important for 
thermogenic respiration (Kazak et al., 2015). The conceptual framework behind the futile 
creatine cycle is as follows: mitochondrial creatine kinases are positioned within the inner 
mitochondrial membrane so that they can immediately utilize the ATP produced from 
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OXPHOS to phosphorylate creatine and generate phosphocreatine and ADP. However, 
through increased creatine transport, increased CKMT1 and CKMT2 activity drive an 
excess of ADP over ATP, driving increased respiration to produce additional ATP in a 
futile cycle (Kazak et al., 2015).  While limited expression of CKMT1 and CKMT2 to 
beige adipocytes might have suggested that creatine futile cycling was limited to browning 
WAT, recently, another mitochondrial creatine kinase, creatine kinase B (CKB) was found 
to drive creatine cycling in the BAT as well (Rahbani et al., 2021). Other studies have 
begun to identify roles for non-shivering thermogenesis in muscle resulting from calcium 
cycling by sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) where sarcolipin 
uncouples the hydrolysis of ATP from Ca2+ transport (Bal et al., 2012; Smith et al., 2002), 
or its expression of UCP1 and UCP3 (Riley et al., 2016). While UCP1-independent 
thermogenic mechanisms are still being discovered and verified, their redundancy 
highlights the importance of mechanisms to maintain and defend core body temperature.  
Given that cold-induced thermogenesis essentially increases energy expenditure by 
burning fat, there has been great interest in whether these pathways can be harnessed as 
therapeutic strategies in the context of obesity. Until the last decade, the presence of BAT 
in human adults had been controversial. However, once the existence of BAT was 
confirmed by multiple studies in 2009 (Cypess et al., 2009; Saito et al., 2009; van Marken 
Lichtenbelt et al., 2009; Virtanen et al., 2009), the therapeutic prospect of increasing 
browning processes as a means to reduce fat mass and improve metabolic homeostasis has 
gained much excitement. Given that human BAT exhibits more heterogeneous molecular 
signatures resembling both classic and beige adipocytes of mice (Sun et al., 2020), 
understanding the mechanisms that activate not only BAT, but also browning of WAT will 
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be important in developing novel therapeutic strategies.  BAT function decreases in rats as 
well as in humans with age and obesity (Cypess et al., 2009; McDonald and Horwitz, 1999; 
Pfannenberg et al., 2010; Saitoh et al., 2008; Vijgen et al., 2011). This decrease in 
thermogenic capacity with age is in part mediated by the NLRP3 inflammasome (Camell 
et al., 2019; Camell et al., 2017). Interestingly CR and MR delays the loss of BAT that 
occurs during aging and promotes thermogenesis of WAT (Valle et al., 2008; Wanders et 
al., 2015). Additionally, intermittent fasting of animals even on a high fat diet (HFD), 
where mice were fed HFD 2 days and fasted for 1day, increased WAT browning to improve 
metabolic homeostasis (Kim et al., 2017). The fact that thermogenesis is increased in the 
context of MR where mice are reported to increase their food intake may suggest that a 
decrease in caloric intake is not the driver of the shift from energy storage towards energy 
expenditure (Hasek et al., 2010). How and why these dietary perturbations lead to increased 
thermogenesis is poorly understood. Understanding the mechanisms that drive this 
response may lead to novel therapeutic strategies that can be targeted in lieu of undergoing 
broad dietary restrictions that are difficult to maintain.  
 
Immune Cells in Regulating Thermogenesis  
One emerging area of organismal regulation of thermogenesis is the crosstalk of 
different resident tissue cell types within the adipose tissues. As the homeostatic role of 
immune cells in adipose tissue have been continually characterized, some studies have 
revealed a role for immune cells in regulating thermogenic processes. For example, 
macrophages in close contact with the numerous sympathetic nerves that densely innervate 
the BAT and SFAT can control thermogenesis by controlling the bioavailability of 
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catecholamines (Camell et al., 2017; Chi et al., 2018; Pirzgalska et al., 2017). Inhibition of 
monoamine oxidase A (MAOA), an enzyme that degrades catecholamines such as 
norepinephrine (NE) and serotonin in macrophages, increased local NE content in adipose 
tissue, leading to increased lipolysis and thermogenesis by upregulation of UCP1 (Camell 
et al., 2017). Moreover, type 2 innate lymphoid cells (ILC2s), eosinophils, invariant natural 
killer (iNK) T and γδ T cells have also been implicated in increasing energy expenditure 
and UCP1 (Brestoff et al., 2015; Hu et al., 2020; Lynch et al., 2016; Qiu et al., 2014). 
Notably, FGF21, which gets induced during dietary restriction, can promote the expression 
of CCL11 by adipocytes to recruit eosinophils, suggesting that immune cells are actively 
recruited and regulated during adaptive adipose tissue remodeling (Huang et al., 2017). 
Conversely, a recent study has identified lymphocyte derived IL-10 to inhibit 
thermogenesis (Rajbhandari et al., 2019). Further studies are required to determine how 
exactly specific immune cells affect UCP1 and alternative thermogenic pathways; whether 
they act directly on adipocytes, or regulate other niche compartments such as the 
sympathetic nervous system or vasculature to control heat production are still unknown. 
Identification of such mechanisms may reveal strategies to divert the fate of dietary lipids 
from storage to heat production through increased mitochondrial uncoupling, thus reducing 
metabolic diseases emanating from lipotoxicity and obesity. 
 
FGF21 Integrates Amino Acid Starvation, ER Stress, and Metabolic Adaptations  
Changes in organismal nutritional state, such as starvation, ketogenic diet, or low 
protein diets drive the expression of FGF21, an endocrine fibroblast growth factor (FGF) 
(De Sousa-Coelho et al., 2013; Fazeli et al., 2015; Laeger et al., 2014; Reitman, 2007). 
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FGF21 is expressed in many organs, but the liver is the main contributor to circulating 
levels of FGF21 (Nishimura et al., 2000). Unlike other members in the FGF family, FGF21 
has reduced affinity for heparin sulfate, allowing for it to disperse and act systemically as 
an endocrine factor and integrate metabolic responses across multiple tissues including the 
liver, adipose tissue, skeletal muscle, pancreas, and the brain (Kharitonenkov et al., 2005). 
FGF21 controls glucose and lipid metabolism via binding to its receptor, β-Klotho in 
complex with its co-receptors FGFR1C, FGFR2C, and FGFR3C (Ogawa et al., 2007). In 
adipose tissue, FGF21 increases response to insulin by increasing the expression of glucose 
transporter GLUT1 (Ge et al., 2011), while also increasing energy expenditure through 
induction of PGC-1α and UCP1 (Fisher et al., 2012; Kwon et al., 2015). More specifically, 
FGF21 acts through β-Klotho receptors in the central nervous system to induce sympathetic 
activation of brown adipose tissue in a neuropeptide corticotropin-releasing factor (CRF)-
dependent manner (Bookout et al., 2013; Owen et al., 2014). In addition, FGF21 
administration in UCP1 KO mice revealed that FGF21 can promote weight loss and 
improve glycemic control in a UCP1 independent manner by reducing food intake (Samms 
et al., 2015).  
 In line with the increased expression of FGF21 during pro-longevity dietary 
interventions CR, PR, and MR, transgenic overexpression of FGF21 in mice leads to a 50% 
increase in median lifespan (Zhang et al., 2012). Interestingly, FGF21 seems to be 
responding specifically to restriction of protein intake, independently of energy intake, as 
CR diets and ketogenic diets supplemented with isocaloric amounts of protein blocked the 
induction of FGF21 (Laeger et al., 2014). More specifically, restriction of specific essential 
amino acids, as such in MR diets, is sufficient to drive robust expression of FGF21 
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(Wanders et al., 2017). Indeed, studies utilizing deprivation of leucine induced FGF21 
expression in a GCN2 and ATF4 dependent manner (De Sousa-Coelho et al., 2013). 
However, unlike leucine or BCAAR diets, MR also induces hepatic FGF21 and lipolytic 
gene signatures independently of GCN2 (Lees et al., 2017). Instead, MR specific hepatic 
changes are driven by PERK and glutathione depletion (Wanders et al., 2016), suggesting 
that besides GCN2-mediated ISR, endoplasmic reticulum (ER) stress and oxidative stress 
may play key roles in regulating FGF21 during amino acid starvation responses.  
 ER stress activates the unfolded protein response (UPR) which can signal through 
three separate branches, each representing distinct ER membrane proteins: PERK and 
ATF4, IRE1α and XBP1, and ATF6. These branches become activated when unfolded or 
misfolded proteins accumulate within the ER. Activation of PERK results in the 
phosphorylation of eIF2α and global translational arrest, leading to the activation of ATF4, 
which regulates the expression of genes involved in amino acid metabolism and anti-
oxidant defense (Pakos-Zebrucka et al., 2016). IRE1α activation leads to the transcription 
of the potently active form of XBP1, which drives the expression of genes involved in ER 
biogenesis and turnover (Iwakoshi et al., 2003; Yoshida et al., 2001). Finally, activation of 
ATF6 leads to its relocation to the Golgi where it is cleaved and is involved in the 
expression of chaperones (Adachi et al., 2008; Shen et al., 2002). Schaap and colleagues 
first showed that ER stress stimuli as well as overexpression of ATF4 can induce the 
expression of FGF21 in hepatocytes, identifying two ATF4 binding sites in the FGF21 
promoter (Schaap et al., 2013). This study suggested that FGF21 may be a downstream 
mediator of the PERK/ATF4/eIF2α branch of the ER stress-driven ISR. Indeed, FGF21 
deficient mice exhibited increased hepatic ER stress in response to postprandial and 
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tunicamycin-induced stress, indicating that FGF21 also directly plays a role in ameliorating 
ER stress (Maruyama et al., 2018). However, ATF4 is a broad effector of ISRs and also 
acts downstream of GCN2 mediated amino acid starvation responses (Harding et al., 2000). 
In addition to ATF4 driven FGF21, Jiang and colleagues found that IRE1α was required 
for the induction of FGF21 in the context of tunicamycin-induced ER stress as IRE1α KO 
mice had reduced FGF21 levels without altering ATF4 expression (Jiang et al., 2014). 
Furthermore, FGF21 directed ERK activation to suppress eIF2α-ATF4-CHOP, indicating 
that FGF21 can reduce ER stress and subsequent activation of alternative branches of the 
UPR program (Jiang et al., 2014). The fact that FGF21 is controlled by at least two 
branches of the UPR supports a role for FGF21 as a mediator of the UPR. Understanding 
the effector function of FGF21 within the context of ER stress response during pro-
longevity diets that have underlying amino acid restriction may lead to the discovery of 
novel physiological phenomena. 
 
Summary and Perspectives 
 Dietary interventions such as CR, PR, and MR extend lifespan and healthspan to 
delay the onset of age-associated chronic diseases and metabolic dysfunction. However, 
practicing these dietary interventions in daily life can be extremely difficult. Studying the 
mechanisms that drive the effects of these pro-longevity interventions can allow for the 
identification of novel therapeutic targets specific for different aspects of aging such as 
inflammation, metabolic perturbations, and immune dysfunction. In particular, the study 
of MR allows for a simplified model of amino acid restriction that still exhibits the benefits 
of the broader dietary restriction regimes such as CR and PR. Many of the metabolic 
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perturbations with age stem from alterations to adipose biology in part caused by increased 
chronic, low-grade inflammation. Investigating how different responses to pro-longevity 
dietary restrictions are integrated within the adipose tissue may yield the discovery of novel 
immunomodulatory metabolic pathways. In this study, we identify the induction of the 
TSP, a pathway involved in the catabolism of methionine to generate cysteine, as an 
intriguing node that may play an important role in modulating the effects observed during 
pro-longevity interventions. This project investigates the role of the TSP in regulating 
inflammation in the context of MR and aging (Chapter 2), and its action in regulating amino 
acid metabolism to maintain adipose tissue homeostasis (Chapter 3).    
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Chapter 2: Regulation of Inflammation by the Transsulfuration 
Pathway 
Introduction 
Despite methionine being an essential amino acid, studies by the Orentreich 
Foundation surprisingly found that restriction of methionine from 0.86% to 0.17% of the 
diet increased lifespan by up to 45% in rats (Orentreich et al., 1993).  Many follow-up 
studies have further established the effects of methionine restriction (MR) diet in delaying 
the onset of age-associated diseases, even when started in adult animals (Ables et al., 2012; 
Lees et al., 2014; Miller et al., 2005; Richie et al., 1994). However, there has been a lack 
of studies exploring the role of MR in regulating inflammation to mediate its effects as a 
pro-longevity intervention. Large scale transcriptomics analysis comparing 20 months 
caloric restriction (CR) and MR across subcutaneous fat (SFAT), brown adipose tissue 
(BAT), liver, and skeletal muscle in mice suggested proinflammatory signaling pathways 
were down-regulated in the SFAT and liver of MR mice (Ghosh et al., 2014; Wanders et 
al., 2014). However, these studies were mostly limited to highlighting pathways involved 
with immune recruitment, accumulation, and activation, rather than actual inflammatory 
signatures, and subsequent follow-up studies have failed to confirm and identify clear 
mechanisms that regulate this reduction in inflammatory profile (Sharma et al., 2019).  
One important driver of inflammation in the context of age and metabolic diseases 
such as obesity and atherosclerosis is the NLRP3 inflammasome (Duewell et al., 2010; 
Vandanmagsar et al., 2011; Youm et al., 2013).  Whether MR can regulate NLRP3 
inflammasome activation has not been established. Methionine restriction in rats and mice 
decreases serum methionine and cysteine levels (Elshorbagy et al., 2010; Mentch et al., 
2015). Methionine is an essential amino acid (EAA) that generates s-adenosyl methionine 
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(SAM), homocysteine, cysteine, creatine, carnitine, and succinyl-coA.  Accordingly, MR 
driven autophagy has been found to be required for lifespan extension in yeast 
(Ruckenstuhl et al., 2014). Autophagy is a known negative regulator of NLRP3 
inflammasome. Zhou et al initially showed that mitochondrial ROS drives increased 
NLRP3 activation, and disruption of autophagy led to the accumulation of damaged 
mitochondria and mitochondrial ROS (Zhou et al., 2011). In addition to mitochondrial 
ROS, DNA released for damaged mitochondria also activates the NLRP3 inflammasome 
(Nakahira et al., 2011). During NLRP3 inflammasome activation, damaged mitochondria 
get ubiquitinated by the E3 ubiquitin ligase Parkin, and removed in a p62 dependent 
manner by selective autophagy (Zhong et al., 2016). Besides damaged mitochondria, 
NLRP3 inflammasome components can also be directly targeted for degradation. NLRP3 
complexes co-localize with autophagosomes, and ASC in the context of the AIM2 
inflammasome complex has been shown to be ubiquitinated, and removed in a p62 
dependent manner (Shi et al., 2012). This interaction of the NLRP3 complex with p62 via 
ASC has been suggested to be dependent on phosphorylation of NLRP3, as NLRP3 lacking 
the phosphorylation site does not interact with p62 and subsequently does not get 
sequestered into the phagosome (Spalinger et al., 2016). These studies have established 
that autophagy of NLRP3 inflammasome components and activators such as damaged 
mitochondria serve as a negative feedback mechanism to prevent excessive inflammation.  
Whether these pathways play a role in regulating inflammation during MR remains to be 
investigated.  
Alternatively, the transsulfuration pathway (TSP) also gets induced during MR 
(Hine et al., 2015; Wang et al., 2019b). The transsulfuration pathway allows for the 
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synthesis of cysteine from methionine (Jackson and Block, 1931). During MR, circulating 
cysteine levels are reduced, and the TSP likely gets activated to generate cysteine 
(Elshorbagy et al., 2010). One of the byproducts of TSP activation is hydrogen sulfide 
(H2S), a gaseous molecule. H2S is produced by cystathionine β-synthase (CBS), and 
cystathionine γ-lyase (CSE), cysteine aminotransferase (CAT), and 3-mercaptopyruvate 
sulfurtransferase (MPST) (Moore et al., 2003). While a role for H2S has been studied in 
various contexts of inflammatory diseases, there have been mixed reports of the role of 
H2S in either inducing or reducing inflammation in the context of pancreatitis, endotoxemia 
and sepsis, edema, colitis, and burn induced injury (Bhatia, 2015). Given that the role of 
H2S in regulating macrophage mediated inflammation was largely unexplored at the start 
of this project, we aimed to explore the role of TSP and H2S in regulating NLRP3 mediated 
inflammation.  
 Cryopyrin-associated periodic syndromes (CAPS) are rare hereditary 
autoinflammatory conditions, clinically characterized by fever and systemic inflammation 
of the subcutaneous skin, joints, the musculoskeletal system, and the central nervous 
system. These conditions are caused by autosomal dominant mutations in the NLRP3 gene 
(Cuisset et al., 1999; Sarrauste de Menthiere et al., 2003). These mutations are mostly 
located within the NACHT domain (Dode et al., 2002), which includes a nucleotide 
binding domain (NBD) (MacDonald et al., 2013). There is a spectrum of NLRP3 driven 
autoinflammatory diseases including familial cold autoinflammatory syndrome (FCAS), 
Muckle-Wells syndrome (MWS), and neonatal-onset multisystem inflammatory disease 
syndrome (NOMID), with FCAS being the least severe, and NOMID being the most severe 
in neonates and young children (Neven et al., 2008). MWS patients present with clinical 
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features similar to FCAS, with periodic fever, chills, and severe fatigue and arthritis, 
oftentimes being diagnosed when they develop hearing loss. In MWS patients, gain of 
function mutations in the NACHT domain of the NLRP3 gene leads to excessive activation 
of the NLRP3 inflammasome (Agostini et al., 2004; Chae et al., 2011). How downstream 
negative regulatory loops are regulated in CAPS patients not well established. Moreover, 
during sepsis and endotoxemia, overwhelming proinflammatory responses drive 
multiorgan damage or failure. This proinflammatory response is driven by the concerted 
action of numerous immune cells and involves NLRP3 inflammasome activation (Anand 
et al., 2011; Danielski et al., 2020). In this chapter, we aim to understand whether MR 
regulates inflammation, specifically mediated by the NLRP3 inflammasome, and whether 
MR can be harnessed to ameliorate NLRP3 mediated diseases such as MWS and sepsis 
associated endotoxemia.  
 
Results 
P62 independent autophagy inhibits inflammasome activation during methionine and 
cysteine restriction. 
To test whether reduction in systemic SAAs could influence inflammasome mediated 
inflammation, bone marrow derived macrophages (BMDMs) were cultured in media 
lacking methionine and cysteine. Using LPS as the priming signal 1 that drives 
transcription of the inflammasome complex, and ATP as the DAMP that serves as signal 2 
that drives the assembly of the NLRP3 inflammasome, we observed a decrease in 
inflammasome activation observed by reduced IL-1β and caspase-1 (casp-1) cleavage 
when methionine and cysteine were restricted acutely at the time of LPS treatment (Fig 
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2.1A). Given that methionine is an essential amino acid that cannot be synthesized, and 
cysteine is a conditional essential amino acid that is synthesized from methionine and 
serine, macrophages rely on the import of SAAs via SLC7A5 and SLC7A11 (Sato et al., 
1999; Yoon et al., 2018).  To understand whether induction of autophagy induced by the 
lack of environmental EAAs was mediating the reduction in inflammasome activation, 
BMDMs were treated with the class III phosphatidylinositol 3-kinase autophagy inhibitor 
3-methyladenine (3-MA) during methionine and cysteine restriction. Indeed, inhibition of 
autophagy reversed the reduction of inflammasome activation, suggesting that autophagy 
is mediating the anti-inflammatory effects of methionine and cysteine restriction (Fig 
2.1B). Some of the effects of autophagy on inflammasome mediated inflammation are 
dependent on mitochondrial removal (Harris et al., 2011; Zhong et al., 2016). NLRP3 
inflammasome activation leads to the accumulation of defective mitochondria and 
increased mitochondrial ROS production and DNA release, which gets removed by p62 
mediated mitophagy to prevent excessive inflammasome activation (Nakahira et al., 2011; 
Zhong et al., 2016; Zhou et al., 2011). To understand whether methionine and cysteine 
restriction induced p62 mediated mitophagy to reduce inflammation, the NLRP3 
inflammasome was activated in BMDMs lacking p62 in the presence or absence of SAAs.  
Interestingly, despite an increase in inflammasome activation caused by p62 deficiency 
alone, methionine and cysteine restriction still reduced inflammasome activation in p62 
deficient macrophages, suggesting that the methionine and cysteine restriction was 
independent of p62 driven mitophagy (Fig 2.1B). Furthermore, methionine and cysteine 
restriction did not alter potassium efflux, suggesting that the autophagy mediated effects 
were downstream of the inflammasome assembly trigger, potassium efflux (Fig 2.1 C). We 
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next tested the impact of methionine and cysteine restriction in a mouse model of 
constitutively active NLRP3, where a mutation found in MWS patients was knocked into 
the Nlrp3 gene (Nlrp3A350VneoR) (Brydges et al., 2009). The mutation found in the NACHT 
region of the Nlrp3 gene, causes auto-assembly of the inflammasome once it is expressed, 
even in the absence of a signal 2 trigger. We found that culturing BMDMs from 
Nlrp3A350VneoR mice in the absence of methionine and cysteine restriction still reduced 
inflammasome activation, observed by decreased IL-1β cleavage and secretion (Fig 2.1 D). 
Since the Nlrp3A350VneoR mutation leads to auto-assembly of the inflammasome complex 
even in the absence of any secondary signals, methionine and restriction driven autophagy 
likely reduces inflammasome activation by increasing the clearance of NLRP3 complex 
components.  
Exogenous hydrogen sulfide inhibits inflammasome activation 
In addition to autophagy, the TSP is increased in the liver during MR, specifically by an 
increase in the expression of CSE (Fig 2.4A). To understand whether intrinsic TSP might 
directly regulate inflammasome activation, we first explored whether macrophages express 
CSE, the enzyme required for the last step of cysteine production within the TSP. Although, 
some studies suggest that CSE is induced in macrophages in the context of bacterial 
infection (Gobert et al., 2019), we find that BMDMs in M1 (LPS + IFNγ) or M2 (IL-4) 
polarization conditions do not express CSE (Fig 2.2A). Preliminary experiments in 
peritoneal macrophages had suggested that CSE may be induced with thioglycollate 
stimulation (Fig 2.3A). However, confirmation with Cth-/- mice revealed that these bands 
were nonspecific (Fig 2.2B). Gene expression analysis of PBS or thioglycolate induced 
peritoneal macrophages did not detect Cth or Cbs expression (data not shown).  
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Furthermore, published RNA-seq data sets from the ImmGen consortium suggest little to 
no expression of Cth in various tissue macrophages (Fig 2.3C) (Heng et al., 2008). These 
analyses establish that macrophages lack cysteine synthesis machinery, and likely import 
cysteine/cystine extracellularly to maintain cellular homeostasis. Given the lack of CSE 
expression in macrophages, we explored the effects of exogenously provided H2S in 
regulating inflammasome activation. We found that treatment with sodium hydrosulfide 
(NaHS), a H2S donor, reduced Il-1β secretion in a dose dependent manner (Fig 2.2B). 
Given reports that H2S can modify NF-κB to regulate its role in the transcription of 
antiapoptotic pathways (Sen et al., 2012), and the role of NF-κB in priming inflammasome 
activation by transcription of NLRP3 components, Nlrp3, Il1b, and Il18, we investigated 
whether transcription of NF-κB targets were altered. However, we find that transcription 
of Nlrp3, Il1b, or Il18 is not changed by exogenous H2S during inflammasome activation 
(Fig 2.2C). Additionally, potassium efflux is not affected with H2S treatment, suggesting 
that detection of secondary DAMP signals is not altered by H2S (Fig 2.2 D). Interestingly, 
H2S treatment is unable to reduce inflammation in Nlrp3
A350VneoR BMDMs, suggesting that 
H2S may be acting during the assembly of the NLRP3 inflammasome complex.  
Methionine restriction improves metabolic health and reduces inflammation during 
aging 
To investigate the effects of MR in vivo, we fed young, 8-week-old mice and old, 18-
month-old mice MR diet for three months. We find that MR prevents weight gain in both 
young and old animals (Fig 2.4 A-B). This reduction in weight gain aligns with a reduction 
in adiposity, with reduced subcutaneous fat (SFAT) mass (Fig 2.4C), visceral epididymal 
fat (EFAT) mass (Fig 2.4D), and lipid content in the liver (Fig 2.4G).  Additionally, MR 
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animals had improved glucose and insulin sensitivity (Fig 2.4E-F), suggesting that MR can 
improve metabolic health, even when started in already aged animals. Consistent with prior 
studies that have shown that macrophages are the main drivers of inflammation in adipose 
tissue of aged mice (Camell et al., 2017; Lumeng et al., 2011; Wu et al., 2007), MR reduced 
EFAT macrophages in both young and old animals, while to a lesser degree, macrophages 
were reduced in the SFAT in young animals with MR (Fig 2.4H-I). Additionally, 
transcription of inflammatory cytokines, IL-1β and IL-6 were reduced in the retroperitoneal 
fat (RPFAT), a visceral adipose depot, with 3 months MR (Fig 2.4J). Similarly, gene 
expression of NLRP3 inflammasome components, Il1b, Nlrp3, and Il6 is also reduced in 
the SFAT of animals that underwent PR (Fig 2.4K). However, reduction in inflammation 
was only observed in the RPFAT of young animals, but not old animals (Fig 2.4J, 2.5E). 
To understand these results, we investigated the expression of the TSP in young and old 
animals. We find that regulation of the TSP during MR is tissue dependent. CSE is most 
highly expressed in the liver and kidney in mice (Fig 3.3C). In response to MR, CSE is 
induced specifically in the liver but not the kidney (Fig 2.5A-B). In the RPFAT, expression 
of CSE is not changed, but MR increases the expression of CBS, another TSP enzyme that 
can generate H2S, in young animals, but not old animals (Fig 2.5C-D). This specific 
increase in the expression of TSP in young animals is consistent with the decreased 
expression of inflammatory cytokines in young animals. Additionally, though RPFAT is a 
visceral adipose depot, the contribution of inflammation in RPFAT towards systemic 
metabolism has not been well characterized. How inflammation and TSP is being regulated 
in other visceral adipose depots such as EFAT, and liver during MR in young and old 
animals may be more relevant to the systemic metabolic changes that are observed.  
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Methionine restriction fails to reduce inflammation in models of NLRP3 
inflammasome activation 
In order to determine whether MR can reduce inflammation in pathological states we 
turned to in vivo models of MWS and acute endotoxemia. Inducible Nlrp3A350VneoR/+ CAG-
cre mice were fed MR diet 1 week prior to tamoxifen treatment. Mice were injected with 
tamoxifen once daily for two days. Nlrp3A350VneoR/+ CAG-cre mice begin to lose weight 
rapidly and in severe cases begin to die (Fig 2.6A). There was no difference in weight loss 
between CTRL and MR fed animals (Fig 2.6A). Despite reduced splenomegaly due to 
inflammation in MR fed animals (Fig 2.6B), parameters of inflammation such as gene 
expression of NLRP3, Casp-1, IFN-γ, TNFα, and IL-18 were not decreased in the spleen, 
and if anything, IL-1β was increased with MR (Fig 2.6C). Furthermore, there were no 
differences in serum levels of IL-1β, IL-6, TNF, and MCP-1 between CTRL and MR fed 
animals (Fig 2.6D). We next tested the impact of MR in a model of acute endotoxemia, 
where young WT mice were injected intraperitoneally (i.p.) with lipopolysaccharide (LPS) 
for four hours after being on CTRL or MR diet for three months. Compared to CTRL diet 
fed animals, MR fed mice showed no differences in metabolic parameters such as decreases 
in blood glucose (Fig 2.6E), core body temperature (CBT) (Fig 2.6F), or systemic 
inflammation, measured by serum IL-1β, IL-6, TNF, and MCP-1 (Fig 2.6G). These results 
suggest that short- and long-term MR may be insufficient to reduce inflammation in 
NLRP3 inflammasome mediated pathological states.  
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Summary and Discussion 
Through in vitro studies utilizing BMDMs, we find that MR can reduce NLRP3 
inflammasome mediated inflammation through two separate mechanisms: the first through 
induction of autophagy due to decreases in systemic SAAs. This induction of autophagy is 
independent of p62 mitophagy, suggesting that SAA restriction may reduce mitochondrial 
ROS through alternative mechanisms. SAA restriction can reduce NLRP3 mediated 
inflammation even in a MWS model of constitutively active NLRP3, indicating that SAA 
restriction mediated autophagy may act downstream of inflammasome assembly, 
potentially through increased degradation of inflammasome components. Some groups 
have shown that pro-IL-1β can be degraded intracellularly by autophagy and proteosomes 
to reduce IL-1β release (Ainscough et al., 2014; Harris et al., 2011). Indeed, pro IL-1β is 
reduced with SAA restriction in an autophagy dependent manner (Fig 2.1B), suggesting 
that increased degradation of pro-IL-1β can also be playing a role in the reduction of 
inflammasome activation during SAA restriction.  
 Besides the activation of autophagy to reduce NLRP3 mediated inflammation, we 
find that exogenously produced H2S can act on macrophages to reduce inflammasome 
activation. This action of H2S is independent of the transcriptional activity of NF-κB in 
response to signal 1, unlike what has previously been shown about the action of H2S on 
NF-κB regulation of antiapoptotic pathways in response to inflammation (Sen et al., 2012). 
Instead, the action of H2S seems to be downstream of sensing of signal 2 and potassium 
efflux, potentially regulating the assembly of the inflammasome complex. H2S can act 
regulate enzymatic activity by posttranslational modification of reactive cysteine thiol 
groups in a process called sulfhydration (Paul and Snyder, 2015). Particularly of interest, 
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many different posttranslational modifications (PTMs) have been detected in NLRP3 and 
have been found to play important roles in NLRP3 inflammasome activation (Shim and 
Lee, 2018). Besides PTMs involved in the phosphorylation and ubiquitination of NLRP3, 
other known PTMs involve modifications of cysteine thiol groups. One of these PTMs 
include alkylation, which was first reported by Juliana et al where inhibitors such as Bay11-
7082 acted through direct alkylation of NLRP3 (Juliana et al., 2010). Cys419, which 
resides in the ATPase catalytic pocket of NLRP3 has been predicted as a potential 
alkylation site (Cocco et al., 2016), which is consistent with reduced ATP binding affinity 
and reduced ATPase activity of NLRP3 post-alkylation (He et al., 2014; Juliana et al., 
2010). This ATPase activity is important for the oligomerization of NLRP3 with itself as 
well as with ASC (Duncan et al., 2007). More recently, diarylsulfonylurea NLRP3 
inhibitors such as MCC950/CRID3 was shown to bind to the ATP binding pocket of the 
NACHT domain (Walle et al., 2019). Subsequently, MCC950/CRID3 was unable to reduce 
circulating IL-1β and IL-18 in CAPS models of mice where there are mutations in the 
NACHT domain (Walle et al., 2019). Given that H2S was unable to reduce inflammasome 
activation in BMDMs modeling MWS (Nlrp3A350VneoR), H2S may similarly be acting in the 
ATP binding pocket to regulate ATPase activity and assembly of inflammasome. More 
recently, the itaconate derivative, 4-OI was shown to alkylate NLRP3 to block interaction 
with NEK7, and could reduce inflammasome activation in human CAPS peripheral blood 
mononuclear cells (PBMCs) (Hooftman et al., 2020). Unlike H2S, 4-OI is much larger, and 
likely creates steric hindrance to prevent NLRP3 binding with its binding partners.  
 In addition to our work, other groups have independently found a role for H2S in 
regulating NLRP3 inflammasome activation. Castelblanco et al. found in BMDMs and 
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THP1 cells that H2S treatment via sodium thiosulfate or GYY4137 inhibited MSU or 
nigericin induced inflammasome via blocking ASC oligomerization (Castelblanco et al., 
2018). However, another study investigating H2S action on human PBMCs and THP1 cells 
found that NaHS treatment contrarily increased the production of IL-1β and IL-18 (Basic 
et al., 2017). This last study treated cells with 1mM NaHS which is an extremely high dose 
of H2S. And while physiological and toxic levels of H2S have been controversial given 
the volatile nature of H2S, making it difficult to accurately measure, these studies 
reinforce the notion that a tight balance of H2S is required to modulate inflammation and 
studies manipulating H2S intrinsically, rather than the use of extrinsic donors, will be 
important to understand the role of H2S physiologically.  
 In line with the in vitro results identifying potential pathways to regulate 
inflammation during MR, we found improved metabolic health in both young and old 
animals that underwent 3 months MR. In the adipose tissue, there was a reduction of 
macrophages, the major expressors of NLRP3 inflammasome with MR and a reduction in 
the expression of NLRP3 mediated inflammatory components in adipose tissue with MR 
and PR. However, this reduction in adipose tissue inflammation was limited to young 
animals and not old animals when the RPFAT was examined. Consistently, TSP was only 
upregulated in the RPFAT of young animals with MR, suggesting that local production of 
H2S may have mediated the specific reduction of inflammation in young animals. 
However, old animals expressed higher basal levels of CBS in the RPFAT on CTRL diet, 
indicating that absolute expression of TSP genes alone cannot predict inflammatory status 
in adipose tissue. Importantly, we were unable to evaluate inflammation and the TSP in 
gonadal visceral tissues in this study, which play important roles in metabolic decline with 
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age (Camell et al., 2019; Camell et al., 2017; Lumeng et al., 2011; Morris et al., 2013). 
Whether MR can reduce inflammation in tissues that are associated with systemic 
metabolic homeostasis such as EFAT and liver to mediate the improved metabolic 
parameters in aged animals needs to be further investigated. 
 Finally, short- and long-term MR diet was unable to reduce inflammation in the in 
vivo models of MWS-NLRP3 inflammasome activation and endotoxemia. Both of these 
models involve acute activation of the NLRP3 inflammasome, whereas aging is 
characterized by more chronic low-grade inflammation. Thus, MR as an intervention may 
not be able to induce autophagy and TSP to levels required to restrict large scale acute 
inflammation.  
 In conclusion, we find that pro-longevity interventions such as MR has the potential 
to reduce NLRP3 inflammasome activation through induction of autophagy and the TSP. 
MR and PR can indeed reduce NLRP3 associated cytokines, IL-1β and IL-6 in the adipose 
tissue of young animals, and improve metabolic parameters, even when started at an old 
age, when age-associated inflammation and metabolic deterioration has already begun. 
However, MR is unable to reduce inflammation in the context of acute strong inflammatory 
stimuli such as CAPS and endotoxemia. Whether the pathways identified from our in vitro 
studies can be further harnessed to reduce inflammation in a broader context of 
inflammatory disease needs to be further investigated.  
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Figures 
 
Figure 2. 1 Methionine and cysteine restriction drives autophagy to reduce 
inflammasome activation. 
A) Differentiated BMDMs were switched to culture media containing or lacking methionine and cysteine 
and stimulated with LPS for 4 hours and ATP for an additional 1 hour. Caspase 1 and IL-1β were detected 
by western blot of lysate and supernatant. B) WT and p62 KO BMDMs were switched to culture media 
containing or lacking methionine and cysteine and stimulated with LPS for 4 hours and ATP for an 
additional 1 hour with or without the treatment of 3-MA. IL-1β cleavage was detected in the lysates by 
western blot. C) Intracellular potassium levels were detected in BMDMs cultured with or without 
methionine and cysteine during LPS and ATP mediated inflammasome activation. D) Nlrp3A350VneoR 
Cag-cre BMDMs were activated with 4-OHT (Tam) and cultured in the presence or absence of 
methionine and cysteine during LPS and ATP mediated inflammasome activation. IL-1β was detected 
in lysates and supernatant by western blot. Data representative of at least 3 independent experiments, 
with the exception of p62 KO BMDM experiments, which was only repeated twice. C) Data expressed 
as mean±SEM. Statistical differences were calculated by unpaired t-test. *p<0.05, **p<0.01, ***p<0.001 
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Figure 2. 2 Exogenously produced hydrogen sulfide inhibits inflammasome 
activation. 
 
A) Differentiated BMDMs were untreated (M0), or polarized with LPS and IFNγ (M1), or IL-4 (M2) for 
24 hours. CSE was detected by western blot, with liver lysate as a control. B) BMDMs were treated with 
0, 10, 50, 100uM of NaHS with 4 hour LPS and 1 hour ATP stimulation. IL-1β was detected in lysate 
and supernatant by western blots. C) BMDMs were treated with 0, 10, 50, 100uM NaHS and stimulated 
with LPS for 4 hours. Inflammasome gene transcripts were quantified by qPCR with Gapdh as the 
reference gene. D) Intracellular potassium levels were detected in BMDMs cultured with increasing 
concentrations of NaHS during LPS and ATP stimulation. E) Nlrp3A350VneoR Cag-cre BMDMs were 
activated with 4-OHT and cultured with increasing NaHS with LPS stimulation. IL-1β was detected in 
lysates and supernatant by western blot. Data representative of at least 3 independent experiments. C-D) 
Data expressed as mean±SEM. Statistical differences were calculated by unpaired t-test. *p<0.05, 
**p<0.01, ***p<0.001 
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Figure 2. 3 CSE is not expressed in macrophages 
A) Expression of CSE in PBS and thioglycollate induced peritoneal macrophages 
measured by western blot. B) Western blot expression of CSE in Cth+/+ and Cth-/- in 
thioglycollate induced peritoneal macrophages shows band is nonspecific. C) RNA-
seq expression of Cth expression in various macrophage and stromal populations 
from the ImmGen Consortium.  
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Figure 2. 4 MR reduces inflammation in vivo. 
A) Body weight curves of young and old mice on Ctrl or MR diets over 12 weeks (n=10,10,7,5/group). 
B) Percent gain in body weight over 13.5 weeks quantified. Dissected C) SFAT and D) EFAT mass 
normalized to body weight. E) GTT post 14 hours fasting and glucose bolus IP in young and old animals 
after 12 weeks Ctrl or MR diet. F) ITT post 4 hour fast and insulin IP after 13 weeks Ctrl or MR diet. 
G) H&E histology sections of liver in young and old animals fed 13.5 weeks CTRL or MR diet. White 
scale bar represents 50um. H) Representative FACs panel of CD11b+ F4/80+ macrophages gated on 
CD45+ CD3- B220- Siglec F- cells in EFAT. I) Macrophage populations gated as in H) quantified in 
EFAT and SFAT. J) Inflammatory cytokines measured by qPCR in RPFAT in young animals fed 13.5 
weeks Ctrl or MR diet. K) Inflammatory genes measured by qPCR in SFAT of animals after 6 months 
PR. (I) Each data point is representative of 2 animals pooled. Data expressed as mean±SEM. Statistical 
differences were calculated by (A, E-F) 2-way ANOVA with Sidak’s correction for multiple 
comparisons and (B-D, I-K) unpaired t-test. *p<0.05, **p<0.01, ***p<0.001 
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Figure 2. 5 CSE expression during MR and inflammation in old adipose tissue. 
 
A) Expression of CSE detected by western blot in liver of young and old animals fed Ctrl and MR diets 
for 13.5 weeks. B) Expression of CSE detected by western blot in kidney of young and old animals fed 
Ctrl and MR diets for 13.5 weeks. Expression of C) Cth and D) Cbs in RPFAT of young and old animals 
fed Ctrl and MR diets for 13.5 weeks. E) Inflammatory cytokines measured by qPCR in RPFAT in old 
animals fed 13.5 weeks Ctrl or MR diet. Data expressed as mean±SEM. Statistical differences were 
calculated by unpaired t-test. 
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Figure 2. 6 MR fails to reduce inflammation in models of MWS and LPS. 
 
A) Body weight curves during daily tamoxifen injections after 1 week Ctrl or MR diet in Nlrp3A350VneoR 
Cag-cre mice. B) Spleen weights in Nlrp3A350VneoR Cag-cre mice after 2 days of tamoxifen injections in 
mice fed Ctrl or MR diet. C) Expression of inflammatory genes in the spleen of Nlrp3A350VneoR Cag-cre 
mice measured by qPCR. D) Inflammatory cytokines measured by Luminex in the serum of 
Nlrp3A350VneoR Cag-cre post tamoxifen injection. E) Percent changes in blood glucose levels after 4 hours 
of PBS or LPS IP in mice fed Ctrl or MR diet for 3 months. F) Percent changes in core body temperature 
after 4 hours of PBS or LPS IP in mice fed Ctrl or MR diet for 3 months. G) Inflammatory cytokines 
measured by Luminex in the serum after 4hour PBS or LPS IP. Data expressed as mean±SEM. Statistical 
differences were calculated by (A-B, D-G) 2-way ANOVA with Sidak’s correction for multiple 
comparisons and (C) unpaired t-test. *p<0.05, **p<0.01, ***p<0.001 
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The transsulfuration pathway (TSP) is induced during dietary interventions such as caloric 
restriction (CR) and methionine restriction (MR) (Hine et al., 2015; Mitchell et al., 2016). 
These diets are associated with improved metabolic health, increased energy expenditure 
(EE), and reduced adiposity (Bruss et al., 2010; Hasek et al., 2010).  While the effects of 
one of the TSP byproducts, H2S, has garnered much attention as discussed in Chapter 2, 
the molecular basis driving the induction of the TSP has not been studied. In this chapter, 
we aim to investigate the basis for TSP induction, to further the understanding of 
mechanisms that drive metabolic adaptations caused by sulfur amino acid (SAA) restriction 
and its impact on organismal energy expenditure.  
Results 
Human calorie restriction induces the transsulfuration pathway in response to 
reduced cysteine derived metabolites 
To study the mechanisms that drive CR effects in human adipose, we analyzed the 
subcutaneous adipose tissue (SFAT) of eight participants that maintained CR for 2 years 
and provided biopsies at baseline, 12 months, and 24 months (Fig 3.1A). Transcriptomic 
analyses of these tissues revealed that CR increased expression of CTH, which encodes for 
the enzyme that catalyzes the synthesis of cysteine from cystathionine (called cystathionine 
γ-lyase, or CSE) (Fig 3.1B). We observed a simultaneous reduction in the expression of 
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BHMT, which encodes for betaine-homocysteine S-methyltransferase, and converts 
homocysteine to methionine, away from cysteine production by the TSP (Fig 3.1B). This 
suggested an activation of the transsulfuration pathway (TSP) to shift SAA metabolism 
towards cysteine production (Fig3.1D). To understand the activation of the TSP during CR, 
we analyzed the metabolites of SFAT after 12 months CR via metabolomics. In line with 
the reduced expression of BHMT, we identified a reduction in dimethylglycine (DMG), a 
byproduct of BHMT. Notably, while metabolites upstream of cysteine such as 
cystathionine, homocysteine, S-adenosylhomocysteine (SAH), S-adenosylmethionine 
(SAM), and methionine were not changed, we found that CR reduced cysteine derived 
metabolites including cysteine, γ-glutamyl-cysteine (γ-Glu-Cys), glutathione (GSH), and 
cysteinylglycine (Cys-Gly) (Fig3.1C). Collectively, these results suggest that sustained CR 
in humans causes activation of the TSP as a metabolic response to maintain cysteine its 
downstream metabolites (Fig 3.1.D). 
Cysteine deficiency drives rapid loss of adipose tissue through an increase in energy 
expenditure.  
 To assess whether cysteine depletion plays an integral role in driving CR effects, 
we developed a model to induce cysteine deficiency in mice. Cysteine is a conditionally 
essential amino acid, because cysteine can be generated by CSE. We developed Cth-/- mice 
which lack CSE, and can therefore no longer produce cysteine, creating a model where 
cysteine has to be sourced from the diet. Cysteine deficiency was thus induced by feeding 
Cth-/- mice a custom amino acid diet that contains (CTRL diet) or lacks cystine (CysF diet) 
as a dietary cysteine source (Appendix 1, Fig 3.2A). The CTRL and CysF diets are 
isocaloric with almost equal ratios of macronutrients, and equal amounts of all other 
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essential amino acids. Cystine was replaced with cornstarch in the CysF diet (Appendix 2), 
but this replacement shifts the balance of calories between protein and carbohydrates by 
less than 1%. Therefore, feeding Cth-/- a CysF diet produces a unique model of systemic 
cysteine deficiency. 
Utilizing this model, we found that mice with cysteine deficiency rapidly lost ~25-
30% body weight within 1 week compared to littermate Cth+/+ fed a CysF diet or Cth-/- fed 
a CTRL diet (Fig 3.2B). Due to severe weight loss, mice are required to be euthanized 
within one week. Despite rapid weight loss, mice remained active and did not display any 
sickness behavior. This weight loss is associated with significant loss of fat mass relative 
to lean mass (Fig 3.2C).  This response is sex-independent, with female cysteine deficient 
animals losing weight at equal rates to males (Fig 3.3, B). In wild type mice, Cth expression 
is highest in the liver and kidney, with much lower expression found in the adipose tissues 
and brain (Fig 3.3C). In order to determine whether tissue specific expression of Cth was 
important to maintain systemic cysteine levels and prevent cysteine deficiency, we 
generated Cthflox/flox animals (Fig 3.3D). Depletion specifically in the liver (Fig 3.3E-F), or 
adipose tissue (Fig 3.3H-I) was insufficient to drive rapid weight loss, suggesting that the 
expression of Cth in multiple tissues could compensate for a loss of Cth expression in a 
specific tissue (Fig 3.3 G, J). In addition, Cth-/- animals co-housed together with Cth+/+ 
mice still maintained weight loss when fed a CysF diet, suggesting that microbiota is not 
the driving factor of this weight loss (Fig 3.3K). In all, these results highlight that redundant 
expression of Cth across multiple tissues defend systemic cysteine levels; loss of cysteine 
maintenance causes severe weight and fat loss in a sex and microbiota-independent 
manner.  
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Consistent with a loss of fat mass, cysteine deficient animals increased their 
normalized energy expenditure (EE) compared to CTRL diet fed animals, particularly 
during the dark cycle (Fig 3. 2B). However, the representation of whole-body energy 
expenditure has been highly debated within the metabolism field, and normalizing 
metabolic rate to body mass has been criticized because it overcompensates for the mass 
effect, leading to potential misinterpretation of actual biology (Tschop et al., 2011). 
Instead, calculation of the analysis of covariance (ANCOVA) or representation of the data 
as regression between energy expenditure and body mass, have been proposed as better 
methods for comparing differences in metabolic rates (Tschop et al., 2011). However, these 
methods have been shown to generate spurious results when mice display no overlap of 
body weight between groups (Fernandez-Verdejo et al., 2019), such as is between the 
Cth+/+ and Cth-/- mice fed CysF diet. Indeed, typical light and dark cycle EE averages for 2 
days against body mass did not allow for proper comparison of the regression of the two 
groups, due to a lack of overlap between the two data sets (Fig 3.4 C). Similarly, regression 
of EE of the light cycle over 2 days against body mass is not significantly different between 
Cth+/+ and Cth-/- mice (Fig 3.4A). But notably, comparison of the regression of EE during 
the dark cycle between Cth+/+ or Cth-/- mice is significantly different, suggesting that EE is 
indeed increased in cysteine deficient animals during the dark cycle (Fig 3.4B). These 
results are consistent with normalized EE shown in Fig 3.2D-E. Careful examination of the 
EE over the full week of CysF diet, clearly portrays that the whole EE curve slowly shifts 
down in cysteine deficient animals that are continuously losing weight (Fig 3.4D). Even as 
the absolute values of EE are decreasing as the mice lose weight, the amplitude of the peaks 
remains consistent (Fig 3.4D). This unique, robust weight loss situation highlights the fact 
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that body mass does indeed contribute to the absolute measurements of EE and may justify 
the use of normalized EE in this context.  
To assess whether the increase in energy expenditure was supported by increased 
fat utilization, we examined the respiratory exchange ratio (RER). RER is measured by the 
ratio between carbon dioxide production and oxygen consumption, and serves as an 
indirect measurement of the respiratory quotient. The respiratory quotient during rest and 
mild activity indicates the fuel preference that is being utilized for metabolism. An RER of 
1.0 indicates a predominant utilization of carbohydrates as the fuel source whereas an RER 
of 0.7 indicates fat as the predominant fuel source. When we measured RER in Cth+/+ and 
Cth-/- mice fed CysF diet, we found that cysteine deficient animals had significant reduction 
in RER through both the light and dark cycle (Fig 3.4E-F), indicating increased fat 
utilization. This supports the decrease in fat mass and increase in EE in cysteine deficient 
animals, as fat is a much more efficient fuel source than carbohydrates.  
Regulation of total body weight is tightly controlled by mechanisms that maintain 
the balance of energy intake and EE. The weight loss during cysteine deficiency could thus 
be caused by a reduction in energy intake in addition to increased EE. When we compared 
food intake of Cth+/+ or Cth-/- mice fed CysF diet, we found no significant differences in 
accumulated food intake (Fig 3.4G). But accurate measurements of food intake were 
difficult due to cysteine deficient animals having an increased propensity to play with their 
food at later time points. To definitively determine the contribution of energy intake vs. EE 
on weight loss, we conducted a paired food intake experiment using a relatively low 
amount of food provided daily to ensure that all the mice finished the daily allotment of 
diet. Given the slight caloric restriction this caused, there was a non-significant, but 
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consistent decrease in body weight in pair fed animals compared to ad libitum fed animals 
(Fig 3.4H). But despite eating the same amount of food, only cysteine deficient pair fed 
animals lost significant body weight and fat mass (Fig 3.4H-I). This supports the notion 
that an increase in EE, rather than a reduction in energy intake was driving the weight loss 
in cysteine deficient animals. 
Serum metabolite analysis confirms systemic cystine deficiency 
We next conducted serum metabolomics to identify systemic changes in metabolite 
profile during cysteine deficiency. Principle component analysis (PCA) displayed clear 
separations of Cth+/+ and Cth-/- metabolite profiles with an additional separation between 
Cth-/- CTRL and CysF fed animals (Fig 3.5A). Fig 3.5B displays the top 25 metabolites 
changing in Cth-/- CysF animals compared to CTRL fed mice. One of these metabolites is 
L-cystine, which is significantly reduced in Cth-/- CysF serum (Fig 3.5B, C). Cysteine and 
its downstream metabolites, γ-Glu-Cys, and GSH are not altered, suggesting that cysteine 
deficiency is really maintained by a reduction in systemic cystine levels (Fig 3.5C). This 
makes sense, as cystine is the predominant form of cysteine in the circulation. Interestingly, 
with the exception of cystathionine which is significantly increased in CysF diet fed Cth-/- 
mice compared to CTRL fed animals, other SAA metabolites such as methionine, SAM, 
SAH, and Hcys, are not significantly changed (Fig 3.5C). Instead, analogs of cysteine and 
GSH associated metabolites, such as 2-aminobutyric acid (2AB) and ophthalmic acid (OA) 
are increased in the serum of cysteine deficient mice (Fig 3.5C). OA is a GSH analog where 
cysteine is replaced by 2AB, and this increased flux towards OA production vs GSH 
production may be indicative of systemic cysteine deficiency (Fig 3.5D). We explored the 
potential bioactivity of several metabolites increased with cysteine deficiency including 
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OA, 2AB, and uridine in the context of lipid mobilization. To do this, we conducted an ex 
vivo lipolysis assay on adipose explants. We were unable to find repeatable effects of these 
metabolites in inducing lipolysis ex vivo, suggesting that these metabolites are not directly 
involved in driving lipid mobilization through action on adipocytes (data not shown). 
Additional studies are required to definitively asses a functional role of these metabolites 
in lipid metabolism. Regardless, serum metabolomics was able to identify that cysteine 
deficiency was indeed being induced in this model, maintained by a decrease in circulating 
cystine.  
Cysteine deficiency drives thermogenesis of adipose tissue. 
The decrease in fat mass during cysteine deficiency is driven by a loss of all major 
adipose depots including subcutaneous fat (SFAT), visceral epididymal fat (EFAT), and 
brown adipose tissue (BAT) (Fig3.6A). Histological analyses revealed this reduction in 
adipose tissue size is associated with a complete transformation of white adipose depots 
into a BAT-like appearance, with the formation of multilocular adipocytes and enlarged 
nuclei, a phenomenon known as browning (Fig3.6B). Surprisingly, these morphological 
changes were quite robust in the EFAT as well, which is normally not considered to be an 
adipose depot amenable to browning (Fig3.6B). Given these robust changes in the adipose 
tissues, we conducted total RNA-sequencing (RNA-seq) of the major adipose depots, 
SFAT, EFAT, and BAT, to broadly asses the molecular basis of the changes occurring in 
adipose tissue during cysteine deficiency. PCA analysis reveals that cysteine deficiency 
drives clear transcriptomic changes in all three tissues (Fig 3.6C), with almost binary 
transcriptional changes occurring in the SFAT and EFAT as displayed by heatmap (Fig 
3.6D). Gene set enrichment analysis comparing Cth-/- CysF vs CysF CTRL identified that 
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the top downregulated pathways are involved in extracellular matrix and collagen 
deposition, highlighting the broad remodeling of the adipose tissue that is also evident from 
the histology (Fig 3.6E). In addition, multiple metabolic pathways appear to be regulated 
by cysteine deficiency within the SFAT with ‘respiratory electron transport chain and heat 
production’ as the top pathway induced during cysteine deficiency (Fig 3.6E). 
Indeed, numerous genes identified by the ‘thermogenesis’ GO-term pathway are 
differentially expressed comparing Cth-/- CTRL and CysF in the SFAT (Fig 3.7A). Brown 
adipocytes are unique from white adipocytes in that they contain high density of 
mitochondria, which are densely packed with cristae and increased respiratory-chain 
components (Himms-Hagen and Desautels, 1978). This increased mitochondrial capacity, 
along with the expression of UCP1, which uncouples oxidative phosphorylation, allows 
for increased heat production. Compared to Cth-/- CTRL, Cth-/- CysF have increased 
proportions of reads that map to the mitochondria in the SFAT, suggesting an increase in 
mitochondrial content like brown adipocytes (Fig 3.7B). Additionally, UCP1, which is 
normally not expressed in white adipose tissues, becomes widely expressed with cysteine 
deficiency in both the SFAT and EFAT as measured by UCP1 staining in paraffin 
embedded sections (Fig 3. 7C).  This increase in UCP1 was confirmed by WB and qPCR 
in the SFAT (Fig 3. 7D-E). The induction of numerous thermogenic genes that were 
identified by RNA-seq including Cidea, Cox7a1, Cox8b, Dio2, Eva1, Pgc1, Elovl3, and 
Slc27a2, was also verified by qPCR (Fig 3.7E-F). These results indicate that surprisingly, 
cysteine availability acts as a thermogenic checkpoint. 
To identify the metabolic pathways important for the tissue remodeling observed 
during cysteine deficiency, we utilized GAM-clustering to identify pathways commonly 
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changing in all three tissues. GAM-clustering is a recently developed, network-based 
computational approach for unbiased identification of key metabolic subnetworks from 
transcriptional profiles generated by RNA-seq. It was recently refined to allow for the 
comparison of multiple groups (Gainullina et al., 2020). GAM-clustering applied to the 
RNA-seq of all three tissues (SFAT, EFAT, and BAT) with all four sample conditions 
(Cth+/+ and Cth-/- fed CTRL or CysF diet) identified 8 distinct metabolic modules (Fig 
3.8A). Some of these modules identified tissue specific metabolic features, such as modules 
1 and 2 which were more specific to BAT, whereas modules 3, 5, and 7 were more specific 
to the white adipose depots, SFAT and EFAT. Within those white adipose tissue modules, 
module 5 was most enriched in EFAT whereas module 3 was most enriched in SFAT (Fig 
3.8A). Interestingly, module 2, which was strongly enriched in the BAT of all animals, was 
also slightly enriched in the SFAT and EFAT of cysteine deficient animals specifically. 
Given the browning of white adipocytes that occur with cysteine deficiency, this module 
may highlight metabolic pathways directly related to thermogenic capacity. Pathways 
enrichment analysis identified branched chain amino acid (BCAA) degradation, TCA 
cycle, and fatty acid (FA) metabolism to be key features in module 2 (Fig 3.8B, E). The 
enrichment of BCAA degradation is quite interesting, as a recent study found that BCAAs 
were actively taken up by BAT upon cold exposure to fuel mitochondrial oxidation 
(Yoneshiro et al., 2019). Similarly, during cysteine deficiency, increased BCAA 
catabolism in the adipose tissues may support mitochondrial oxidation to drive 
thermogenesis.  
Module 4 represented metabolic features that were downregulated by cysteine 
deficiency across all three tissues (Fig 3.8A, C). This module was characterized by steroid 
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and cholesterol biosynthesis, suggesting that cholesterol biosynthesis is decreased in the 
adipose tissues during cysteine deficiency (Fig 3.8 C, F). Conversely, module 6 represented 
metabolic features that were increased by cysteine deficiency across all three tissues (Fig 
3.8A, D). This module was specific to lipid metabolism (Fig 3.8D, G). These unbiased 
analyses point towards increased changes in lipid metabolism and BCAA metabolism to 
support increased mitochondrial oxidation and thermogenic capacity of adipose tissues 
during cysteine deficiency. 
Redox status of adipose tissue during cysteine deficiency 
One important aspect of cysteine metabolism is its role in redox homeostasis. 
Cysteine is a component of glutathione, one of the major antioxidants that neutralize 
oxidative damage. Chouchani et al have demonstrated that mitochondrial ROS is acutely 
increased during cold challenge, and is required for UCP1 activity. They showed that 
sulfenylation of UCP1 due to increased mitochondrial ROS exposure is required to activate 
UCP1 from its purine inhibited state (Chouchani et al., 2016). Similarly, forcing oxidative 
redox state by treatment with a glutathione depleting agent, buthionine sulfoximine, 
increases the expression of thermogenic programs in adipose tissue (Barbato et al., 2015). 
These studies suggest that increased oxidative stress is an additional regulator of 
thermogenesis in the adipose tissues.  Given the requirement of cysteine for glutathione 
synthesis, oxidative stress could be induced during cysteine deficiency. We performed 
metabolomics in the SFAT to assess the impact of cysteine deficiency on glutathione and 
cysteine metabolism in the adipose tissue undergoing a thermogenic response.  
Surprisingly, we detected no differences in glutathione in its reduced form (GSH) by 
orbitrap type mass spectrometry (Fig 3.9A). However, the oxidized form of glutathione 
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(GSSG) was decreased in the SFAT, suggesting that oxidative status during cysteine 
deficiency in the adipose tissue may actually be reduced (Fig 3.9A). Furthermore, cysteine 
levels were increased while cystine levels in the adipose tissue are not altered, supporting 
a lack of GSH depletion in adipose tissue and a less oxidative redox state (Fig 3.9B). 
However, in contrast to our results where we do not find serum or tissue reductions of 
GSH, other groups that have investigated cysteine deficiency, report reductions of GSH in 
the plasma (Mani et al., 2011), and liver (Ishii et al., 2010; Mani et al., 2011). Further 
evaluation of redox status by measuring ROS production and confirmation of GSH levels 
through other methods may be important to make definitive conclusions of the redox status 
in adipose tissues during cysteine deficiency. Ophthalmic acid (OA) has been suggested as 
an oxidative stress biomarker indicative a hepatic GSH consumption (Soga et al., 2006).  
In addition to serum OA, we find OA is increased in the SFAT during cysteine deficiency 
(Fig 3.9D). Gene expression of enzymes involved in the synthesis of GSH and OA, Gclc 
and Gss were elevated (Fig 3.9C), suggesting that there may indeed be increased pressures 
to maintain GSH and OA during cysteine deficiency. However, cysteine deficiency also 
increases threonine levels in the SFAT, which is an upstream metabolite that generates 
2AB and OA (Fig 3.9D-E). Thus, substrate availability could drive the activation of this 
pathway and OA production independently of glutathione synthesis. Collectively, 
metabolomics of SFAT during cysteine deficiency suggests that redox homeostasis is 
shifted towards a more reduced state, rather than oxidative state, and thus unlikely to be a 
driving mechanism of thermogenesis in this context. 
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scRNA-seq of SFAT stromal vascular fraction suggests increased mobilization of 
preadipocytes. 
 To understand the cellular basis of adipose tissue remodeling during cysteine 
deficiency, we isolated the SFAT stromal vascular fraction by enzymatic digestion and 
conducted single cell RNA sequencing (scRNA-seq) by 10x Genomics. We isolated cells 
from Cth+/+ and Cth-/- fed CTRL or CysF diet for 4 days to identify changes occurring 
before full remodeling of the tissue, with each sample pooled from 4 animals (Fig 3.10A). 
A total of 4,666 cells in Cth+/+ CTRL; 5,658 cells in Cth+/+ CysF; 4,756 cells in Cth-/- CTRL; 
and 3,786 cells in Cth-/- CysF were analyzed for scRNA-seq (Fig 3.10D). By unbiased 
clustering, we were able to identify a total of 15 cell populations, including 3 adipocyte 
progenitor populations; endothelial and pericytes; mixed T cell populations including αβ T 
cells, γδ T cells, ILC2s, and NK T cells; B cells; reticulocytes; mesothelial-like cells; 
Schwann cells; and several myeloid clusters (Fig 3.10B-C). Comparison of Cth-/- CysF 
with other groups revealed dramatic changes in cellular composition and transcriptional 
state (Fig 3.10D).  
Particularly, a significant loss of clusters 0, 1, and 2 were apparent during cysteine 
deficiency (Fig 3.10D-E). Furthermore, these clusters contained the highest numbers of 
differentially expressed genes (Fig 3.11E), highlighting them as important populations in 
mediating the effects of cysteine deficiency. By expression of Pdgfra, we were able 
identify these clusters as adipocyte progenitors (Fig 3.10C, F). To understand the 
differential changes amongst these clusters, we conducted pseudotime analysis to place 
these clusters on a trajectory to help allocate their cell lineage. Trajectory analysis based 
on pseudotime suggested that cluster 2 differentiates into two separate preadipocyte 
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clusters, cluster 0 and 1 (Fig 3.10G-H).  Cth-/- CysF animals proportionally lost Clusters 0 
and 1, while relatively maintaining cluster 2 compared to the other groups (Fig 3.10D-E), 
suggesting that more differentiated preadipocytes were becoming mobilized and lost 
during cysteine deficiency. Indeed, cluster 2 expressed Dpp4, an early progenitor marker 
that has been shown to give rise to different committed preadipocytes (Merrick et al., 
2019)(Fig 3.10I). Cluster 0 was enriched for both Icam1 and F3, which have been shown 
to be expressed by committed adipogenic, and antiadipogenic preadipocytes, respectively 
(Hepler et al., 2018; Merrick et al., 2019)(Fig 3.10I). Cd9, a fibrogenic marker in 
preadipocytes (Hepler et al., 2018; Marcelin et al., 2017), along with the collagen gene, 
Col5a3, were broadly expressed across clusters 0 and 1, and was specifically lost by day 4 
of inducing cysteine deficiency (Fig 3.10I). We next sought to identify beige/brown 
adipocyte precursors in our scRNA-seq dataset to understand whether there was an 
increased commitment towards brown adipocytes. To do this, we examined the expression 
of a CL-316,243 β3-adrenergic receptor agonist-stimulated gene signature reported by Burl 
et al, because β3-adrenergic signaling induces the differentiation of brown adipocytes (Burl 
et al., 2018). We found that cluster 1 had the most pronounced expression of this gene 
signature (Appendix 5, Fig 3.11B), and indeed Tagln, or Sm22, which have been 
previously described in beige adipocytes (Berry et al., 2016; Long et al., 2014; Oguri et al., 
2020), is specifically expressed by a subset of cells in cluster 1 (Fig 3.10I). Interestingly, 
these Tagln expressing cells are completely lost with cysteine deficiency (Fig 3.10I). Given 
the strong browning phenotype observed at day 6, it is possible that these cells become 
mobilized and differentiate early on during cysteine deficiency, leading to the absence of 
these cells. Indeed, when we performed pathways analysis on cluster 1, comparing gene 
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expression of Cth-/- CysF with Cth-/- CTRL, we found that one of the top upregulated 
pathways was ‘adipogenesis’ (Fig 3.11C). Furthermore, when we examined the expression 
of stem associated markers and mature adipocyte markers in the adipocyte progenitor 
clusters, we observed a clear downregulation of stem markers and increase in mature 
adipocyte markers, suggesting that cysteine deficiency was driving the maturation of 
progenitor cells, which are not captured within the stromal vascular fraction (Fig 3.11A). 
However, given the robust transformation of the adipose tissue during cysteine deficiency, 
where significant portions of the white adipose tissue have become brown, it is unlikely 
that mobilization of brown precursors alone is mediating this response. Trans-
differentiation of mature white adipocytes into brown adipocytes can also contribute to the 
browning of SFAT and needs to be further examined. 
  
Cysteine deficiency increases lipolysis via activation of sympathetic nervous system  
To determine the mechanism of adipose thermogenesis post-cysteine deficiency, 
we next investigated the processes upstream of increased fatty acid oxidation. Activation 
of the sympathetic nerves leads to release of catecholamines such as norepinephrine. 
Norepinephrine acts on adipocytes through β3-adrenergic receptors and stored 
triglycerides are hydrolyzed and converted to free fatty acids (FFAs) in a catabolic process 
called lipolysis. These FFAs subsequently fuel mitochondrial respiration and ATP 
production or uncoupling by UCP1 to generate heat (Fig 3.12A).  Lipolysis is mainly 
regulated by two lipases in white adipose tissue, hormone sensitive lipase (HSL) and 
adipose triglyceride lipase (ATGL) (Zechner et al., 2009). When we measured the 
activation of lipolysis in the SFAT by pHSL and ATGL by western blot, we found that 
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cysteine deficiency increases ATGL expression without affecting pHSL levels (Fig 3.12B).  
ATGL preferentially catalyzes the first step of triglyceride hydrolysis whereas HSL has a 
much broader range of substrates with a preference for diacylglycerols and cholesteryl 
esters (Haemmerle et al., 2002; Zimmermann et al., 2004). Our data suggests that 
mobilization of lipids during cysteine deficiency is mainly mediated by ATGL, without 
significant activation of HSL. Given a dramatic browning response in WAT during 
cysteine deficiency, the increased ATGL expression is consistent with work that shows 
BAT relies heavily on the action of ATGL to mobilize lipid substrates for uncoupling and 
heat production (Morak et al., 2012).  
Upstream of lipolysis, non-shivering thermogenesis is mainly activated by the 
sympathetic nervous system and thyroid hormone. We find that norepinephrine levels are 
significantly increased in Cth-/- CysF SFAT, compared to cysteine sufficient controls, 
Cth+/+ CTRL, Cth+/+ CysF, and Cth-/- CTRL (Fig 3.12C), indicating that sympathetic 
activation is significantly increased in the SFAT of cysteine deficient animals. 
Furthermore, when we examined the RNA-seq of SFAT during cysteine deficiency, we 
found that the expression of norepinephrine degradation enzymes, Comt and Maoa were 
decreased in cysteine deficient mice (Fig 3.12D-E). Confirmation by qPCR revealed that 
Maoa expression was indeed decreased (Fig 3.12G). However, the expression of Comt was 
not consistently decreased in the SFAT with cysteine deficiency when measured by qPCR 
(Fig 3.12F). Despite these disparities between different methods of accessing gene 
expression of Comt, protein expression of COMT was lowered in cysteine deficient SFAT 
when measured by western blot (Fig 3.12H). This reduction was more apparent in the 
membrane bound form of COMT (MB-COMT). Furthermore, we found increased levels 
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of S-adenosyl homocysteine (SAH) in the SFAT of cysteine deficiency, which can inhibit 
the enzymatic activity of methyltransferases like COMT (Fig 3.12I). In all, these results 
suggest the decreased degradation of norepinephrine during cysteine deficiency increases 
catecholamine bioavailability together with sympathetic activation to promote lipolysis 
and thermogenesis in SFAT (Fig 3.12J). Consistent with this, application of imaging mass 
spectrometry to detect norepinephrine localization in BAT sections identified increased 
concentrations and distribution of norepinephrine throughout the BAT tissue of cysteine 
deficient animals (Fig 3.12K). These results suggest that cysteine deficiency drives 
increased sympathetic activation, in part by a decrease in catecholamine degradation 
enzymes. This increases lipolysis, mediated mainly by an increase in ATGL, which 
provides the substrates required for mitochondrial respiration. 
 
Cysteine deficiency leads to a loss of monocyte derived macrophages but enrichment 
of resident macrophages. 
 Previously, it was shown that macrophages expressing catecholamine degradation 
enzymes, COMT and MAOA, could regulate sympathetic activation in the context of aging 
and obesity (Camell et al., 2017; Pirzgalska et al., 2017). Given the increased sympathetic 
activation of SFAT and BAT during cysteine deficiency, we next aimed to understand 
whether this process was being regulated by tissue resident macrophages. Besides a loss in 
adipocyte progenitor populations, scRNA-seq of the stromal vascular fraction revealed a 
decrease in multiple myeloid populations, such as cluster 8 and 11, as well as an enrichment 
of a more resident macrophage population, cluster 4 (Fig 3.10E). Furthermore, in addition 
to adipocyte progenitors, resident macrophages expressed a large number of differentially 
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regulated genes, suggesting that they may play an important role in the remodeling of 
adipose tissue during cysteine deficiency (Fig 3.11 E). When we examined macrophage 
populations by flow cytometry, we were able to confirm a 50% reduction in macrophages 
after 6 days of CysF diet in Cth-/- compared to Cth+/+ animals (Fig 3.13A).  
To further understand the dynamic changes occurring in the macrophage 
population, we performed scRNA-seq of resident myeloid cells after induction of cysteine 
deficiency. Given that cysteine deficiency is accompanied by a loss of macrophages in an 
already much smaller tissue, we chose a relatively early timepoint of 3 days of diet, and 
pooled cells from 5 animals per group, to ensure we had enough cells for analysis. To target 
resident cells within the tissue parenchyma, we utilized short-term intravenous (i.v.) 
labeling of CD45 to exclude circulating cells, along with additional markers CD3, B220, 
and Siglec F, to exclude T cells, B cells, and eosinophils, and CD11b that were stained 
after single cell suspension to sort resident myeloid cells specifically (Fig 3.13B). We 
performed scRNA-seq on a total of 7,877 cells from Cth+/+ and Cth-/- (Fig 3.13C), with 
2,383 cells from Cth-/- CTRL and 2,679 cells from Cth-/- CysF (Fig 3.13D). Cth+/+ 
conditions were processed on a separate day from Cth-/- conditions, and we achieved much 
fewer cells with 1,616 cells from the CTRL, and 1,199 cells in the CysF group (data not 
shown). Of note, dendritic cell (DC) populations resembling conventional DCs, Cluster 5 
and 6, were only identified in the Cth+/+ samples, suggesting potential inconsistencies in 
the processing of these samples (Fig 3.13C). Due to the biases introduced by processing on 
different days, we only show data from the Cth-/- from here onward.  
In the scRNA-seq analysis of Cth-/- samples, we identified 5 other clusters of 
macrophages, including (0) lipid associated macrophages that express high levels of Cd36; 
  58 
(1) Cd209 and Cd9 expressing macrophages/DCs; (2) Ly6c2 expressing monocyte derived 
macrophages; (3) Lyve1 expressing resident macrophages; and (4) proliferating 
macrophages (Fig 3.13C, 3.14A).  Given our previous work identifying macrophages 
tightly associating with nerve fibers and bundles (Camell et al., 2017), we hypothesized 
that amongst the tissue resident macrophages, these nerve-associated macrophages 
(NAMs) would play important roles in taking up and metabolizing catecholamines released 
by sympathetic nerves to limit the availability of catecholamines to surrounding 
adipocytes. Alterations to the function of NAMs may thus play important roles in 
controlling sympathetic activation during cysteine deficiency. Currently, there are no 
known markers for NAMs in the adipose tissue. To try to identify these macrophages in 
our scRNA-seq datasets, we identified genes commonly expressed in NAMs of other 
various tissues, such as the lung, gut, skin, and sciatic nerves (Chakarov et al., 2019; 
Gabanyi et al., 2016; Kolter et al., 2019; Mueller et al., 2003; Pirzgalska et al., 2017; Ural 
et al., 2020). When we overlayed this gene set (Appendix 6) onto our scRNA-seq data, 
these genes were enriched in cluster 3 (Fig 3.13F). This cluster also specifically expressed 
Maoa, one of the enzymes that degrade norepinephrine, supporting the notion that NAMs 
are present within cluster 3 (Fig 3.13 G). Besides Maoa, cluster 3 macrophages also 
expressed C1qa, Gas6, Mertk, and Lyve1 (Fig 3.13E, Fig 3.14A).   
To verify an increase in NAMs during cysteine deficiency, we looked for cell 
surface markers unique to cluster 3. We found that CD163 is highly expressed in cluster 3 
(Fig 3.13H), and was able to verify an increase of CD163+ macrophages after 6 days of 
inducing cysteine deficiency by flow cytometry (Fig 3.13I). However, it is important to 
note that CD163 is not exclusively expressed in NAMs and can also be expressed by other 
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resident macrophages in clusters 1 (Fig 13.H). In fact, transcriptionally, cluster 3 seemed 
to be quite heterogeneous, with other markers such as Lyve1 present, which have been 
described to be expressed in perivascular macrophages within the fat (Silva et al., 2019), 
and Trem2 (Fig 14.A), which have been described in lipid associated macrophages that 
increase in obesity (Jaitin et al., 2019). Indeed, when we examined the expression of 
CD163 and Lyve1 by confocal whole mount imaging, we found that both CD163 and 
Lyve1 were expressed by NAMs directly in contact with nerves, as well as parenchymal 
macrophages that were further away from nerves (Fig 3.14B). Furthermore, the expression 
of MAOA was detected in both NAMs as well as CD163+ macrophages that were 
associated with adipocytes (Fig 3.14C-D). Collectively, these data suggest that 
macrophages in the adipose tissue are not easily classified into distinct functional subsets 
based on previously described markers. Nonetheless, the expression of Comt is widely 
decreased in all macrophages with cysteine deficiency, suggesting that decreased 
catecholamine degradation in macrophages may contribute to the increased sympathetic 
tone in SFAT (Fig 3.13J).  
To further understand the changes in the resident macrophage cluster where NAM-
like macrophages appear to be enriched, we examined the pathway enrichment of 
differentially regulated genes with cysteine deficiency in cluster 3 (Fig 3.14E). We found 
that some of the top pathways increased in resident macrophages included 
‘phosphodiesterases in neuronal function’ and ‘complement cascade’ (Fig 3.14E). 
Particularly, recent work has found that microglia interact with neurons and synapses to 
regulate neuronal function through the expression of complement and complement 
receptors (Hong et al., 2016; Wang et al., 2020). Cluster 3 is indeed enriched in the 
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expression of complement genes such as C1qa (Fig 3.14A). These pathways suggest 
NAMs could be altering their interaction with nerves in the context of cysteine deficiency, 
to support increased sympathetic activation (Fig 3.14 E).  
 
UCP1 is not necessary for thermogenesis during cysteine deficiency  
 Given the robust activation of thermogenic pathways during cysteine deficiency, 
we next investigated whether cysteine deficiency triggers adaptive thermogenesis to defend 
core body temperature. We first evaluated whether core body temperature was being 
altered during cysteine deficiency. Utilizing temperature data loggers surgically implanted 
into the peritoneal cavity, we measured core body temperature of Cth-/- mice on CTRL or 
CysF diet over 6 days. We found that core body temperature was not significantly different 
between the two groups (Fig 3.15A-B).  A recent study investigating the thermoneutral 
point in mice, found that after ambient temperatures reached the thermoneutral point for 
mice, energy expenditure remained constant at higher temperatures (Skop et al., 2020). 
Instead, the body temperature of the mice began to increase as ambient temperatures 
increased beyond the thermoneutral point (Skop et al., 2020). This study suggests that once 
core body temperature is defended, energy expenditure levels are maintained at a minimal 
level for basic bodily functions independent of core body temperature maintenance in mice. 
During cysteine deficiency, mice have increased energy expenditure, but not higher core 
body temperatures, suggesting that the increased energy expenditure is being utilized to 
generate heat and defend core body temperature. To confirm that energy expenditure was 
actually being utilized to generate heat, we utilized a magnetic resonance imaging (MRI) 
method called BIRDS (Biosensor Imaging of Redundant Deviation in Shifts) to measure 
  61 
temperatures of BAT in Cth+/+ and Cth-/- animals after 6 days of CysF diet (Fig 3.15C). 
This method relies on differing relaxation times of the non-exchanging protons of an 
exogenous contrast agent, thulium and macrocyclic chelate, which becomes altered by 
temperature. The chemical shifts that occur paramagnetically are detected by BIRDS and 
converted into physicochemical parameters to obtain absolute temperatures with high 
sensitivity (Coman et al., 2013; Coman et al., 2010). We adapted this method to measure 
in vivo temperature differences of BAT in the context of cysteine deficiency. We found 
that the relative temperature of the BAT compared to its surrounding tissue was higher in 
Cth-/- mice compared to Cth+/+ mice (Fig 3.15C-D), suggesting that the adipose tissue was 
increasing energy expenditure to indeed generate heat and defend core body temperature.  
 Cysteine deficiency seems to increase susceptibility to cold such that it is required 
to increase heat production to maintain core body temperature. Considering that in animal 
facilities, mice are normally housed at temperatures below their thermoneutral zone, mice 
are constantly under thermogenic stress. To further confirm that mice were indeed inducing 
thermogenesis to defend core body temperature due to increased susceptibility to cold, we 
housed mice at 30°C in addition to 22°C. We found that housing at 30°C reduced the 
browning phenotype of SFAT when cysteine deficiency was induced by 6 days of CysF 
diet (Fig 3.15E-F). In addition, gene expression of Ucp1, required for uncoupling mediated 
heat production, was reduced when housed at 30°C (Fig 3.15G), suggesting that indeed a 
need to generate heat significantly drove thermogenic browning of the SFAT.  However, 
surprisingly, despite reduced fat mobilization and heat production, cysteine deficient 
animals still significantly lost weight at 30°C (Fig 3.15E). Furthermore, transcriptional 
expression of some mitochondrial enzymes involved in fatty acid oxidation such as Acadm 
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and Cox8b were even further increased at 30°C with cysteine deficiency (Fig 3.15G), 
suggesting that the browning responses are only attenuated and additional pressures to 
mobilize fat metabolism and weight loss may be present during cysteine deficiency.  
 Given that these results suggested that cysteine deficiency somehow increased 
pressures to defend core body temperature, we next tested whether UCP1 was required to 
maintain core body temperature during cysteine deficiency. To do this, we generated Cth-
/- Ucp1-/- double KO (DKO) mice. Interestingly, we found that Cth-/- Ucp1-/- DKO mice lost 
weight at a similar rate to its Cth-/- littermates on a CysF diet (Fig 3.16A), but had increased 
fat mass, suggesting that less lipids were being mobilized and utilized for heat production 
in the Cth-/- Ucp1-/- DKO animals (Fig 3.16B). This increase in fat mass particularly came 
from the SFAT and BAT, whereas loss of visceral gonadal peri-uterine/ovarian fat 
(Ut/OvFAT) was not significantly different (Fig 3.16C). This reduction in browning is 
evident from histology, where the SFAT from Cth-/- Ucp1-/- DKO post 6 days of CysF diet 
shows slightly larger lipid droplets compared to the Cth-/- mice (Fig3.16D). However, 
robust browning of the SFAT is still observed by the formation of multilocular adipocytes 
in Cth-/- Ucp1-/- DKO on CysF diet (Fig 3.16D), suggesting that lipid mobilization is still 
highly activated even in the absence of UCP1 during cysteine deficiency. In line with the 
amelioration of fat loss in the Cth-/- Ucp1-/- DKO mice compared to Cth-/-, Cth-/- Ucp1-/- 
DKO have reduced energy expenditures measured by indirect calorimetry in metabolic 
chambers (Fig 3.16E-F). Given the similar body weights in these animals, it was possible 
to represent the data without normalization, as is the gold standard (Fig 3.16E), and conduct 
linear regression analysis of EE against body mass to show significant decreased EE in 
Cth-/- Ucp1-/- DKO compared to Cth-/- animals (Fig 3.16F). Despite this reduction in EE of 
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Cth-/- Ucp1-/-, surprisingly, Cth-/- Ucp1-/- mice were able to maintain core body temperature 
identically to the Cth-/- mice on CysF diet (Fig 3.16G). This indicated that UCP1 was not 
required for the maintenance of core body temperature.  
Furthermore, RER dropped similarly over time in both Cth-/- and Cth-/- Ucp1-/- 
DKO, indicating that they both increased utilization of fat as the major fuel source for 
metabolism during cysteine deficiency (Fig 3.17A). If anything, Cth-/- Ucp1-/- DKO had 
even lower RER on the very last dark cycle on the diet, suggesting greater fat utilization 
(Fig 3.17B). Consistent with this lower RER, Cth-/- Ucp1-/- DKO mice expressed higher 
levels of ATGL and tyrosine hydroxylase (TH) measured by western blot in the SFAT (Fig 
3.17C-E). These results suggest that Cth-/- Ucp1-/- DKO mice increase their mobilization of 
lipids through increased lipolysis.  TH is the rate limiting enzyme for norepinephrine 
production and is predominantly expressed in sympathetic nerves innervating the adipose 
tissue. Increased TH expression suggests that Cth-/- Ucp1-/- DKO may potentially have 
increased sympathetic activation compared to Cth-/- at 6 days post-cysteine deficiency. 
However, TH is also increased in Ucp1-/- independently of cysteine deficiency (data not 
shown), and further evaluation of sympathetic tone by measuring catecholamines is 
required.  
Despite a lack of UCP1, gene expression of activators of the thermogenic program 
such as Ppargc1, Cidea, Cpt1 are significantly increased in Cth-/- Ucp1-/- DKO compared 
to Cth-/- in the BAT after 6 days of CysF diet (Fig 3.17F). Furthermore, gene expression of 
other mediators of the thermogenic program such as Acadm, Cox7a1, Elovl3, and Slc27a 
are also significantly increased in Cth-/- Ucp1-/- DKO mice compared to Cth-/- (Fig 3.17F). 
These data suggest that Cth-/- Ucp1-/- DKO mice are increasing their mobilization of lipids 
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for mitochondrial respiration, even more so than the Cth-/-, which already rely on 
significantly elevated mitochondrial respiration in response to cysteine deficiency. The 
lack of UCP1 may force Cth-/- Ucp1-/- DKO mice to rely on less efficient mechanisms of 
thermogenesis, which could potentially explain the increase in FA metabolism and 
mitochondrial respiration.  
Several UCP1 independent thermogenic mechanisms have been identified in recent 
years. We evaluated one such mechanism, creatine futile cycling, by measuring gene 
expression of the enzymes involved in this process, Gatm, Gamt, Ckmt1, Ckmt2, and 
Slc6a8. While the expression of creatine synthesis genes, Gatm and Gamt were not 
differentially induced with cysteine deficiency in Cth-/- Ucp1-/- DKO mice compared to Cth-
/- animals, the expression of one of the creatine kinases that utilize ATP, Ckmt2, was 
significantly increased and the transporter for creatine, Slc6a8, albeit not significantly, was 
slightly increased in the BAT (Fig 3.17G). These results indicate that creatine futile cycling 
may be one mechanism that becomes activated to generate heat in the absence of UCP1 in 
Cth-/- Ucp1-/- DKO mice. In all, it seems that UCP1 is not strictly necessary to maintain 
core body temperature during cysteine deficiency. However, the reduction in energy 
expenditure despite increased activation of FA metabolism leaves many questions 
unanswered. Furthermore, weight loss is maintained even when energy expenditure is 
reduced. More studies will be necessary to fully understand the dynamic metabolic changes 
occurring during cysteine deficiency.  
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Summary & Discussion 
We find that during CR, the TSP is induced to defend against reduced cysteine 
levels. We developed a model to study the effects of cysteine deficiency by knocking out 
the gene, Cth, to force a requirement for cysteine from the diet. Surprisingly, we discovered 
that cysteine deficiency drives rapid mobilization and utilization of lipids in adipose tissues 
to increase heat production via browning of SFAT and EFAT. Activation of browning in 
these white adipose depots is mediated through an increase in sympathetic signaling that 
drives increased lipolysis in the SFAT and BAT. We find that increased sympathetic 
activation is in part mediated by a decrease in degradation of norepinephrine; the 
expression of COMT and MAOA is decreased in the adipose tissues. Particularly, COMT 
expression is decreased in resident macrophages during cysteine deficiency.   
Whether macrophages are indeed playing a critical role in regulating sympathetic 
tone and browning during cysteine deficiency still needs to be verified. And if so, whether 
specific populations of macrophages are mediating its effects is unclear. Recent studies 
have begun to redefine macrophages within the adipose tissue. While early studies had 
purely divided macrophages into proinflammatory and anti-inflammatory macrophages 
(Lumeng et al., 2007a; Weisberg et al., 2003), more recent studies utilizing scRNA-
sequencing have started to categorize adipose macrophages according to their function and 
niche (further discussed in Chapter 4). Given an increase in sympathetic activity, we 
aimed to study whether NAMs mediate neuro-immune crosstalk to impact adipose 
metabolism during cysteine deficiency. Indeed, our data demonstrates that residential 
macrophages were enriched during cysteine deficiency in the SFAT, and their expression 
of Comt was decreased. However, due to the heterogeneity within cluster 3, and limitations 
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of sensitivity of scRNA-seq, we were unable to identify exclusive iron-clad markers for 
NAMs in the SFAT. Instead, we found that this population of resident macrophages were 
likely a mixed population, including perivascular macrophages, parenchymal adipocyte 
adjacent macrophages, and nerve associated macrophages, and thus may be acting through 
several different mechanisms. This heterogeneity of residential macrophages in adipose 
tissue may highlight the complexity of the adipose tissue niche, where nerves and blood 
vessels have been found to be highly integrated with adipocytes, and nearly every 
adipocyte has been suggested to be in close contact with a nerve (Cao et al., 2018; Chi et 
al., 2018; Wolf et al., 2017). We plan to further investigate whether these macrophages are 
important in mediating the remodeling of adipose tissue during cysteine deficiency by 
depleting macrophages using clodronate liposomes. Recently, a study found that adipose 
tissue macrophages were important in mediating a model of thermogenesis where 
adipocytes were deficient in fatty acid synthase (Henriques et al., 2020). This study 
suggested that macrophages can promote browning independently of mediating 
sympathetic activation, and additional detailed studies are required to determine if indeed 
NAMs or parenchymal residential macrophages can regulate the thermogenic response in 
the context of cysteine deficiency.  
Given the significant decrease in monocyte derived macrophages in addition to the 
enrichment of residential macrophages during cysteine deficiency, loss of specific adipose 
tissue macrophages could also play a role in adipose tissue remodeling.  Ideally, depletion 
of resident macrophages specifically would delineate the role of enriched resident 
macrophages vs the loss of monocyte derived macrophages during cysteine deficiency. 
Pilot studies attempting to deplete adipose resident macrophages utilizing CD169-cre 
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iDTR mice in our lab have not been successful and require further optimization to 
successfully deplete resident macrophages in the adipose tissue. However, if macrophage 
depletion by clodronate liposomes further enhances weight loss during cysteine deficiency, 
it may suggest that alternatively, macrophages, including monocyte-derived macrophages 
are required to maintain adiposity, and loss of these macrophages during cysteine 
deficiency promote unchecked thermogenesis.  
Our results suggest that cysteine is an important metabolite in maintaining core 
body temperature, and loss of mechanisms to maintain cysteine levels severely challenges 
homeostatic thermoregulation. While it is still unclear why cysteine deficiency requires the 
activation of thermogenic processes, it appears that thermogenesis can be successfully 
maintained even in the absence of UCP1. Moreover, it appears that even when fat mass 
loss is ameliorated by housing at thermoneutrality, weight loss is still maintained, 
suggesting that lean mass is significantly lost during cysteine deficiency as well. In 
agreement with our cysteine deficiency studies, recently, a group studying the effects of 
protein content in diet ranging from 20% to 1%, found that mice preferentially lost adipose 
depots including subcutaneous adipose, epididymal adipose, mesenteric adipose, 
retroperitoneal adipose, and brown adipose in response to low protein diet (Wu et al., 
2021). They also report that mice on low protein diets lost the mass of reproductive organs, 
pancreas, and liver while other lean organs such as the brain, lungs, heart, kidneys, and 
spleen were protected (Wu et al., 2021). And while this study did not measure skeletal 
muscle, in a study that deleted Cth in a 129/SvJ mouse background, mice fed a low cysteine 
diet before adulthood (3 weeks of age), prevented developmental growth, and developed 
severe paralysis of the lower extremities after one week (Ishii et al., 2010). This paralysis 
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was caused by increase autophagy in the skeletal muscle, suggesting that cysteine 
deficiency during development promoted degradation or atrophy of the skeletal muscle 
(Ishii et al., 2010). Evaluating how these different lean organs are changing during cysteine 
deficiency in adult mice may help us understand the biology driving weight loss and 
adipose thermogenesis. 
Particularly, the increase in BCAA degradation pathways in the adipose tissue is 
intriguing. Normally, BCAAs are primarily oxidized in the skeletal muscle. However, 
recent studies utilizing mouse models lacking BAT (UCP1-cre x PPARγ) found that in 
addition to skeletal muscle, BAT plays an active role in clearing BCAAs from the 
circulation (Yoneshiro et al., 2019). Clearance of BCAAs from the circulation is important, 
as buildup of these amino acids and byproducts are toxic to the brain and other organs, and 
can lead to serious health problems associated with maple syrup urine disease (Dancis et 
al., 1960; Menkes et al., 1954).  Because we do not actually detect differences in BCAAs 
in the serum of cysteine deficient mice, investigation of adaptations in the skeletal muscle, 
such as protein turnover and autophagy may provide important clues to how and why 
BCAA metabolism gets enriched in adipose tissue. Similarly, we observe an increased flux 
towards OA production in the SFAT during cysteine deficiency. While this could be 
interpreted as an increased pressure to generate glutathione, we also observe increased 
levels of threonine in the adipose tissues, which give rise to 2-oxybutric acid and 
subsequently 2AB. Thus, rather than regulation of glutathione production, the induction of 
this pathway may serve as a mechanism to clear amino acids that have been released by 
skeletal muscle. 
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In conclusion, our data demonstrates that cysteine availability is a previously 
unidentified key checkpoint in maintaining core body temperature. Through the generation 
of CSE deficient animal fed a cysteine free diet, we show that when cysteine levels are not 
maintained, thermogenic pathways are activated in the adipose tissues, leading to rapid 
weight loss to the point of mortality, as mice are required to be euthanized at 30% weight 
loss. This response is mediated by an increase in sympathetic signaling in the adipose 
tissue. How this metabolic response in the adipose tissue is being integrated by adaptations 
of other metabolic organs such as the skeletal muscle, liver, and hypothalamus remains to 
be characterized and may provide further understanding of how cysteine metabolism 
guards thermogenic homeostasis.  
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Figures 
 
Figure 3. 1 Human calorie restriction activates the transsulfuration pathway 
A) Schematic of human CALERIE II study. Participants provided subcutaneous adipose (SFAT) biopsies 
at baseline, 12 months, and 24months of CR for RNA-seq and metabolomics (n=8 per timepoint). B) 
Normalized expression of changing transsulfuration pathway genes CTH, and BHMT in human SFAT at 
baseline, 12 months, and 24 months CR. Adjusted p-values (padj) were calculated in the differential gene 
expression analysis (n=8). C) Selected metabolites involved in cysteine metabolism measured by MS/MS 
in human SFAT at baseline and 12 months CR. Significance was calculated using paired t-tests. *p<0.05, 
**p<0.01, ***p<0.001. D) Schematic summary of changing TSP genes and metabolites from baseline to 
12 months CR that were measured in human SFAT. Green lines represent measured, but unchanging 
metabolites, blue arrows indicate significantly decreasing, and red arrows indicate significantly 
increasing metabolites or genes via paired t-test (p<0.05). 
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Figure 3. 2 Cysteine deficiency in mice drives rapid fat loss 
A) Schematic of mouse model used to achieve cysteine deficiency utilizing Cth-/- fed a Cystine free 
(CysF) diet. B-C) Male Cth+/+ and Cth-/- were fed CTRL or CysF diets for 6 days (n=5 Cth+/+ CTRL, 
n=12 Cth+/+ CysF, n=8 Cth-/- CTRL, n=17 Cth-/- CysF, 3 expts pooled). B) Percent body weight over 6 
days of diet. C) Fat mass and lean mass measured by EchoMRI at day 6 of diet. D) Energy expenditure 
measured in metabolic cages at day 4 and 5 of diet and E) quantified day and night averages, normalized 
by daily body weight (n=10 Cth+/+ CysF, n=12 Cth-/- CysF, 3 expts pooled). Data expressed as 
mean±SEM. Statistical differences were calculated by (B,D,E) 2-way ANOVA with Sidak’s correction 
for multiple comparisons and (C) unpaired t-test. *p<0.05, **p<0.01, ***p<0.001 
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Figure 3. 3 Whole body depletion of Cth is required for cysteine deficiency response 
A-B) Female Cth+/+ and Cth-/- were fed CTRL or CysF diets for 6 days (n=5 Cth+/+ CTRL, n=5 Cth+/+ 
CysF, n=6 Cth-/- CTRL, n=8 Cth-/- CysF, 2 expts represented). A) Body weight curve and B) fat mass 
and lean mass measured by EchoMRI at day 6 of diet. C) Expression of Cth in various tissues of WT 
mice (n=3). D) Schematic of Cthf/f mice generation used to cross to either Alb-cre or Adipoq-cre. Protein 
expression of CSE in Alb-cre Cthf/f and Cthf/f mice measured by western blot in E) liver and F) kidney to 
confirm deletion. G) Body weight over 6 days of CTRL or CysF diet in Alb-cre Cthf/f and Cthf/f mice. H) 
Protein expression of CSE in Adipoq-cre Cthf/f and Cthf/f mice measured by western blot in H) SFAT and 
I) liver to confirm deletion. J) Body weight over 6 days of CTRL or CysF diet in Adipoq-cre Cthf/f and 
Cthf/f mice. K) Body weight over 6 days of CysF diet in co-housed Cth+/+ and Cth-/- mice (n=4/group, 2 
expts represented). Data expressed as mean±SEM. Statistical differences were calculated by (B) unpaired 
t-test. *p<0.05, **p<0.01, ***p<0.001. 
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Figure 3. 4 Metabolic parameters during cysteine deficiency 
A-G) Metabolic cage data of Cth+/+ and Cth-/- on 6 days of CysF diet after 3 days acclimation (n=10 Cth+/+, 
n=12 and Cth-/-). Linear regression analysis of unnormalized average energy expenditure measured by 
indirect calorimetry against body mass in Cth+/+ and Cth-/- on days 4 and 5 of CysF diet A) for the light 
cycle, B) dark cycle, and c) light and dark cycle combined. D) Unnormalized EE over the full course of 6 
days on CysF diet. E) RER over the full course of 6 days on CysF diet. F) Area under the curve quantified 
for RER. G) Accumulated food intake over the full course of 6 days. H-I) Cth+/+ and Cth-/-pair fed CTRL or 
CysF diet over 6 days (n=4 Cth+/+CysF ad lib, n=4 Cth+/+CysF pair fed, n=6 Cth-/- CTRL pair fed, n=5 Cth-
/- CysF pair fed). H) Percent body weight over 6 days, and I) fat mass and lean mass measured by EchoMRI 
on day 6. Data expressed as mean±SEM. Statistical differences were calculated by (B) linear regression 
analysis, by (H) 2-way ANOVA with Sidak’s correction for multiple comparisons, and by (F, I) unpaired t-
test. *p<0.05, **p<0.01, ***p<0.001. 
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Figure 3. 5 Serum metabolomics of Cth+/+ and Cth-/- mice fed CTRL or CysF diet 
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Figure 3. 6 Transcriptional response of adipose tissues to cysteine deficiency 
A) Principal component analysis (PCA) of serum metabolomic profile measured by orbitrap MS/MS in 
Cth+/+ or Cth-/- mice fed CTRL or CysF diet for 6 days (n=5 Cth+/+ CTRL, n=6 Cth+/+ CysF, n=4 Cth-/- 
CTRL, n=5 Cth-/- CysF). B) Normalized heat map of top 25 metabolites changing in the serum of Cth-/- 
mice fed CTRL or CysF diet for 6 days. C) Box plots of select metabolites involved in TSP from serum 
of Cth-/- mice fed CTRL or CysF diet for 6 days. D) Schematic summary of changing metabolites in the 
serum of Cth-/- mice fed CTRL or CysF diet for 6 days. Green lines represent measured, but unchanging 
metabolites, blue arrows indicate significantly decreasing, and red arrows indicate significantly 
increasing metabolites. Statistical differences were calculated by unpaired t-test. *p<0.05, **p<0.01, 
***p<0.001. 
 
A) Representative subcutaneous, visceral, and brown adipose depots of Cth+/+ and Cth-/- post 6 days of 
CysF diet. B) Representative H&E histology images of SFAT and EFAT of Cth-/- mice fed CTRL or 
CysF diet for 6 days. C-D) Whole tissue RNA-seq of SFAT, EFAT, and BAT of Cth+/+ and Cth-/- fed 6 
days of CTRL or CysF diet (n=4/group). C) PCA and D) heat map highlighting changes specifically 
occurring in cysteine deficiency. E) Select top pathways being up- and down-regulated in Cth-/- CysF vs 
CTRL in the SFAT. 
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Figure 3. 7 Cysteine deficiency induces thermogenesis in white adipose tissue  
A) Heatmap of representative genes involved in thermogenesis that are differentially regulated by 
cysteine deficiency in the SFAT detected by RNA-seq (n=4/group). B) Percentage of reads coming from 
nuclear and mitochondrial transcripts. C) Representative images of SFAT and EFAT stained for UCP1 
from Cth-/- mice fed CTRL or CysF diet at day 6. D) Western blot detection of UCP1 in the SFAT of 
Cth-/- mice fed CTRL or CysF diet at day 6. E-F) qPCR analysis of SFAT expression of thermogenic 
genes after 6 days of CTRL or CysF diet. Statistical differences were calculated by unpaired t-test. 
*p<0.05, **p<0.01, ***p<0.001. 
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Figure 3. 8 GAM-clustering analysis of RNA-seq 
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A-D) High expression is represented as red, low expression is represented as blue. Each column 
represents a different sample. A) GAM-clustering algorithm was applied to RNA-seq data of BAT, 
EFAT, and SFAT. 8 different metabolic modules were identified. B) Highlight of subnetworks within 
module 2 by pathways enrichment analysis. Heat map of representative genes within BCAA degradation, 
TCA cycle, and FA metabolism are shown. C) Module 4 pathways enrichment analysis identifies 
cholesterol/steroid biosynthesis as top correlated pathway. Heat map of representative genes within 
cholesterol biosynthesis are shown. D) Module 6 pathways enrichment analysis identifies lipid 
metabolism as top correlated pathway. Heatmap of representative genes within lipid metabolism are 
shown. E-G) Corresponding subnetwork schematic diagrams for Modules 2, 4, and 6. Edges of modules 
are attributed with color according to correlation of its enzyme’s gene expression to this particular 
module pattern, and thickness according to its score. Red represents high correlation and green represents 
low correlation. E) Subnetwork generated for module 2 highlighting several different metabolic nodes 
such as amino acid metabolism, TCA cycle, FA metabolism. F) Subnetwork generated for module 4, 
highlighting cholesterol and steroid biosynthesis. G) Subnetwork generated for module 6, highlighting 
lipid metabolism. (BCAA: Branched chain amino acids; TCA: Tricarboxylic acid cycle; FA: Fatty acid; 
SAA: Sulfur amino acids; PIP3:Phosphatidylinositol 3,4,5 triphosphate) 
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Figure 3. 9 Increased production of ophthalmic acid in the SFAT during cysteine 
deficiency. 
A, B, D) Metabolites measured by Orbitrap type mass spectrometry in the SFAT of Cth-/- CTRL and Cth-
/- CysF (n=6/group). Arbitrary units represent area under peak/internal standard/tissue weight. A) 
Measurements of GSH and GSSG in the SFAT of Cth-/- CTRL and Cth-/- CysF. B) Measurements of 
cysteine and cystine in the SFAT of Cth-/- CTRL and Cth-/- CysF. C) RNA-seq expression of Got1, Gclc, 
and Gss in the SFAT of Cth-/- CTRL and Cth-/- CysF. (n=4/group) D) Measurements of OA, 2AB, and 
threonine in the SFAT of Cth-/- CTRL and Cth-/- CysF. D) Schematic showing changes in gene and 
metabolite expression in glutathione and ophthalmic acid synthesis pathway. Significantly increased 
have red arrows, significantly decreased have blue arrows, and unchanging have green dashes. Each dot 
represents a single mouse. Statistical differences were calculated by unpaired t-test. *p<0.05, **p<0.01, 
***p<0.001. (2OB: 2-oxalobutyric acid; 2AB: 2-aminobutryic acid; Cys: Cysteine; OA: ophthalmic acid; 
GSH: Glutathione (reduced); GSSG: Glutathione (oxidized); γGlu-Cys: γ-Glutamyl-Cysteine; γGlu-
2AB: γ-Glutamyl-2-Aminobutyric acid; AST: Aspartate transaminase (Got1); γGCS: Gamma-
Glutamylcysteine synthetase (Gclc); GS: Glutathione synthetase (Gss)). 
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Figure 3. 10 scRNA-seq of stromal vascular fraction SFAT during cysteine 
deficiency. 
A) Schematic of cell processing of SFAT stromal vascular fraction (SVF) for scRNA-seq. B) t-SNE plot 
of SFAT stromal vascular fraction with cluster identities. C) Heat map of normalized gene expression of 
select markers to identify major cell lineages. D) t-SNE plot showing SVF of Cth+/+ CTRL, Cth+/+ CysF, 
Cth-/- CTRL, and Cth-/- CysF diet. Population statistics of select clusters have been overlayed. E) Bar 
chart showing population fold changes in relative abundance of each cluster comparing Cth-/- CysF vs. 
Cth+/+ CysF. F) t-SNE plot displaying Pdgfra expression in red across all populations. G) Monocle 
analysis clusters 0, 1, and 2, with coloring by pseudotime to show right most cluster giving rise to two 
separate clusters. H) Monocle analysis with each cluster represented by color in Cth-/- CTRL, and Cth-/- 
CysF. I) t-SNE plots displaying Dpp4, Cd9, Icam1, Col5a3, F3, and Tagln expression in red across all 
populations in Cth-/- CTRL, and Cth-/- CysF samples.  




Figure 3. 11 scRNAseq of stromal vascular fraction of SFAT during cysteine 
deficiency. 
A) Heatmap of gene expression of select stem and mature adipocyte genes in cells of clusters 0, 1, and 
2 in all samples. B) Enrichment of CL-316,243 activated gene set overlaid on all populations in all 
samples. C) Select top pathways from gene set enrichment comparing Cth-/- CysF vs. Cth+/+ CysF in 
cluster 1. D) Volcano plot of differentially expressed genes (DEGs) comparing Cth-/- CysF vs. Cth+/+ 
CysF in cluster 1. E) Table of number of DEGs per cluster when compared to Cth-/- CysF.  
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Figure 3. 12 Cysteine deficiency increases sympathetic tone by reducing degradation 
of norepinephrine. 
A) Schematic showing activation of browning in adipose tissue via sympathetic activation and lipolysis. 
B) Western blot analysis of lipolytic proteins, pHSL and ATGL, in SFAT of Cth-/- mice fed CTRL or 
CysF diet at day 6. C) Measurement of norepinephrine by orbitrap MS/MS in the SFAT of Cth+/+ and 
Cth-/- fed 6 days CTRL or CysF diet (n=5 Cth+/+ CTRL, n=5 Cth+/+ CysF, n=6 Cth-/- CTRL, n=6 Cth-/- 
CysF). Boxplots of D) Comt and E) Maoa FPKMs from RNA-seq of SFAT (n=4/group). Gene expression 
of F) Comt and G) Maoa in the SFAT measured by qPCR (n=8 Cth+/+ CysF, n=10 Cth-/- CysF). H) 
Measurement of COMT by western blot in SFAT. I)SAH measured by orpitrap MS/MS J) Schematic of 
norepinephrine degradation K) imaging mass spec of norepinephrine in the BAT. Data expressed as 
mean±SEM. Statistical differences were calculated unpaired t-test. *p<0.05, **p<0.01, ***p<0.001. 
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Figure 3. 13 scRNA-seq of SFAT residential myeloid cells during cysteine deficiency. 
A) Schematic depicting cell sorting strategy of SFAT resident myeloid cells for scRNA-seq. B) t-SNE 
plot of SFAT resident myeloid cells with cluster identities of Cth+/+ CTRL, Cth+/+ CysF, Cth-/- CTRL, 
and Cth-/- CysF. B) t-SNE plots of resident myeloid cells from Cth-/- CTRL and Cth-/- CysF with 
proportional population statistics displayed for each cluster. D) Heat map of normalized gene expression 
of select markers to identify major cell lineages. E) Enrichment NAM gene signature overlaid on all 
populations in all samples. F) t-SNE plot displaying Maoa expression in all samples. G) t-SNE plot 
displaying Cd163 expression in Cth-/- CTRL and Cth-/- CysF. Representative FACS plot of H) CD11b+ 
F4/80+ macrophages with quantification and I) CD163+ macrophages with quantification. J) Violin plots 
of Comt expression within all cells from each group. 
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Figure 3. 14 Analysis of resident macrophage cluster in SFAT during cysteine 
deficiency. 
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A) t-SNE plots showing expression of genes enriched in each cluster B) Volcano plot of DEGs comparing 
Cth-/- CysF vs. Cth-/- CTRL in cluster 3. C) Selected top pathways identified by pathways enrichment 
analysis of cluster 1, comparing Cth-/- CysF vs. Cth-/- CTRL. D-F) Representative confocal image of wild 
type -whole mount SFAT, stained for CD163 (yellow), Tubb3 (green), Lyve1 (red), and MAOA (blue). 
D) NAMs and adipose tissue macrophages near a nerve. Yellow arrow indicates CD163+ adipose 
macrophage that is not a NAM. White arrows indicate NAMs that stain both CD163 and Lyve1. Red 
arrow indicates a Lyve1+ macrophage away from the nerve. E) NAM expressing CD163, Lyve1, and 
intracellular MAOA. F) Adipose tissue macrophage expressing CD163 and Lyve1, and intracellular 
MAOA. B-D) Image was generously provided by Elsie Gonzalez-Hurtado  
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Figure 3. 15 Thermogenesis is induced to maintain core body temperature. 
A) Core body temperatures (CBT) measured in the peritoneal cavity by implantation of Star oddi loggers 
over 6 days of diet in male Cth-/- mice fed CTRL or CysF diet. Recordings were taken every 30min (n=11 
Cth-/- CTRL, n=12 Cth-/- CysF, 3 expts represented).  B) Average day and night temperatures quantified. 
C) Measurement of BAT temperature, utilizing MRI imaging technique, BIRDS and D) quantification. 
E-F) Cth+/+ and Cth-/- housed at 22°C or 30°C while on CysF diet for six days. E) Percent body weight 
curves. F) Representative H&E histology images of SFAT at day6 of CysF diet. G) Expression of 
thermogenic genes measured by qPCR. Data expressed as mean±SEM. Statistical differences were 
calculated by (B,E,D) 2-way ANOVA with Sidak’s correction for multiple comparisons, and by (D) 
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Figure 3. 16 Cth-/- Ucp1-/- induce reduced thermogenesis in response to cysteine 
deficiency. 
A-D) Female Cth-/- and Cth-/- Ucp1-/- fed a CysF diet for 6 days (n=8 Cth-/-, n=8 Cth-/- Ucp1-/-). A) Percent 
body weight, and B) fat mass measured by echoMRI. C) Dissected gonadal, subcutaneous, and brown 
adipose tissue weights. D) Representative H&E histology images of SFAT after 6 days of diet. E) EE 
measured in metabolic cages on day 4-5 of CysF diet ((n=8 Cth-/-, n=8 Cth-/- Ucp1-/-) and F) linear 
regression analysis of average EE day4-5 against body mass. G) Core body temperatures (CBT) 
measured in the peritoneal cavity by implantation of Star oddi loggers over 6 days of diet in male Cth-/- 
mice fed CTRL or CysF diet. Recordings were taken every 30min and representative day 4 shown (n=7 
Cth-/-, n=5 Cth-/- Ucp1-/-). Data expressed as mean±SEM. Statistical differences were calculated by (A, 
G) 2-way ANOVA with Sidak’s correction for multiple comparisons, by linear regression analysis (F), 
and by (B, C) unpaired t-test. *p<0.05, **p<0.01, ***p<0.001. 
  88 
 
Figure 3. 17 Cth-/- Ucp1-/- display increased lipolytic and creatine futile cycling 
signature  
A) RER measured in metabolic cages over 6 days of CysF diet (n=8 Cth-/-, n=8 Cth-/- Ucp1-/-) and B) 
day and night averages quantified. C) Western blot analysis of ATGL, TH, and UCP1 in BAT of Cth-/- 
and Cth-/- Ucp1-/- fed a CysF diet for 6 days and D) quantified against tubulin. F) Gene expression 
analysis of thermogenic genes in BAT of Cth-/- Ucp1-/- fed a CysF diet for 6 days, measured by qPCR. 
G) Gene expression analysis of creatine futile cycling genes in BAT of Cth-/- Ucp1-/- fed a CysF diet for 
6 days, measured by qPCR (n=8 Cth-/-, n=10 Cth-/- Ucp1-/-). Data expressed as mean±SEM. Statistical 
differences were calculated by (B, F, G) 2-way ANOVA with Sidak’s correction for multiple 
comparisons, and by (D, E) unpaired t-test. *p<0.05, **p<0.01, ***p<0.001. 
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Chapter 4: Dietary regulation of Immunity 
 
The following chapter was published as a review in Volume 53, Issue 3 in Immunity, 2020 
(Lee and Dixit, 2020). This review was written together with Vishwa D. Dixit.  
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SUMMARY 
Integrated immunometabolic responses link dietary intake, energy utilization, and storage 
to immune regulation of tissue function and is therefore essential for the maintenance and 
restoration of homeostasis.  Adipose resident leukocytes have non-traditional 
immunological functions that regulate organismal metabolism by controlling insulin-
action, lipolysis, and mitochondrial respiration to control the usage of substrates for 
production of heat versus ATP.  Energetically expensive vital functions such as 
immunological responses may have thus evolved to respond accordingly to dietary surplus 
and deficit of macronutrient intake. Notably, chronic positive energy balance manifested 
as obesity compromises immunity, increasing morbidity and mortality from infections 
including Covid-19. Conversely, negative energy balance induced by glucose deprivation 
leads to fatty acid utilization and ketogenesis, promoting longevity and reducing disease 
burden. Here, we discuss the immunometabolic checkpoints that promote healthspan and 




The hominids that were destined to become humans evolved with larger and intensive 
energetic demands for brain function. Host survival thus required mechanisms that balance 
the energetic costs of essential functions such as successful immune response against 
infections and tissue repair.  Accordingly, humans have developed an integrated 
immunometabolic response (IIMR) that involves sensing of nutrient balance by neuronal 
(sympathetic and sensory innervation) and humoral signals (e.g., hormones like insulin, 
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incretins, FGF21, GDF15, ghrelin and leptin) between the hypothalamus and peripheral 
tissues to allow the host to prioritize storage and/or utilize substrates for tissue growth, 
maintenance and immune responses. The evolutionary pressure to maintain healthy 
adiposity concurrently with tissue protective inflammatory responses to injuries and 
infections are important drivers of IIMR. It has been hypothesized that because energy rich 
nutrients have been scarce throughout most of human evolution, dominant genetic 
pathways evolved to favor increasing intake of calorie rich diets and storage of energy as 
triglycerides in adipose tissue.  Within this evolutionary pressure to store calories, 
consumption of energy rich diets in the modern world has given rise to obesity. Excessive 
adiposity or obesity with a body mass index (BMI) of > 30, is a multisystem disorder 
resulting from chronic caloric intake and perturbation of IIMR. A large body of literature 
suggests that altered IIMR in obesity causes a chronic proinflammatory state that is linked 
to diseases such as Type-2 diabetes, non-alcoholic steatohepatitis, and cardiovascular 
disease (Christ et al., 2019). In addition, obesity impairs adaptive immune responses and 
is a major risk factor for mortality and morbidity from H1N1 influenza (Van Kerkhove et 
al., 2011). 
 In opposition to obesity, negative energy balance without malnutrition is induced 
by restriction of calories, and is one of the most effective means for lifespan and healthspan 
extension in multiple species (Anderson et al., 2017; Weindruch and Sohal, 1997). Caloric 
restriction (CR) limits glucose availability and therefore the host must engage fatty acid 
oxidation to generate ATP. The effector immune functions that rely on glucose as their 
primary substrates are likely modulated by such dietary interventions and such 
interventions could be promising avenues to prevent or treat diseases that involve 
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hyperinflammatory responses. It is recognized that severe reduction in nutrient and energy 
intake may cause tradeoffs in non-essential functions. As posited by the disposable soma 
theory, this involves diversion of resources from host growth and reproduction toward 
cellular maintenance, with the evolutionary rationale that when nutrients become available 
again, the conserved pathways dedicated for host defense are preserved and can be re-
engaged (Kirkwood et al., 2000). Which scenarios induce such a tradeoff and whether the 
immune system is indeed dispensable when energy is limiting are open questions. 
However, emerging evidence suggest that immune response to infectious challenges is 
maintained during moderate dietary restriction (Collins et al., 2019; Jordan et al., 2019; 
Nagai et al., 2019) and is boosted when carbohydrate deficient, high fat diet intake induces 
ketogenesis (Goldberg et al., 2019). Surprisingly, restriction of proteins, including the 
restriction of essential amino acid methionine in adult life extends lifespan in rodents by 
almost 40-50% (Orentreich et al., 1993; Solon-Biet et al., 2014). The biochemical 
metabolic pathways engaged by such dietary alterations may hold the keys to identifying 
as of yet unknown mechanisms that could be harnessed to control reparative responses, 
inflammation, and immune-surveillance. In this review we discuss the interaction of dietary 
intake of macronutrients and their metabolic fate on immune system including adipose 
tissue resident leukocytes in regulation of inflammation and organismal metabolism.  
 
Immune Defense in Diet Induced Obesity 
Modern diets are rich in saturated fats and processed carbohydrates, such as high fructose 
corn syrup, and are deficient in fiber, vitamins, and minerals, while containing high 
levels of salt. These diets are a leading cause of the emergence of obesity associated 
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chronic diseases, the majority of which are linked to chronic inflammation (Bray et al., 
2017). A vast number of studies have described a predominant role of inflammation, 
originating from visceral adipose tissue and lipotoxicity, in engaging innate immune 
cells that lead to development of type 2 diabetes through their production of TNFα, IL-
1β and IL-6 (Donath and Shoelson, 2011; Hotamisligil, 2006; Saltiel and Olefsky, 2017). 
There is however, also increasing evidence of obesity as an independent risk factor for 
dysregulated adaptive immune response against various infections. The retrospective 
analyses post 2009 H1N1 pandemic across the globe revealed obesity to be comorbid 
with influenza in nearly one-third of hospitalized patients with increased fatality post 
infection (Van Kerkhove et al., 2011). The mechanism by which obesity disrupts 
immune response and recovery from influenza are manifold and represent the impact of 
chronic metabolic perturbation on multiple cell types.  Diet-induced obese (DIO) mice 
have reduced levels of H1N1-specific antibodies as well as lower neutralization response 
during influenza infection (Honce et al., 2020). Whether obesity impacts germinal center 
reactions, class-switching of antibodies, or the B cell repertoire remains unknown. There 
are data that suggest that obesity restricts T cell receptor (TCR) repertoire diversity 
(Yang et al., 2010) and decreases the number of T cell receptor excision circles (TRECs) 
in blood of obese and diabetic individuals suggesting reduced thymic generation of naïve 
T cells (Yang et al., 2009b).  
In addition, the differentiation of naïve T cells (CD4 and CD8) into an effector state 
upon antigen recognition is dependent on glucose and glutamine (Jacobs et al., 2008; 
Michalek et al., 2011; Pearce et al., 2009; Wang et al., 2011b). It is thus likely that 
hyperglycemia and dyslipidemia seen in obesity affects T cell immune activation against 
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influenza infection. Interestingly, high-fat diet feeding expands γδ T cells in lungs that are 
IL-17 competent but lack a tissue protective transcriptional profile and fail to confer 
protection against influenza (Goldberg et al., 2019). Whether altered lipid versus glucose 
metabolism drives dysfunctional γδ T responses in obesity remains to be characterized.  
 Furthermore, effective memory T cell response relies on efficient transition from 
glycolytic to a more oxidative metabolism (Pearce et al., 2009), although this distinction 
may not be binary in vivo. Recent studies using 13C-based stable isotope labeling 
techniques in T cells highlight that glucose use by CD8+ cells is dynamically regulated 
during the course of an immune response to Listeria infection and identified that glucose 
dependent serine biosynthesis as a key metabolic program for optimal T cell expansion in 
vivo (Ma et al., 2019).  How diet-induced obesity impacts the metabolic reprogramming of 
T cells in vivo in bacterial or viral infection requires further investigation. Initial analyses 
suggest that indeed altered glycolytic and oxidative respiration in memory T cells of obese 
animals is a likely mechanism influencing influenza disease susceptibility (Rebeles et al., 
2019). In addition, Mauro et al found that saturated fatty acid-induced metabolic stress 
affects T cell differentiation and causes preferential trafficking of CD4+ T cells to non-
lymphoid effector sites in obesity.  Palmitate drove CD4+ T cells to acquire a specific 
CD44hi CCR7lo CD62Llo CXCR3+ LFA1+ pro-inflammatory dysfunctional phenotype via 
the activation of a PI3K p110δ-Akt-dependent pathway (Mauro et al., 2017). Interestingly, 
adipose tissue serves as a reservoir of memory T cells specific to several viruses including 
but not limited to lymphocytic choriomeningitis virus (LCMV) and HIV (Damouche et al., 
2015), as well as bacteria like Yersenia, and protozoa like Toxoplasma (Han et al., 2017). 
It is possible that antigen-specific T cells may enter the adipose tissue to potentially resolve 
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the infection but then remain as a memory population distinct from memory T cells in 
classical sites of immune response. Formal studies would be required to test the hypothesis 
that adipose microenvironment shapes the specific transcriptional signatures of memory 
phenotype that is compromised in obesity. It is however known that in obese mice, upon 
re-challenge to infection, adipose memory T cells upregulate lipases and cause severe 
disease including calcification of adipose tissue, pancreatitis, and reduce survival (Misumi 
et al., 2019). Concernedly, data from the COVID-19 pandemic has identified obesity and 
diabetes as a major risk factor in disease severity and mortality (Drucker, 2020) (Box 1). 
Given that in the US, over one third of adults are obese, urgent research efforts are required 
to determine immunoregulatory mechanisms that impact immune response, disease 
tolerance, treatment, and potential vaccination failure in this large high-risk population. 
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Adipose Tissue as an Immunological Organ  
Of the metabolic organs responding in the IIMR during chronic positive energy balance 
(Figure 4.2), adipose tissue has been best characterized and strongly contributes to the 
Box1 Immunometabolic regulators of COVID-19 severity: In addition to old age, 
metabolic syndrome, diabetes, and obesity are independent risk factors for increased 
SARS-COV2 induced mortality and morbidity. Given the prevalence of obesity is 
10% among younger adults aged 20-39, 45% among adults aged 40-59 years and 43% 
among older adults aged 60 and over (Hales et al., 2020), there is urgent need for 
studies that define the mechanism of aberrant immune response that promotes 
predisposition to infection and disease.  Recent analyses show that 47% of cases of 
COVID-19 hospitalization represented obese patients with BMI >30. Moreover, 85% 
of patients above the BMI of 35 developed hyperinflammatory response in lungs that 
required mechanical ventilation to boost oxygen saturation (Simonnet et al., 2020). 
Macrophage activation and neutrophil influx mediate hyperinflammatory response in 
lungs in COVID-19 (Zhou et al., 2020). Given obesity’s known effects on increasing 
inflammation, future studies will be required to determine the immunological 
mechanism of diet driven complications of SARS-Cov2 viral infection. Of note, 
NLRP3 inflammasome, a myeloid cell expressed multiprotein complex that senses 
pathogen associated molecular patterns (PAMPS) and danger associated molecular 
patterns (DAMPS) to cause IL-1β and IL-18 release, is activated in obesity, type-2 
diabetes, atherosclerosis, and aging (Camell et al., 2015; Goldberg and Dixit, 2015). 
There is increasing evidence that SARS-COV2 infection activates the NLRP3 
inflammasome (Siu et al., 2019) with increased levels of IL-18 and lactate 
dehydrogenase (LDH) levels due to inflammasome mediated pyroptotic cell death 
(Lucas et al., 2020; Zhou et al., 2020).  Interestingly, SARS-CoV open reading frame 
3a (ORF3a) and ORF8b activates the NLRP3 inflammasome (Siu et al., 2019) by 
inducing ER stress and lysosomal damage (Shi et al., 2019), mechanisms that are 
independently shown to be elevated in obesity. It is now known that increased 
glycolysis, which also induces transcriptional upregulation of inflammasome 
machinery, causes aberrant activation of myeloid cells and worsens COVID-19 (Codo 
et al., 2020). This raises the question whether dietary approaches that mimic a 
glucoprivic state by feeding of a low carbohydrate, high fat diet, which necessitates 
the switch from glycolysis to production of ketone metabolites, can be employed to 
stave off COVID-19. Indeed, ketone bodies inhibits the Nlrp3 inflammasome (Youm 
et al., 2015) and ketogenic diet protects against influenza-induced lethality in mice by 
expanding γδ-T cells (Goldberg et al., 2019). Thus, raising the possibility that 
harnessing specific immunometabolic checkpoints, such as glycolytic-to-ketogenic 
switch maybe relevant to several infections, including SARS-COV2.  
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pathogenesis of obesity. Obese adipose contains approximately 2 to 5 million stromal-
vascular cells per gram, of which approximately 60-70% are immune cells. In severe 
obesity, adipose tissue can expand to constitute up to 30-50% of total body mass 
(Kanneganti and Dixit, 2012). Thus, the adipose tissue represents an underappreciated 
immunological organ that harbors distinct subpopulations of immune cells that localize to 
specific niches to perform potentially unique functions.  
Even before it was recognized that immune function could be regulated by cellular 
metabolism (Buck et al., 2015; Frauwirth et al., 2002; O'Neill et al., 2016), the discovery 
that obesity-induced insulin resistance was directly caused by elevated TNF levels in 
adipose tissues launched the field of immunometabolism, pioneering the association of the 
immune system with metabolic processes (Hotamisligil et al., 1993). Although, initially 
thought to be derived from adipocytes, later studies clarified that accumulation of 
macrophages in the adipose were the main drivers of inflammatory cytokine production 
(Lumeng et al., 2007b; Weisberg et al., 2003). It has now been elucidated that during 
obesity, in addition to macrophages, there are large changes in the adipose immune 
landscape as certain cells are recruited and activated while other cell types are depleted and 
replaced, leading to a more proinflammatory environment that drives type 2 diabetes and 
chronic disease progression (Figure 4.3). Mechanistically, proinflammatory cytokines such 
as TNF, IL-6 and IL-1β have been shown to block insulin receptor signaling through 
inhibition of insulin receptor substrates (IRSs), by increasing their serine phosphorylation 
(Hotamisligil et al., 1996; Werner et al., 2004). Conversely, gain of function of IKKβ in 
the liver was found to reduce ER stress by elevated XBP1 activity leading to an actual 
improvement in insulin-sensitivity (Liu et al., 2016). Additional studies are required to 
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determine the delicate balance of chronic pro- and anti-inflammatory cytokine signaling 
required to repair and restore metabolic homeostasis. 
 
Adipose Tissue Macrophages in Obesity 
It is now understood that macrophages are resident immune cells found in almost every 
tissue, and play key roles in maintaining homeostasis (Lavin et al., 2014; Okabe and 
Medzhitov, 2014). In healthy adipose tissue, macrophages are thought to constitute about 
10% of the hematopoietic cell composition. However, it is possible that enzymatic 
digestion protocols of adipose tissue are not releasing all macrophages from their tissue 
niches and thus current analyses may be underestimating the total quantity of cells residing 
in fat. During obesity, an infiltration of monocytes and macrophages, local proliferation, 
reduced egress, and increased cell longevity leads to a further accumulation of 
macrophages (Amano et al., 2014; Hill et al., 2015; Nagareddy et al., 2014; Oh et al., 2012) 
so that more than 50% of the cells in the fat depot can be made up of macrophages (Lumeng 
et al., 2007b; Weisberg et al., 2003). 
Proinflammatory ATMs drive obesity induced insulin resistance by activating 
kinases such as IκB Kinase (IKK) and JNK (Arkan et al., 2005; Han et al., 2013; Solinas 
et al., 2007). ATMs that accumulate at crown-like structures (CLSs) further secrete 
exosomes containing miR155 that act on adipocytes to block insulin signaling (Ying et al., 
2017). Ablation of proinflammatory CD11c+ ATMS during DIO reduces local and 
systemic proinflammatory cytokine levels, reduces CLSs and infiltrating macrophages, and 
leads to rapid normalization of insulin sensitivity, thus highlighting the role of 
inflammatory ATMs in driving metabolic disease (Patsouris et al., 2008). However, ATMs 
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can be divided into various populations of diverse lineages and functionality that respond 
dynamically to local metabolic cues within their unique niches. While these macrophage 
subsets are still being defined, careful examination of the transcriptional profiles of 
different ATM groups have clarified that there are numerous ways to define macrophage 
subsets and most infiltrating macrophages in adipose tissue in chronic inflammation do not 
fit a simple M1/M2 polarization model (Camell et al., 2017; Kratz et al., 2014). 
 In lean adipose tissue, macrophages are a mixed heterogeneous population of yolk 
sac derived, self-maintaining macrophages and bone marrow (BM) derived monocytes and 
macrophages that are continuously replenished (Amano et al., 2014; Hassnain Waqas et 
al., 2017; Schulz et al., 2012; Silva et al., 2019).  Silva et al have recently described 4 
different groups of lean visceral ATMs. The group of macrophages which make up the 
majority of ATMs in lean adipose tissue express high levels of CD206 and are CD11b+ 
MHCII+ Tim4+ (Silva et al., 2019). Through bone marrow chimera experiments, these 
macrophages were found to be largely tissue resident with minimal replenishment from the 
periphery (Amano et al., 2014; Silva et al., 2019). Surprisingly, these macrophages were 
found to be laden with lipids even in the lean state (Silva et al., 2019). One of the roles of 
macrophages in lean adipose is to clear dead adipocytes. ATMs form CLSs around dying 
adipocytes to clear the dying cell and lipids in a contained manner (Murano et al., 2008). 
Because adipocytes are too large to fully be engulfed by macrophages, ATMs release acidic 
exosomes laden with lysosomal enzymes that can take up and degrade large adipocyte 
fragments which can then be taken up by the macrophages in a process called exophagy 
(Haka et al., 2016). This process allows for macrophages to internalize large amounts of 
lipids. During obesity, this process becomes increasingly overburdened as there is an 
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increase in the number of dying adipocytes and CLSs. The accumulation of macrophages 
in response to high fat diet is mostly attributed to an influx of peripheral BM derived 
monocytes that quickly differentiate and proliferate locally (Amano et al., 2014; Hill et al., 
2018; Jaitin et al., 2019; Nagareddy et al., 2014; Oh et al., 2012; Silva et al., 2019). The 
macrophages that accumulate with obesity are also heterogeneous and further studies may 
clarify the specific roles of each subset in disease progression (Hill et al., 2018; Jaitin et 
al., 2019).  
Most of the infiltrating macrophages are found at CLSs and proliferate locally. 
They are largely CD9+ and are enriched with signatures for lipid metabolism, lysosomal 
biosynthesis, and phagocytosis (Hill et al., 2018; Jaitin et al., 2019; Xu et al., 2013). 
Transcriptomic profiling has identified that CD9+ macrophages that accumulate with diet-
induced obesity also express CD163 and Trem2. Due to their association with enlarged 
adipocytes at CLSs, these macrophages have been named lipid associated macrophages, or 
LAMs (Jaitin et al., 2019). Depletion of TREM2+ LAMs led to reduced lipid uptake by 
macrophages and increased adipocyte hypertrophy and weight gain, and a worsening of 
glucose homeostasis, challenging the idea that infiltrating ATMs during obesity purely 
cause disease progression, but also play critical protective roles in the adaptation to 
metabolic stresses that occur during obesity (Jaitin et al., 2019). 
 Adipose tissue is highly vascularized. As adipocytes increase in size and number 
via hypertrophy and hyperplasia to store excess calories as triglycerides, hypoxia ensues 
as the diffusion limit of oxygen is reached. Pockets of local hypoxia leads to angiogenesis 
to meet the oxygen demands required for hypertrophy and increased mitochondrial 
respiration. Lyve1+ macrophages express MMP-7,-9, and -12 to remodel the ECM and 
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promote angiogenesis (Cho et al., 2007). In lean adipose, macrophages are found tightly 
wound around blood vessels as a subset of perivascular macrophages, or PVMs (Hilgendorf 
et al., 2019; Silva et al., 2019). These self-maintaining PVMs that are in direct contact with 
the vasculature make up a large proportion of macrophages in healthy adipose and express 
high levels of CD206 (Silva et al., 2019). Surprisingly, PVMs store lipid droplets even in 
the lean state, and rapidly take up dextran and OVA from the circulation, suggesting that 
they are constantly surveilling and buffering lipids within the adipose circulation and may 
play important roles in presenting antigen and maintaining T cells within the adipose tissue 
(Silva et al., 2019). During obesity, PVMs change in morphology from an elongated shape 
to a rounded shape and have a reduction in their capacity to take up dextran, suggesting 
that their homeostatic functions are diminished in response to high-fat diet (Silva et al., 
2019). As PVMs may play important roles as APCs, how this may impact the interaction 
of PVMs with other immune populations during DIO remains to be elucidated.  
 Adipose tissue is also densely innervated by both sympathetic and sensory nerves 
which are important in controlling lipolysis and thermogenesis (Bartness et al., 2014; Chi 
et al., 2018; Slavin and Ballard, 1978). Density of innervation varies amongst different fat 
depots, with brown adipose having the most, then subcutaneous adipose depots, and 
various visceral adipose tissues such as the mesenteric adipose and gonadal adipose tissues. 
Release of catecholamines such as norepinephrine (NE) by sympathetic nerves is essential 
for hydrolysis of triglycerides into fatty acids, a process called lipolysis that provides 
substrates for energetic and synthetic purposes. (Bartness et al., 2010).  Interestingly, 
macrophages also reside on nerves in the adipose tissue as nerve associated macrophages, 
or NAMs (Camell et al., 2017; Pirzgalska et al., 2017; Wolf et al., 2017). While a 
  102 
significant portion of brown adipose NAMs are self-maintaining, long lived resident 
macrophages, white adipose NAMs are more frequently replenished by BM derived 
macrophages (Pirzgalska et al., 2017; Wolf et al., 2017). NAMs lack tyrosine hydroxylase 
and therefore do not produce catecholamines (Fischer et al 2017. Pirzgalska et al 2017, 
Spadaro et al 2017). Instead, they express the canonical catecholamine transporter, Slc6a2, 
allowing for the uptake of catecholamines from the local environment and express 
catecholamine degradation enzymes such as monoamine oxidase A (MAOA) and catechol-
o-methyl transferase (COMT) to control local availability of catecholamines (Camell et al., 
2017; Pirzgalska et al., 2017). Furthermore, the expression of MAOA and COMT in NAMs 
is upregulated by NLRP3 mediated inflammation during obesity and aging, leading to 
increased catecholamine degradation by NAMs to contribute to metabolic dysregulation 
(Camell et al., 2017). How NAMs integrate metabolic and immune sensing in adipose 
tissue in response to diet is not well understood and is likely to reveal important non-
traditional functions of macrophages in maintaining tissue homeostasis. 
 
Impact of Diet Induced Obesity on Adipose Leukocytes 
Besides macrophages, many other immune cell types have been described in 
adipose tissue and in the context of obesity. Adipose tissue is relatively enriched with 
innate lymphoid cells such as eosinophils, innate lymphoid cells (ILCs), iNKT cells, and 
γδ T cells and have been well described in other reviews (Kane and Lynch, 2019; Mraz 
and Haluzik, 2014).  In brief, mast cells, ILC1s, γδ T cells, and neutrophils all increase in 
adipose tissue with obesity and are associated with inflammation. Mast cells increase in 
the visceral adipose tissue (VAT), particularly around CLSs and actively degranulate to 
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release TNFα, IL-6, and IFNγ to promote obesity and diabetes (Altintas et al., 2011; Liu et 
al., 2009). Recently, Zhang et al. have demonstrated that dietary cholesterol leads to 
activation of mast cells, suggesting mast cells may be directly sensing and responding to 
dysregulated metabolites (Zhang et al., 2019). Neutrophils are transiently increased during 
obesity, and are one of the earliest cells to infiltrate adipose tissue and secrete elastase to 
contribute to pathology (Elgazar-Carmon et al., 2008; Talukdar et al., 2012). ILC1s or NK 
cells were found to contribute to obesity by producing IL-2 and IFNγ to promote M1 
skewing in macrophages, and displayed higher killing activity towards M2 like 
macrophages over M1 like macrophages (Boulenouar et al., 2017; O'Sullivan et al., 2016). 
In humans, CD1c+, CD11c+CD83+ DCs increase in obese adipose and induce Th17 
differentiation (Bertola et al., 2012).  
γδ T cells are tissue resident and increase during diet induced obesity (Mehta et al., 
2015). Mice lacking γδ T cells have reduced accumulation of proinflammatory 
macrophages and significant reductions in systemic insulin resistance, suggesting that γδ 
T cells play a role in driving the proinflammatory response during diet induced obesity 
(Mehta et al., 2015). However, γδ T cells may also serve homeostatic functions in healthy 
adipose tissue as IL-17A production by γδ T cells stimulates the secretion of IL-33 in 
stromal cells to maintain the expansion of Tregs in adipose tissue during development 
(Kohlgruber et al., 2018).  Conversely, iNKT cells, ILC2s, eosinophils are reduced in the 
adipose tissue during obesity and their presence is associated with a reduction in metabolic 
inflammation, increased insulin signaling and promotion of thermogenesis (Lynch et al., 
2016; Lynch et al., 2009; Molofsky et al., 2015; Wu et al., 2011).  
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Besides innate immune cells, B and T cells also become dysregulated during 
obesity. B cells in healthy adipose tissue are thought to express IL-10 to negatively control 
adipose tissue inflammation (Nishimura et al., 2013). During obesity, although adipose B 
are fewer than T cells, there overall numbers are increased and contribute to insulin 
resistance by secreting autoreactive, pathogenic IgG antibodies and cytokines that drive 
inflammatory macrophages, Th17 polarization, and CD8+ T cell cytotoxicity (DeFuria et 
al., 2013; Duffaut et al., 2009; Winer et al., 2011). Cytotoxic CD8 T cells increase with 
high fat diet even before macrophages accumulate (Rausch et al., 2008) and along with 
increased Th1 cells contribute to insulin resistance during obesity (Nishimura et al., 2009; 
Pacifico et al., 2006; Winer et al., 2009). The expansion of T cells before infiltration of 
peripheral monocytes and macrophages occurs through antigen expression of resident 
ATMs, especially within CLSs, but the increase in T cells may not be exclusively through 
clonal expansion during obesity (Morris et al., 2013). Regulatory T cells and iNKT cells 
largely contribute to the homeostasis of adipose tissue and produce anti-inflammatory 
factors such as IL-10, IL-4, and TGF-β to promote metabolic homeostasis (Feuerer et al., 
2009; Lynch et al., 2012; Schipper et al., 2012). During obesity, both Tregs and iNKT cells 
are reduced in adipose tissue (Feuerer et al., 2009; Lynch et al., 2009). How many of these 
immune cells are sensing metabolic dysregulation and macronutrient availability remains 
to be established.  
 
Immune Cells Regulate Thermogenesis  
Maintenance of core-body temperature in homeotherms through heat production is a high 
priority metabolic event that is crucial for survival. The invaginations of the inner 
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mitochondrial membrane that forms cristae are the sites of oxidative phosphorylation 
(OXPHOS) complexes that generate ATP (Kozak and Harper, 2000). In addition to ATP 
synthesis, mitochondrial OXPHOS generates heat as an energy byproduct. To enhance 
adaptive thermogenesis, adipocytes upregulate the expression of UCP1 (uncoupling 
protein 1) that forms pores in the inner mitochondrial membrane to allow protons to pass 
through without producing ATP (Kozak and Harper, 2000). Therefore, in the uncoupled 
mitochondria, the rate of OXPHOS is significantly boosted and releases heat instead of 
ATP. While UCP1 was long thought to be the primary mediator of non-shivering 
thermogenesis, the discovery that UCP1-/- mice are able to adapt to long term cold exposure 
exposed the possibility of alternative thermogenic mechanisms independent of UCP1 
(Ukropec et al., 2006). More recently, studies have revealed that other mechanisms such 
as futile creatine cycling, sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) mediated 
calcium cycling, and UCP3 can also contribute to fat thermogenesis (Ikeda et al., 2017; 
Kazak et al., 2015; Riley et al., 2016).  
Macrophages control thermogenesis by controlling the bioavailability of 
catecholamines. Inhibition of MAOA in macrophages, increases NE content in adipose 
tissue leading to increased lipolysis and thermogenesis by upregulation of UCP1 (Camell 
et al., 2017). Moreover, ILC2s, eosinophils, iNK T and γδ T cells have also been implicated 
in increasing thermogenesis and upregulating UCP1 (Brestoff et al., 2015; Hu et al., 2020; 
Lynch et al., 2016; Qiu et al., 2014). Notably, FGF21, which gets induced during dietary 
restriction, can promote the expression of CCL11 by adipocytes to recruit eosinophils, 
suggesting that immune cells are actively regulated during adaptive adipose tissue 
remodeling (Huang et al., 2017). Future studies are required to determine whether immune 
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cells directly affect UCP1 and alternative thermogenic pathways, differentiation of de novo 
brown/beige adipocytes, or regulate the sympathetic nervous system to control heat 
production. Identification of such mechanisms may reveal strategies to divert the fate of 
dietary lipids from storage to heat production through increased mitochondrial uncoupling, 
thus reducing metabolic diseases emanating from lipotoxicity and obesity. 
 
Inflammation and Adipose Tissue Fibrosis 
Metabolic perturbations such as diet induced obesity or dietary restriction lead to rapid 
remodeling of the adipose tissue, where alterations in extracellular matrix (ECM) proteins 
play an important role in maintaining adipose tissue homeostasis. During obesity, there are 
dynamic changes in the deposition of ECM components such as collagens, fibrillins, 
proteoglycans, and specific matrix metalloproteases. While obesity is associated with an 
excessive accumulation of hypoxia driven fibrosis that directly leads to poor metabolic 
output (Halberg et al., 2009), the regulation and interaction of adipose ECM and the 
immune system is still being established. Chronic inflammation had been thought to be the 
main driver of fibrosis and metabolic dysfunction during obesity, but studies have revealed 
that fibrosis may precede and occur independently of tissue inflammation (Halberg et al., 
2009). Furthermore, repression of fibrosis alone can improve metabolic parameters without 
largely affecting inflammation (Hasegawa et al., 2018; Khan et al., 2009). However, 
immune cells may contribute to the continued pathologic fibrosis during chronic obesity. 
Wang and colleagues have demonstrated that IFNγ producing ILC1s can increase TGF-β 
output by macrophages to increase fibrosis, while sensing of dying adipocytes and hypoxia 
by Mincle and HIF1-α in macrophages within CLSs can further drive adipose tissue 
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fibrosis (Henegar et al., 2008; Tanaka et al., 2014; Wang et al., 2019a). Recent studies 
suggest that Mincle may potentially be sensing cholesterol moieties released by dying 
adipocytes, as human Mincle can bind crystalline cholesterol and Mincle was shown to 
sense cholesterol sulfate in mouse skin (Kiyotake et al., 2015; Kostarnoy et al., 2017). 
Further understanding of how different ECM components interact with the immune system 
to mediate adipose homeostasis and pathology remains to be elucidated. 
  
Obesity is not accelerated aging of adipose resident immune system 
Both obesity and aging are characterized by NLRP3 inflammasome driven low grade 
chronic inflammation and metabolic dysregulation. Despite these shared similarities, 
obesity is not an accelerated model of aging. While aging is commonly associated with 
visceral obesity, there are distinct immunological changes that underlie the pathological 
disease progression of each condition (Figure 4.3).  
In adipose tissue, obesity leads to an increase in most of the defined macrophage 
subsets (Jaitin et al., 2019; Silva et al., 2019). During aging, however, the opposite trend is 
observed where macrophage numbers modestly decline (Camell et al., 2017; Lumeng et 
al., 2011). Age associated VAT ATMs are enriched for NLRP3 dependent senescence and 
catecholamine catabolism gene signatures, with GDF3 being the most highly upregulated 
gene with age (Camell et al., 2017). While an accumulation of senescent pre-adipocytes, 
endothelial cells, and T cells have been described with age in adipose tissue, these 
signatures have yet to be highlighted in highly proliferative obese ATMs (Salvestrini et al., 
2019). Careful investigation of how these newly defined subsets of macrophages and their 
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niches change with age may help identify therapeutic targets in ameliorating metabolic 
pathogenesis in aging. 
 In contrast to the reduction of innate macrophage populations with aging, adaptive 
B and T cells increase in fat with age (Camell et al., 2019; Lumeng et al., 2011).  While 
there is also an increase in T and B cells in obese adipose tissue, during aging these cells 
accumulate in specific niches called fat associated lymphoid clusters (FALCs). Hence, 
FALCs increase their size and number with age (Lumeng et al., 2011). FALCs are a form 
of non-classical lymphoid structures that are not encapsulated like traditional lymph nodes 
but can form germinal centers and respond to immunological challenges (Cruz-Migoni and 
Caamano, 2016).  While sterile peritoneal inflammation induced by zymosan increases the 
size and numbers of FALCs in visceral adipose depots, an increase in FALC formation is 
not associated with inflamed obese fat (Benezech et al., 2015). During aging, there is a 
NLRP3 dependent accumulation of adipose tissue resident B cells within FALCs that 
produce inflammatory mediators such as IL-1β and CCL2. Depletion of adipose B cells in 
aged mice improves lipolytic signaling and insulin sensitivity, identifying aged adipose B 
cells as important mediators of age associated insulin resistance, lipolysis resistance, and 
adipose dysfunction (Camell et al., 2019).  
Tregs play important regulatory roles in protecting metabolic homeostasis in the 
adipose of young animals and their dramatic reduction during obesity contributes to 
pathology (Feuerer et al., 2009). Conversely Tregs accumulate in adipose with age (Bapat 
et al., 2015; Lumeng et al., 2011). Unlike young Tregs, the accumulation of aged adipose 
Tregs drive insulin resistance and depletion of Tregs in aged animals improves metabolic 
health (Bapat et al., 2015). However, when aged animals are challenged with HFD to 
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induce obesity, metabolic homeostasis is not maintained by depletion of Tregs, confirming 
that distinct mechanisms drive the pathophysiology of age and obesity associated insulin 
resistance (Bapat et al., 2015).  
Other adipose resident immune cells which have been characterized in healthy and 
obese adipose tissue still require additional examination in the context of aging. While 
eosinophils which are associated with promoting homeostasis in healthy adipose are 
decreased in obese fat, there seem to be no substantial changes during aging (Bapat et al., 
2015; Wu et al., 2011). Innate T lymphocytes such as iNKT cells are decreased during 
obesity whereas iNKTs significantly increase with age, and γδT cells increase during both 
obesity and age in the visceral adipose tissue (Kohlgruber et al., 2018). Surprisingly, ILC2s 
which reside in visceral adipose tissues, including in FALCs, and produce IL-5 and IL-13 
to recruit and maintain eosinophils are also reduced with aging (Molofsky et al., 2015; 
Moro and Koyasu, 2010). In fact, many of the age associated immunological changes that 
drive metabolic pathology predominantly occur within the visceral adipose. While immune 
composition remains to be characterized within the BAT, the depletion of macrophages, 
and accumulation of FALCs and Tregs with age occur mainly in the visceral adipose 
depots. Similarly, during obesity, changes in pro-inflammatory subsets such as 
macrophages are much stronger in visceral adipose depots compared to subcutaneous 
adipose tissue (Weisberg et al., 2003).These depot specific immune perturbations likely 
drive tissue differences as visceral adiposity is strongly associated with increased risk for 
metabolic dysfunction and disease whereas SFAT has been considered to be more 
beneficial by acting as a metabolic sink that can buffer daily influx of nutrients to prevent 
ectopic lipid storage in visceral organs (Chusyd et al., 2016). As the immune system within 
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adipose continues to be explored, it is becoming clear there are complex crosstalk between 
different immune cell types. How these homeostatic interactions become dysregulated 
during obesity and aging, and their specific tissue niches, remain to be carefully 
investigated. 
 
Dietary Protein and Amino Acid Restriction  
While the mechanisms of CR are not completely understood, protein quality and amino 
acid composition of diet have been more strongly associated with metabolic and age 
associated health. Independently of caloric intake, low protein and high carbohydrate diets 
were found to have the strongest extension of lifespan (Solon-Biet et al., 2014). In addition 
to dietary protein restriction (PR), some studies suggest it is the restriction of essential 
amino acids (EAAs) that drive beneficial effects, as supplementing dietary restriction with 
EAAs but not non-essential amino acids were sufficient to reverse prolongevity effects 
(Grandison et al., 2009; Yoshida et al., 2018). Restriction of specific EAAs, such as the 
restriction of sulfur-containing amino acids (SAAs), methionine and cysteine, or 
methionine restriction (MR), and deficiency of the branched chain amino acids, leucine, 
isoleucine, and valine, or branched chain amino acid restriction (BCAAR), have been 
extensively characterized to increase metabolic homeostasis and promote healthy aging 
(Fontana et al., 2016; Lee et al., 2016; Solon-Biet et al., 2014). These dietary interventions 
commonly lead to reduced adiposity and inflammation, increased insulin sensitivity and 
lipolytic gene signatures, and reduction of lipogenesis in adipose tissue and liver (Kitada 
et al., 2019). Although much less characterized, restriction of tryptophan can also lead to 
increased lifespan and increases recovery to cold stress, suggesting an increase in 
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thermogenic capacity (Segall and Timiras, 1975, 1976; Zapata et al., 2018). Surprisingly, 
these studies indicate that deficiencies of specific essential amino acids drive remodeling 
and programming of metabolic tissues to promote health. Despite numerous studies 
investigating the mechanisms driving increased longevity during these dietary 
interventions, alterations to the immune system and their role in tissue reprogramming have 
been lacking.  
One of the pathways that are induced with CR, PR, and amino acid restriction, is 
the transsulfuration pathway (TSP) (Hine et al., 2015; Mitchell et al., 2016). The TSP 
involves the metabolism of SAAs and involves the catabolism of methionine to generate 
intermediates such as the methyl donor S-adenosylmethionine (SAM), S-
Adenosylhomocysteine (SAH), homocysteine, and cystathionine. The TSP also allows for 
the generation of cysteine through the action of cystathionine-γ lyase (CSE) which can 
further provide important metabolites and byproducts such as glutathione, pyruvate, and 
hydrogen sulfide (H2S) (Figure 4.4). Some TSP metabolites such as SAM and 
homocysteine are increased with obesity and aging and have been implicated with 
inflammation and disease risk (Elshorbagy et al., 2013; Obata and Miura, 2015; Rodriguez 
et al., 2006; Vaya et al., 2012).  
Another exciting, relevant byproduct of the TSP is H2S. Hydrogen sulfide is a 
gaseous signaling molecule produced by three mammalian enzymes, cystathionine-gamma 
lyase (CSE), cystathionine-beta synthase (CBS), and 3-mercaptopyruvate sulfurtransferase 
(MPST), but some studies have shown that H2S may be produced via non enzymatic 
reactions (Glorieux et al., 2020). Of note, lifespan extension induced by CR in Drosophila 
was abolished when treated with the inhibitor of CSE, propargylglycine (PPG) (Kabil et 
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al., 2011), and overexpression of another TSP enzyme, cystathionine β-synthase (CBS) or 
treatment with H2S increased median lifespan in C. elegans and yeast respectively, 
highlighting TSP mediated H2S production as an important mediator of dietary benefits 
(Hine et al., 2015). Interestingly, a role for H2S in immune responses is emerging. In T 
cells, H2S is required for the differentiation of regulatory T cells by promoting 
demethylation at the Foxp3 locus by Tet1 and Tet2 (Yang et al., 2015). An anti-
inflammatory role for H2S has been implicated by its action on NF-κB to regulate its 
transcriptional activity in macrophages (Sen et al., 2012), and its action on antioxidant gene 
regulation (Yang et al., 2013).  These studies highlight that H2S may generally promote a 
more anti-inflammatory phenotype in immune cells. In myeloid cells, H2S can act 
specifically to inhibit inflammasome activation (Castelblanco et al., 2018; Lin et al., 2018), 
which may act as an important mechanism to reduce inflammation and initiate tissue 
remodeling during dietary interventions. However, studies with H2S have been largely 
limited to in vitro studies using H2S donors, inhibitors, or whole-body deletions of TSP 
enzymes, particularly CSE. CBS deficiency in mice leads to neonatal lethality (Gupta et 
al., 2009), further complicating the investigation of the role of H2S in immune cells. These 
complications have led to numerous contradictory reports of the action of H2S on immune 
cells, such as the action of H2S in regulating leukocyte adherence and tissue infiltration or 
NLRP3 activation (Basic et al., 2017; Spiller et al., 2010; Zanardo et al., 2006).  Cell 
specific and tissue specific genetic deletion may allow for careful dissection of the role of 
the TSP in modulating immune response in physiological contexts.  
 Another pathway that is increased during protein and amino acid restriction is 
integrated stress response mediated autophagy. The integrated stress response allows for 
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adaptive responses to various stresses such as starvation and ER stress. Stressors are sensed 
by four different sensors: general control nonderepressible 2 (GCN2), protein kinase R 
(PKR), haem-regulated inhibitor (HRI), and PKR like endoplasmic reticulum kinase 
(PERK) (Pakos-Zebrucka et al., 2016). GCN2 senses amino acid depletion by sensing the 
accumulation of uncharged tRNAs (Gallinetti et al., 2013). HRI recognizes heme 
deficiency, while PKR senses viral infection through activation by double stranded RNA 
(Pakos-Zebrucka et al., 2016). Finally, PERK is activated by ER stress (Pakos-Zebrucka et 
al., 2016). Activation of these sensors are integrated by the activation and phosphorylation 
of eIF2ɑ leading to global translational arrest (Pakos-Zebrucka et al., 2016). One central 
component of the integrated stress response is autophagy (Kroemer et al., 2010). In 
addition to GCN2 sensing of uncharged tRNAs, depletion of EAAs leads to interaction of 
their specific sensors such as SAMTOR (SAM sensor), sestrin 2 (leucine sensor), and 
CASTOR (arginine sensor) with GATOR1 or GATOR2 to prevent mTORC1 activation 
and promote autophagy (Kim and Guan, 2019) (Figure 3). Interestingly, autophagy and 
amino acid sensing also regulates immune function. It is now well established that 
autophagy inhibits inflammasome activation (Sun et al., 2017). In a model of colitis, PR 
and leucine restriction were able to reduce inflammation through the inhibition of NLRP3 
inflammasome mediated inflammation and reduction of Th17 differentiation. This 
response was dependent on amino acid sensing through GCN2 (Ravindran et al., 2016). 
Furthermore, treatment with halofuginone, which activates starvation responses by 
inhibiting prolyl tRNA charging, also inhibits Th17 cell differentiation (Sundrud et al., 
2009). These studies highlight the induction of amino acid starvation responses in immune 
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cells as potential strategies against inflammation driven pathological states such as obesity, 
aging, and autoimmunity.  
While these different dietary amino acid restrictions may be inducing some 
common pathways, specific amino acids may target different pathways. Unlike leucine or 
BCAA restriction diets, MR also induces hepatic FGF21 and lipolytic gene signatures 
independently of GCN2 (Lees et al., 2017). Instead, MR specific hepatic changes are driven 
by PERK and glutathione depletion (Wanders et al., 2016). Thus, different mechanisms 
may drive adaptations to specific amino acid deficiencies in tissues and immune cells 
(Figure 3). Despite numerous studies investigating the broad metabolic adaptations that 
occur during PR, how immune cell function is being altered have been lacking. A plethora 
of early studies have investigated immune defense in the context of protein malnutrition, 
suggesting alterations in both macrophage and lymphocytic responses to infection. 
However, these studies were conducted prior to the classification of broad immune subsets 
and advancement of technological tools and need to be revisited to properly understand 
how the immune system may be responding during PR without malnutrition in the context 
of both tissue adaptation and immune defense.  
 
Integrated Immunometabolic Response to Carbohydrate and Caloric Restriction  
In an event of low glucose availability, such as food restriction, the limited glycogen 
reserves in the liver and muscle cannot sustain nonessential metabolic demand. Instead, 
triglycerides undergo fatty acid oxidation, ketogenesis, and ketolysis to support ATP 
production.  
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It is known that long-term CR lowers inflammation and protects against thymic 
lipoatrophy and maintains T cell repertoire during aging (Yang et al., 2009a). Intriguingly, 
however, CR causes a major redistribution of circulating leukocytes. A two-year 
multicenter randomized controlled trial where healthy humans achieved approximately 
14% CR (CALERIE-II) provided evidence that CR reduces the number of circulating 
lymphocytes and monocytes without compromising vaccine responses or increasing 
susceptibility to infections (Meydani et al., 2016). Similarly, studies from Jordan et al 
found that 19hr of fasting in humans led to reduction of monocytes and dendritic cells in 
blood but instead increased retention of pro-inflammatory Ly6Chi monocytes in the BM 
(Jordan et al., 2019). In agreement with prior studies (De Rosa et al., 2015) fasting reduced 
systemic inflammation in a mouse model of multiple sclerosis. Importantly, monocytes 
could still respond and control Listeria monocytogenes infection during fasting in a PPARα 
dependent manner (Jordan et al., 2019). Similarly, negative energy balance mediated 
reduction in mTOR also led to CXCL13 driven homing of naïve B cells from Peyer’s 
patches to BM. Moreover, Collins et al found that mice subjected to 50% dietary restriction 
for 3 weeks caused a loss of peripheral memory CD8 T cells and their surprising 
accumulation in the BM. Markedly, this redistribution of B and memory T cells led to 
enhanced protection against secondary bacterial infection (Collins et al., 2019). It is 
intriguing that during energy deficit, memory T cells do not prefer adipose tissue that is 
undergoing increased lipolysis with abundant fatty acids as energy substrates, and home 
instead to BM. CR’s salutary effects on immune system and control of inflammation 
require further characterization. From the current evidence, switch from glycolysis to fatty 
acid oxidation appears to be an important immunometabolic checkpoint affected by CR. 
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For example, production of ketone bodies like β-hydroxybutyrate downstream of fatty acid 
oxidation, inhibits Nlrp3 inflammasome mediated inflammation and protects against 
influenza infection by expanding tissue protective γδ T cells in lung and adipose tissue 
(Goldberg et al 2019). Whether low carbohydrate high fat ketogenic diet that increases 
fatty acid oxidation and BHB can be harnessed to protect against inflammatory damage, as 
in Covid-19 immunopathology, requires careful testing. The endogenous 
immunometabolic mediators that drive CR salutary effects thus offer a promising avenue 
to regulate inflammation and enhance healthspan.  
 
Concluding Remarks 
Significant progress over the last decade has firmly established that reciprocal interactions 
between immune and metabolic systems are required for the host to maintain homeostasis. 
Immunometabolism, not only encompasses immune cell intrinsic regulation of glycolysis, 
TCA cycle, pentose phosphate pathway, and fatty acid metabolism to impact inflammation 
and effector functions, but also entails immune regulation of systemic whole-body 
metabolism and coupling of positive and negative energy balance to successful immune 
response. As outlined in this review, the integrated immunometabolic response is in fact 
vital for regulation of organismal metabolism and host defense. A major influencer of IIMR 
is the diet. It is evident that metabolic fate of fat, protein and carbohydrates is important 
for immunologic function. However, how macronutrient intake elicits specific pathways in 
a host to either induce disease or promote health and longevity is only beginning to be 
understood. In addition, both immune response and metabolism are regulated by the 
autonomic nervous system which are not under our conscious control. The neural 
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regulation of immunometabolism, by which the autonomic nervous system integrates the 
central nervous system, immune system, and metabolic organs to maintain essential 
functions and prepare the host for surmounting stressful challenges, is not well understood. 
Thus, study of Neuro-Immunometabolism may reveal new mechanisms to promote health 
and understand disease. Identification of immune cells like macrophages in sympathetic 
nerve niches in adipose tissue represents one mode of neuroimmunometabolic crosstalk 
that controls inflammation and lipolysis setpoints. These advances have set the stage for 
the next era of immunometabolism studies where regulation of diet driven metabolic 
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Figures 
 
Figure 4. 2 Negative energy balance drives integrated immuno-metabolic responses 
to counterbalance homeostatic processes to promote longevity. 
Negative energy balance is achieved with energy consumed is less than energy expended. This drives 
neuroendocrine hormone effectors such as ghrelin, FGF21, and GDF15, and the usage of alternative 
metabolic fuels such as fatty acids and ketone bodies. These signals get integrated by organs such as the 
brain, liver, adipose tissue, gut, and skeletal muscle with the immune system to promote metabolic 
reprogramming that prioritizes fatty acid oxidation over glycolysis. These changes adjust the balance of 
normal physiological processes such as body temperature, growth, reproduction, and immune response 
in a way that promotes longevity and health. 
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Figure 4. 3 Obesity and Aging lead to Distinct changes in the immune profile of adipose 
tissue to drive inflammation and pathology. 
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Healthy, lean adipose tissue is associated with anti-inflammatory immune subsets, such as CD206 
expressing macrophage subsets (Adipose tissue macrophages (ATMs), nerve associated macrophages 
(NAMs), and vascular associated macrophages (VAMs)), IL-4 expressing eosinophils, IL-10 expressing 
iNKT cells, B cells, and Tregs, and IL-5 expressing ILC2s. Energy imbalance leads to a disruption of 
immune and metabolic homeostasis, leading to an infiltration of inflammatory immune cells such as IL-
6 and TNFα producing lipid associated macrophages (LAM), elastase producing neutrophils, IgG2C 
producing B cells, degranulating mast cells, IFNγ producing CD4 T cells, IL-17 producing γδ T cells, 
and cytotoxic CD8 T cells. Accumulation of danger associated molecular patterns (DAMPs) such as free 
fatty acids (FA), oxidized LDL (oxLDL), cholesterol crystals, and islet amyloid polypeptides (IAPP) in 
obesity further drives the activation of NLRP3 inflammasome. These changes in immune mediated 
inflammation drive pathologies such as insulin resistance, type II diabetes, cardiovascular disease, and 
cancer, while weakening immune defense against pathogens, leading to higher risk for premature 
death. Unlike obesity, which is characterized by an accumulation crown like structures (CLS) where 
immune cells such as T cells and CD9+ macrophages, associated with increased lipid processing and 
inflammation, accumulate to deal with dying adipocytes, aging sees a reduction of adipose tissue 
macrophages, which instead increase GDF3 and catecholamine degradation enzymes such as MAOA and 
COMT to promote lipolysis resistance. Aging also leads to an increase of fat associated lymphoid clusters 
(FALCs) where B cells and T cells accumulate and contribute to dysregulated adipose homeostasis such 
as reduced insulin signaling and thermogenesis. While γδ T cells increase with both age and obesity, 
iNKT cells and Tregs increase with age and decrease with obesity, and while no marked changes in 
eosinophils are reported in aged adipose, obesity is associated with significant decreases in eosinophil 
populations. These differences in immune profiles and immune lymphoid structures during aging and 
obesity suggest that distinct mechanisms contribute to the pathologies associated with each condition.  
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Figure 4. 4 Protein and essential amino acid restriction induces the transsulfuration 
pathway and the integrated stress response to regulate immune response. 
  
Induction of the transsulfuration pathway leads to production of byproducts such as hydrogen sulfide, 
which can reduce NLRP3 inflammasome mediated inflammation and promote and maintain regulatory 
T cell differentiation. Low amino acid availability leads to the interaction of amino acid sensors such as 
Sestrin 2 and SAMTOR with GATOR2 and GATOR1 respectively to restrict mTORC1 activation. 
Furthermore, sensing of uncharged amino acids by GCN2 and lack of glutathione by PERK further 
inhibits mTORC1 and leads to the activation of eIF2α, stress response genes, and autophagy, inhibiting 
NLRP3 inflammasome mediated inflammation and Th17 responses.  
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Chapter 5: Summary and Perspectives 
 
 This project began with the aim to identify novel mechanisms that mediated the 
health benefits during caloric restriction (CR), a pro-longevity intervention. Specifically, 
we sought to identify novel therapeutic targets to reduce inflammation and improve 
metabolic health, because many chronic diseases associated with aging and obesity are 
caused by inflammation-driven metabolic pathology. And while dietary interventions such 
as CR or protein restriction are successful in reducing inflammation and promoting weight 
loss and improved metabolic function, they are untested in humans and are extremely 
difficult to implement in everyday life. We thus investigated transcriptional and metabolic 
changes in adipose tissue from healthy adults that underwent 2 years of 14% CR (Ravussin 
et al., 2015), Dixit, unpublished). Through investigation of human caloric restriction, our 
studies identify that defense of cysteine availability by the transsulfuration pathway is a 
critical immune-metabolic checkpoint. We find that during caloric restriction, the TSP is 
induced in response to a depletion of cysteine and its downstream metabolites. Induction 
of the TSP in turn, can reduce inflammation through the production of H2S. We show that 
H2S can inhibit the activation of NLRP3 inflammasome, through inhibition of the assembly 
of NLRP3 inflammasome complex. Furthermore, reduction in sulfur amino acid 
availability can reduce inflammasome activation by mediating p62-independent autophagy 
in macrophages. Indeed, the health benefits of methionine restriction (MR), another pro-
longevity intervention are blocked by cysteine supplementation, suggesting that limited 
cysteine availability underlies the benefits of restrictive dietary pro-longevity interventions 
(Elshorbagy et al., 2011).  
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 Importantly, we generated a model of cysteine deficiency to discover that cysteine 
availability is required for the defense of core body temperature, and deficiency of cysteine 
drives unchecked thermogenesis to the point of mortality. Thermogenesis is activated 
through increased sympathetic signaling that drives lipolysis and UCP1 to generate heat. 
We discovered that ablation of CSE together with dietary restriction of cysteine in mice 
causes a complete transformation of the white adipose tissues into a thermogenic brown-
like depot. This process involved increased mobilization of adipocyte progenitors and loss 
of monocyte-derived macrophages. Concurrently, tissue resident macrophages were 
enriched, with reduced expression of catecholamine degradation enzymes such as COMT, 
which increases norepinephrine availability to drive adipose tissue browning. While two 
other groups have previously investigated Cth-/- mice in the context of low cysteine diets 
(Ishii et al., 2010; Mani et al., 2011), we discovered time that cysteine deficiency mobilizes 
adipose to generate heat due to increased pressures to defend core body temperature.  
 This discovery may have therapeutic implications in a few clinical settings. The 
inhibition of CSE together with restriction of cysteine using specific prescribed diets can 
serve as a therapeutic strategy to activate thermogenesis as a short-term weight loss 
intervention in obese patients under a supervised clinical setting. Preliminary experiments 
suggest that even in the context of high fat diet, cysteine deficiency causes weight loss in 
Cth-/- mice. While long-term cysteine deficiency is not sustainable due to life-threatening 
unchecked weight loss, short-term cysteine deficiency through inactivation of the TSP may 
allow for quick weight loss in specific situations, such as weight loss for surgery. 
Alternatively, cysteine supplementation may help with unwanted weight loss during 
specific conditions such as cachexia. The increase in BCAA degradation and threonine in 
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adipose tissue suggests that skeletal muscle degradation may provide additional amino acid 
sources for mitochondrial respiration in the adipose tissues. Early studies by Droge and 
colleagues found that low plasma cystine levels were found in several diseases such as late-
stage HIV infection, cancer, sepsis, Crohn’s disease, and major injury and trauma and is 
associated with skeletal muscle wasting (Droge et al., 1998; Hack et al., 1997). This process 
has been described as the “Low CG Syndrome” where plasma cysteine, glutamine, and 
glutathione levels are abnormally low. Supplementation of N-acetyl-cysteine has been a 
successful therapeutic strategy in the context of HIV (Droge and Holm, 1997; Sekhar et 
al., 2015). Cysteine supplementation may thus serve as a mechanism to combat cachexia 
in a number of other diseases. Further investigation on how different metabolic organs such 
as adipose tissue and skeletal muscle are responding to cysteine deficiency and 
communicating with each other may allow for the untangling of fat and lean mass loss to 
provide more precise therapeutic targets in the context of weight loss and cachexia. 
 In conclusion, we discover that maintenance of cysteine metabolism by the TSP is 
important for inflammatory and metabolic homeostasis. Further investigation of how 
adaptations to cysteine deficiency are integrated in different metabolic organs may allow 
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Chapter 6: Materials and Methods 
 
Human Samples 
The participants in this study were part of the CALERIE Phase 2 (Rochon et al., 2011) 
study which was a multi-center, parallel-group, randomized controlled trial by recruitment 
of non-obese healthy individuals. 238 adults participated at 3 different locations: 
Pennington Biomedical Research Center (Baton Rouge, LA), Washington University (St. 
Louis, MO) and Tufts University (Boston, MA) (NCT00427193). Duke University, 
(Durham, NC) served as a coordinating center. Participants were randomly assigned to of 
25% caloric restriction or ad libitum caloric intake for two years. CR group participants 
actually reached 14% of CR (Ravussin et al., 2015). Men were between 20 and 50 years 
old and women were between 20 and 47 years old. Their body mass index (BMI) was 
between 22.0 and 27.9 kg/m2 at the initial visit. Samples were collected at baseline, 1 year, 
and 2 years of intervention. Abdominal subcutaneous adipose tissue biopsy was performed 
on a portion of CR group participants and used for RNA-sequencing and metabolomics in 
this study. Only 8 participants completed all three time points. All studies were performed 
under protocol approved by the Pennington institutional review board with informed 
consent from participants. 
 
Mice 
All mice were on the C57BL/6J (B6) genetic background except methionine restriction 
cohorts, which were on a C57BL/6M background from the NIA. B6 mice were purchased 
from Jackson Laboratories and maintained in our lab. Cth-/- mice (C57BL/6NTac-
Cthtm1a(EUCOMM)Hmgu/Ieg) were purchased from the European Mouse Mutant Cell Repository. 
Breeding these mice to Flipase transgenic mice from Jackson Laboratories generated Cthfl/fl 
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mice which were crossed to Adipoq-cre and Albumin-cre, purchased from Jackson 
Laboratories. Nlrp3A350VneoR and Tg(CAG-(cre/Esr1*)5Amc (CAG-ERcre) were purchased 
from Jackson laboratories and crossed to generate MWS model mice.  Ucp1-/- mice were 
purchased from Jackson laboratories and crossed to Cth-/- mice. Fgf21-/- mice were kindly 
provided by Dr. Steven Kliewer (UT Southwestern) as described previously (Potthoff et 
al., 2009), and crossed to Cth-/- mice. 17-18 month animals were provided by the NIA.  All 
mice used in this study were housed in specific pathogen-free facilities in ventilated cage 
racks that deliver HEPA-filtered air to each cage with free access to sterile water through 
a Hydropac system at Yale School of Medicine. Mice were fed a standard vivarium chow 
(Harlan 2018s) unless special diet was provided, and housed under 12 h light/dark cycles. 
All experiments and animal use were approved by the Institutional Animal Care and Use 
Committee (IACUC) at Yale University. 
 
Diet studies 
For methionine restriction (MR) studies, diets were purchased from Dyets (Appendix 1). 
C57BL/6M mice were started on control or MR diets at 8wks old or 17-18 months old and 
were kept on diet for 3 months. For LPS studies, adult C57BL/6J were maintained on 
control or MR diet for 3 months.  
Mice were acutely injected with LPS (Sigma) i.p. at a dose of 2mg/kg for 4 hours. Blood 
glucose (Breeze) and rectal core body temperature (Physitemp) were measured before and 
after injection.  
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Nlrp3A350VneoR CAG-ERcre mice were fed control or MR diet for 1 week prior to i.p. 
injection of tamoxifen (Sigma). Tamoxifen was injected for 2 consecutive days at 50mg/kg 
per day while being maintained on diet.  
Adipose samples from protein restricted (PR) mice were kindly provided by Dr. 
Christopher Morrison (Pennington University). Control and PR diets were produced by 
Research diets, and were designed to be isocaloric by equaling varying protein and 
carbohydrate, while keeping fat constant. Control diet contained 20% casein by weight, 
while PR diet contained 5% casein. Mice were maintained on diet ad libitum for 6 months.  
For cysteine deficiency and leucine deficiency studies, mice were fed special amino acid 
diets:  control diet, CysF diet, or LeuF diet purchased from Dyets (Appendix 2), for 6 days 
unless specified otherwise.  Prior to amino acid diets, mice were fed standard vivarium 
chow (Harlan 2018s).  Mice were started on amino acid diets between 3-6 months of age. 




All steps were performed using sterile technique.  To prepare BMDMs, femurs and tibias 
were collected in RPMI (Life Technologies) + 10% FBS (Omega Scientific).  Both ends 
of the femur were then cut and the femur was flushed with RPMI.  The bone marrow was 
centrifuge at 450 g for 5 min, the supernatant was decanted and red blood cells were lysed 
using ACK lysis buffer (Quality Biological).  After neutralization, bone marrow cells were 
centrifuged, resuspended in 10 ml of RPMI and placed into one well of a 6 well plate.  Non-
adherent cells were collected the following morning.  The non-adherent cells were 
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resuspended in media consisting of 10 ml supernatant of non-adherent cells, 14.4 ml L929 
conditioned media, 13.6 ml RPMI and MCSF (10ng/ml).  An additional 2 ml of fresh media 
was added 4 d after isolation.  Non-adherent cells were collected on day 7 and resuspended 
at 1x106 cells/ml and allowed to adhere overnight.  
For M1 polarization, cells were treated with LPS at 1ug/ml + recombinant IFNg 
(Ebioscience) at 20ng/ml for 24 hours. For M2 polarization, cells were treated with 
recombinant IL-4 (BD) for 24 hours. For inflammasome activation, cells were treated with 
ultrapure LPS (Sigma) at 1ug/ml for 4 hours alone or subsequently with 5mM ATP (Sigma) 
for one hour. For hydrogen sulfide treatment experiments, cells were treated with sodium 
hydrosulfide (Sigma) at 0-100uM at the time of LPS treatment. For methionine and 
cysteine restricted experiments, before LPS treatment, cells were washed in PBS and 
switched to DMEM lacking methionine and cysteine and glutamine. Glutamine () was 
added at 2.5mM, and L-methionine (Sigma) and L-cysteine (Sigma) were each added at 
200uM per well. 3-methyladenine (Sigma) was treated at 5mM at the time of LPS 
treatment. LysM-cre p62fl/fl femurs were kindly provided by Dr. Michael Karin, and were 
received overnight in RPMI. All following steps were done identically as described above. 
BMDMs from Nlrp3A350VneoR mice were prepared as described above. The day before 
inflammasome activation, the cells were treated with 4-hydroxy-tamoxifen (4-OHT) at 
0.25mM.  
 
Potassium efflux assay 
On the day before inflammasome activation, cells were plated 100,000 cells per well of a 
96 well plate in 200ul. Conditions were consistent as above. After all cell treatments, media 
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was changed to fresh media and Asante potassium green 2 (APG4) (Abcam) was added at 
5uM and incubated at 37C for 30min. After 2 washes in PBS, the plate was read in 50ul of 
PBS according to manufacturer’s directions.  
 
Thioglycolate 
Mice were injected with a one-time 1ml intraperitoneal injection of 3% thioglycolate 
medium (BD). 4 days later, peritoneal cells were collected by peritoneal lavage. 
 
Western blot analysis 
Cell lysates were prepared using RIPA buffer and optionally frozen and stored at -80°C. 
Samples were left on ice, vortexing every ten min for 30 min. For tissue samples, snap 
frozen tissues were ground by mortar and pestle in liquid nitrogen and resuspended in RIPA 
buffer with protease and phosphatase inhibitors. Samples were centrifuged at 14,000g for 
15min and the supernatant was collected protein concentration was determined using the 
DC Protein Assay (Bio-Rad) and transferred to a nitrocellulose membrane. The following 
antibodies (and source) were used to measure protein expression: IL-1β (Genetex), NLRP3 
(Adipogen), β-Actin (Cell Signaling), pHSL p660 (Cell Signaling), ATGL (Cell 
Signaling), UCP1 (Abcam), CSE (Novus), Caspase-1 (generously provided by Genentech), 
Tubulin (Sigma), HSL (Cell Signaling), COMT (Biorad), MAOA (Abcam), TH (Cell 
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Gene expression analysis  
Cells or ground tissue (described above) were collected in STAT-60 (). RNA from cells 
were extracted using Qiagen RNeasy micro kits following manufacturer’s instructions. For 
tissue samples, RNA was extracted using Zymo mini kits following manufacturer’s 
instructions. During RNA extraction, DNA was digested using RNase free DNase set 
(Qiagen). Synthesis of cDNA was performed using iScript cDNA synthesis kit (Bio-Rad) 
and real time quantitative PCR (Q-PCR) was conducted using Power SYBR Green 
detection reagent (Thermo Fischer Scientific) on a Light Cycler 480 II (Roche). Primers 
used for qPCR are described in Appendix 3.   
 
Glucose tolerance tests/ Insulin tolerance test 
Mice were fasted 14hr prior to glucose tolerance test. Glucose was given by i.p. injection 
based on body weight (0.4g/kg). For insulin tolerance test, mice were fasted for 4 hours 
and insulin was given by i.p. injection based on body weight (0.8U/kg). Blood glucose 
levels were measured by handheld glucometer (Breeze, Bayer Health Care).   
 
Multiplex 
Serum was prepared by collecting blood and allowing to clot at room temperature for 2 
hours. Samples were then centrifuged for 20 min at 4°C and stored at -80°C until analysis. 
Inflammatory cytokines, IL-6, MCP-1, IL-1β, and TNFa, were measured in the serum using 
custom Procartaplex kit (Life Technologies), and measured on a Luminex 200 analyzer.  
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Flow Cytometry 
Intravascular labeling was performed by iv injection of 2.5ug CD45.2-FITC diluted in 
100ul PBS. Mice were euthanized exactly 3 minutes after injection for tissue collection. 
Adipose tissue was digested in HBSS (Life Technologies) + 0.1% collagenase I or II 
(Worthington Biochemicals). The stromal vascular fraction was collected by 
centrifugation, and washed and filtered using 100um and 70um strainers. Cells were 
stained with LIVE/DEAD™ Fixable Aqua Dead Cell Stain Kit (Thermo Fisher Scientific) 
and then for surface markers including CD45, CD3, B220, CD11b, F4/80, Ly6G, Siglec F, 
CD163 and all antibodies were purchased from eBioscience or Biolegend. Cells were fixed 
in 2% PFA. Samples were acquired on a custom LSR II and data was analyzed in FlowJo.  
 
Single-cell RNA sequencing 
For stromal vascular fraction, female Cth+/+ and Cth-/- mice were fed CTRL of CysF diet 
for 4 days. SFAT was collected, with lymph nodes removed, pooled, and digested. For 
myeloid cells, Cth+/+ and Cth-/- mice were fed CTRL of CysF diet for 3 days. Intravascular 
labeling was performed by i.v. injection of 2.5ug CD45.2 diluted in PBS for 3 min. SFAT 
was collected, with lymph nodes removed, pooled, digested, and stained for live/dead, 
CD11b, CD45, and dump (CD3, B220, Siglec F). Cells were sorted on BD FACSAria, for 
CD45+ CD11b+ cells that were negative for CD45.2 and the dump channel. Isolated cells 
were subjected to droplet-based 3’ end massively parallel single-cell RNA sequencing 
using Chromium Single Cell 3’ Reagent Kits as per manufacturer’s instructions (10x 
Genomics). The libraries were sequenced using a HiSeq3000 instrument (Illumina). 
Sample demultiplexing, barcode processing, and single-cell 3’ counting was performed 
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using the Cell Ranger Single-Cell Software Suite (10x Genomics). Cellranger count was 
used to align samples to the reference genome (mm10), quantify reads, and filter reads with 
a quality score below 30. The Seurat package in R was used for subsequent analysis (Butler 
et al., 2018). Cells with mitochondrial content greater than 0.05 percent were removed and 
data was normalized using a scaling factor of 10,000, and nUMI was regressed with a 
negative binomial model. Principal component analysis was performed using the top 3000 
most variable genes and t-SNE analysis was performed with the top 20 PCAs. Clustering 
was performed using a resolution of 0.4. The highly variable genes were selected using the 
FindVariableFeatures function with mean greater than 0.0125 or less then 3 and dispersion 
greater than 0.5. These genes are used in performing the linear dimensionality reduction. 
Principal component analysis was performed prior to clustering and the first 20 PC’s were 
used based on the ElbowPlot. Clustering was performed using the FindClusters function 
which works on K-nearest neighbor (KNN) graph model with the granularity ranging from 
0.1-0.9 and selected 0.4 for the downstream clustering. For identifying the biomarkers for 
each cluster, we have performed differential expression between each cluster to all other 
clusters identifying positive markers for that cluster. To perform pathway analysis, we 
compared differential gene expression parameters (0 fold and threshold of at least 10% of 
cells) between samples. Gene-set enrichment analysis (GSEA) was performed using the 
FGSEA package in R with the canonical pathways (CP). To understand the trajectory of 
the adipocyte progenitors, we used Monocle2 to analyze scRNA-seq data of Clusters 0, 1, 
and 2 (Trapnell et al., 2014). 
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Whole tissue RNA sequencing and transcriptome Analysis 
Snap frozen tissues were ground by mortar and pestle in liquid nitrogen and resuspended 
in STAT-60. RNA was extracted using Zymo mini kits. RNA was sequenced on a 
HiSeq2500. The quality of raw reads was assessed with FastQC [FastQC]. Raw reads were 
mapped to the GENCODE vM9 mouse reference genome [GENCODE] using STAR 
aligner [STAR] with the following options: --outFilterMultimapNmax 15 --
outFilterMismatchNmax 6  --outSAMstrandField All --outSAMtype BAM 
SortedByCoordinate --quantMode TranscriptomeSAM. The quality control of mapped 
reads was performed using in-house scripts that employ Picard tools [Picard]. The list of 
rRNA genomic intervals that we used for this quality control was prepared on the basis of 
UCSC mm10 rRNA annotation file [UCSC] and GENCODE primary assembly annotation 
for vM9 [GENCODE]. rRNA intervals from these two annotations were combined and 
merged to obtain the final list of rRNA intervals. These intervals were used for the 
calculation of the percentage of reads mapped to rRNA genomic loci. Strand specificity of 
the RNA-Seq experiment was determined using an in-house script, on the basis of Picard 
[Picard] mapping statistics. Expression quantification was performed using RSEM 
[RSEM]. For the assessment of expression of mitochondrial genes, we used all genes 
annotated on the mitochondrial chromosome in the GENCODE vM9 mouse reference 
genome [GENCODE]. PCA was performed in R. For the PCA, donor effect was removed 
using the ComBat function from the sva R-package [sva]. Gene differential expression was 
calculated using DESeq2 [DESeq2]. ]. Pathway analysis was done using fgsea (fast GSEA) 
R-package [fgsea] with the minimum of 15 and maximum of 500 genes in a pathway and 
with 1 million of permutations. For the pathway analysis, we used the Canonical Pathways 
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from the MSigDB C2 pathway set [MSigDB1, MSigDB2], v6.1. The elimination of 
redundant significantly regulated pathways (adjusted p-value < 0.05) was done using an 
in-house Python script in the following way. We considered all ordered pairs of pathways, 
where the first pathway had normalized enrichment score equal to or greater than the 
second pathway. For each ordered pair of pathways, we analyzed the leading gene sets of 
these pathways. The leading gene sets were obtained using fgsea [fgsea]. If at least one of 
the leading gene sets in a pair of pathways had more than 60% of genes in common with 
the other leading gene set, then we eliminated the second pathway in the pair.  
 
GAM-clustering, identifies modules describing dynamic regulation of metabolism and is 
based on the previously developed GAM method (Sergushichev et al., 2016). GAM-
clustering extends the GAM method by setting the task to find not one but several 
metabolic modules (connected subnetworks of metabolic network) with the condition that 
each of these modules should contain as many metabolic genes with high pairwise 
correlation of their expression as possible. The initial approximation of the final set of 
modules is carried out by k-medoids clustering of a gene expression matrix for all 
metabolic genes of a dataset with some arbitrary k (here we used k=32). Each cluster forms 
a corresponding expression pattern which can be determined as averaged value of its z-
normalized gene expression values. The metabolic network used for further analysis is 
presented as a graph where vertices are metabolites and edges are KEGG database reactions 
which are mapped with catalyzing them enzymes and corresponding genes. For each 
particular pattern edges of this graph are scored (weighted) based on their gene expression 
similarity with this pattern and dissimilarity with other patterns. 
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For each case of weighted graph, a connected subgraph of maximal weight is found by a 
signal GMWCS (generalized maximum weight connected subgraph) solver (Ulland et al., 
2017) (https://github.com/ctlab/sgmwcs-solver) and is called a metabolic module. This 
solver uses the IBM ILOG CPLEX library, which efficiently performs many iterations of 
this method in a reasonable amount of time. Then, each pattern is updated by replacing it 
with an averaged gene expression of the module’s edges with a positive score. If the pattern 
is changed, a new score set is calculated and a new iteration is performed. Before moving 
to the next iteration, small graphs are eliminated from further analysis so that there are no 
graphs with less than five edges and diameter less than four in the output solution. The 
algorithm continues until the pattern content stops changing (Gainullina et al., 2020). 
 
 
Metabolomics and Lipidomics 
Metabolite extraction from tissue blocks for metabolome analyses was performed as 
described previously (Miyazawa et al., 2017). Briefly, one frozen block together with 
internal standard (IS) compounds (see below) was homogenized in ice-cold methanol 
(500μl) using a manual homogenizer (Finger Masher (AM79330), Sarstedt), followed by 
the addition of an equal volume of chloroform and 0.4 times the volume of ultrapure water 
(LC/MS grade, Wako). The suspension was then centrifuged at 15,000 g for 15 min at 4°C. 
After centrifugation, the aqueous phase was ultrafiltered using an ultrafiltration tube 
(Ultrafree MC-PLHCC, Human Metabolome Technologies). The filtrate was concentrated 
with a vacuum concentrator (SpeedVac, Thermo). The concentrated filtrate was dissolved 
in 50μl of ultrapure water and used for LC-MS/MS and IC-MS analyses.  
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We used both internal (added to the tissue before extraction) and external (used to produce 
calibration curves for each compound) standard compounds for concentration calculation. 
The detailed method is as follows: 
Internal standard (IS) compounds 
We used 2-morpholinoethanesulfonic acid (MES) and 1,3,5-benzenetricarboxylic acid 
(trimesate) as ISs for anionic metabolites. These compounds are not present in the tissues; 
thus, they serve as ideal standards. Loss of endogenous metabolites during sample 
preparation was corrected by calculating the recovery rate (%) for each sample 
measurement. 
External standard (ES) compounds 
An external calibration curve was used to calculate the absolute abundance of metabolites. 
Before sample measurement, we measured the mixture of authentic compounds of target 
metabolites at three different concentrations in ultrapure water to generate calibration 
curves. Quantification (amount of metabolites, nmol/mg tissue) was performed by 
comparing the IS-normalized peak areas against the calibration curves. 
Ion chromatography-tandem mass spectrometry for anionic metabolites  
For metabolome analysis focused on glucose metabolic central pathways, namely 
glycolysis, TCA-cycle and PPP, those anionic metabolites were measured using an 
orbitrap-type MS (Q-Exactive focus, Thermo Fisher Scientific, San Jose, CA), connected 
to an high performance ion-chromatography system (ICS-5000+, Thermo Fisher 
Scientific) that enables us to perform highly selective and sensitive metabolite 
quantification owing to the IC-separation and Fourier Transfer MS principle (Hu et al., 
2015).  
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The IC was equipped with an anion electrolytic suppressor (Thermo Scientific Dionex 
AERS 500) to convert the potassium hydroxide gradient into pure water before the sample 
enters the mass spectrometer. The separation was performed using a Thermo Scientific 
Dionex IonPac AS11-HC, 4-μm particle size column. IC flow rate was 0.25 mL/min 
supplemented post-column with 0.18 mL/min makeup flow of MeOH. The potassium 
hydroxide gradient conditions for IC separation are as follows: from 1 mM to 100 mM (0–
40 min), 100 mM (40–50 min), and 1 mM (50.1–60 min), at a column temperature of 30°C. 
The Q Exactive focus mass spectrometer was operated under an ESI negative mode for all 
detections. Full mass scan (m/z 70−900) was used at a resolution of 70,000. The automatic 
gain control (AGC) target was set at 3 × 106 ions, and maximum ion injection time (IT) 
was 100ms. Source ionization parameters were optimized with the spray voltage at 3 kV 
and other parameters were as follows: transfer temperature at 320°C, S-Lens level at 50, 
heater temperature at 300°C, Sheath gas at 36, and Aux gas at 10. 
 
Liquid chromatography-tandem mass spectrometry for amino acid measurement 
The amount of cationic metabolite including amino-acids in the tissues was quantified 
using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Briefly, a triple-
quadrupole mass spectrometer equipped with an electrospray ionization (ESI) ion source 
(LCMS-8040, Shimadzu Corporation) was used in the positive and negative-ESI and 
multiple reaction monitoring (MRM) modes. The samples were resolved on the Discovery 
HS F5-3 column (2.1 mmI.D. x 150 mmL, 3μm particle, Sigma-Aldrich), using a step 
gradient with mobile phase A (0.1% formate) and mobile phase B (0.1% acetonitrile) at 
ratios of 100:0 (0–5 min), 75:25 (5–11 min), 65:35 (11–15 min), 5:95 (15–20 min) and 
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100:0 (20–25 min), at a flow rate of 0.25 mL/min and a column temperature of 40°C. MRM 
conditions for each amino acids are listed in Appendix 4. 
 
Liquid chromatography-mass spectrometry for lipid measurement 
The amount of lipids in the tissues was measured using an orbitrap-type MS (Q-Exactive 
focus, Thermo Fisher Scientific, San Jose, CA) connected to an high performance liquid 
chromatography system (UltiMate 3000 RSLC system, Thermo Scientific ). 
Briefly, the samples were resolved on the Accucore C18 column (2.1 x 150 mm, 2.6 μm, 
Thermo Scientific), using a step gradient with mobile phase A (10 mM HCOONH4 in 50% 
ACN (v) + 0.1% HCOOH (v)) and mobile phase B (2 mM HCOONH4 in ACN / IPA / 
H2O 10:88:2 (v/v/v) + 0.02% HCOOH (v) ) at ratios of 65:35 (0 min), 40:60 (0–11 min), 
15:85 (11–12 min), 0:100 (12–21 min), at a flow rate of 0.4 mL/min and a column 
temperature of 35°C. 
The Q Exactive focus mass spectrometer was operated under an ESI positive mode for all 
detections. Full mass scan (m/z 100−1200) was used at a resolution of 70,000. The 
automatic gain control (AGC) target was set at 3 × 106 ions, and maximum ion injection 
time (IT) was 100 ms. Source ionization parameters were optimized with the spray voltage 
at 3 kV and other parameters were as follows: transfer temperature at 285°C, S-Lens level 
at 45, heater temperature at 370°C, Sheath gas at 60, and Aux gas at 20. 
 
Imaging Mass Spectrometry 
Tissues were sectioned at 8-µm thick and thaw-mounted on a conductive indium-tin-oxide 
(ITO)-coated glass slides (Matsunami Glass Industries, Osaka, Japan). The samples were 
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measured by a MALDI-Fourier transformation ion cyclotron resonance (FT-ICR) mass 
spectrometer (solariX XR 7T, Bruker Daltonics), or a linear ion trap (LIT) mass 
spectrometer (LTQ XL, Thermo Fishcer Scientific). The raster scan pitch was set 
depending on the experiment from 30 to 150 µm. Data were acquired from m/z 286.65 to 
450.00 (for FT-ICR data) in positive ion mode. For LIT data, signals of 5-HT-DPP (m/z 
391 > 232) were monitored with a precursor ion isolation width of 1.0 m/z and a normalized 
collision energy of 45%. Ion images were reconstructed with msIQuant 2.0.1.1466, 
ImageQuest 1.1.0 software (Thermo Fischer Scientific) the FT-ICR data, and the LIT data, 
respectively. After finishing the measurement, the sections were stained by H&E stain to 
annotate the regions. 
 
MRI-BIRDS temperature mapping 
The animals were anesthetized with isoflurane, first at 3% isoflurane in an induction 
chamber and then at 2-3% during surgery. The animal was laid back on a microwaveable 
heating pad. Prior to incision, a single dose of bupivacaine was given for analgesia. A 1-2 
cm midline incision was made on the neck to expose the jugular vein. Another small 
incision (<1 cm) was made at the back of the neck. A sterile polyurethane or silicone 
catheter with a metal guide was inserted from the back of the neck, where the vascular port 
was fixed to the jugular vein. Prior to implantation the port and the catheter were flushed 
with heparinized saline (25 IU/ml). The jugular vein was catheterized toward the heart. The 
skin was closed with surgical sutures after application of triple antibiotic ointment and the 
vascular port was fixed. The duration of the surgical procedure was 15-20 min.For MR 
data acquisition, TmDOTMA- was purchased from Macrocyclics (Plano, TX, USA). 
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Temperature mapping with BIRDS was performed on a 9.4T Bruker scanner (Billerica, 
MA).  The respiration rate was monitored during the entire duration of the experiment. A 
200mM TmDOTMA- solution was infused at a rate of 60 to 80 µl/h for 1 to 2 hours. The 
infusion rate was adjusted according to animal physiology. The T2 weighted magnetic 
resonance (MR) images were acquired with an FOV of 23x23mm2, 128x128 matrix, 23 
slices of 0.5mm thickness, TR=3s and TE=9ms. The extremely short T1 and T2 relaxation 
times (<5ms) of the TmDOTMA- methyl group allowed ultrafast temperature mapping 
with BIRDS using 3D chemical shift imaging (CSI) acquisition with a short TR (10ms) 
and wide bandwidths (±150ppm). Temperature mapping with BIRDS was started 
immediately after detection of global MR signal of TmDOTMA- methyl group, at about 1 
hour after the start of the infusion. The CSI was acquired using a FOV of 23x15x23mm3, 
809 spherical encoding steps, 21min acquisition, and reconstructed to 23x15x23, with a 
voxel resolution of 1x1x1mm3. Selective excitation of the TmDOTMA- methyl group was 
achieved using a single band 200µs Shinnar-Le Roux (SLR) RF pulse. The MR spectrum 
in each voxel was line broadened (200 Hz) and phased (zero-order) in Matlab (MathWorks 
Inc., MA, USA), and the corresponding temperature Tc was calculated from the chemical 
shift 
3CH
 of the TmDOTMA- methyl group according to 
2
0CH20CH10c )(a)(aaT 33 −+−+=                                             
where d0 = -103.0 ppm and the coefficients a0 = 34.45 ± 0.01, a1 = 1.460 ± 0.003 and a2 = 
0.0152 ± 0.0009 were calculated from the linear least-squares fit of temperature as a 
function of chemical shift 
3CH
 (Coman et al., 2010).  
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Temperature Loggers 
Animals were anesthetized with isoflurane, first at a rate of 2-3% and maintained at 0.5-
2% in oxygen during surgery. Mice were kept on a heating pad throughout surgery. Mice 
were injected with buprenorphine and bupivacaine as pre-emptive analgesia. A small 
ventral incision of 1cm was made after clipping hair and disinfection with betadine and 
70% ethanol. DST nano-T temperature loggers (Star Oddi) were placed in the peritoneal 
cavity, and abdominal muscle and skin were sutured closed. Post-surgery, mice were singly 
housed and provided with Meloixcam for 48 hours. After 7 days, sutures were removed. 
10 days after surgery, mice were started on CTRL or CysF diet, and loggers were removed 
for data collection after euthanization. Loggers were programmed to take temperature 
readings every 30 minutes.  
 
Metabolic cages 
The energy expenditure (EE), respiratory exchange ratio (RER), activity, food intake and 
water consumption of mice were monitored using the TSE PhenoMaster System (V3.0.3) 
Indirect Calorimetry System. Each mouse was located in individual chambers for 3 days 
for acclimation, and switched to experimental diet for 6 days. Each parameter was 
measured every 30 min. EE and RER were calculated based on the oxygen consumption 
(O2) and carbon dioxide production (CO2). Mouse activity was detected by infrared 
sensors, and food intake and water consumption were measured via weight sensors on food 
and water dispensers located in the cage. 
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EchoMRI 
The parameters of body composition were measured in vivo by magnetic resonance 
imaging (EchoMRI; Echo Medical Systems). The amount of fat mass, lean mass and free 
water were measured by the analysis. For the analysis, each mouse was placed in an acrylic 
tube with breathing holes and the tube was inserted in the MRI machine. The analysis per 




Mice were acclimated in climate chambers at either 30°C or 22°C, with humidity 
maintained at 50% under 12 h light/dark cycles. After one week acclimation, mice were 
switched to custom amino acid diets, either CTRL or CysF diet for 6 days, while 
maintained in the climate chambers. Mice were handled daily to measure body weight.  
 
Histology 
Tissues were collected in 10% formalin, embedded in paraffin and sectioned into 5um thick 
sections. Tissues were stained with hematoxylin and eosin (H&E), or stained for UCP1 
(Abcam) and Goat anti-rabbit HRP (DAKO) and developed for color using Abcam DAB 
substrate kit.  
 
Quantification and statistical analysis 
Statistical differences between groups were calculated by unpaired 2-tailed t-tests. For 
comparing groups over time, mice were individually tracked and groups were compared 
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using paired 2-way ANOVA with Sidak’s correction for multiple comparisons. For all 
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Appendix 1: Chapter 2 Custom Amino Acid Diets 
 
    CTRL MR 
  Diet # 510027  DYET# 510029 
L-Arginine 11.2   11.2   
Glycine 23.3   23.3   
L-Glutamic Acid 27   33.88   
L-Histidine 3.3   3.3   
L-Isoleucine 8.2   8.2   
L-Leucine 11.1   11.1   
L-Lysine-HCl 18   18   
L-Phenylalanine 11.6   11.6   
L-Threonine 8.2   8.2   
L-Tryptophan 1.8   1.8   
DL-Methionine 8.6   1.72   
L-Valine 8.2   8.2   
L-Cystine 0   0   
  gm/Kg kcal/gm gm/Kg kcal/gm 
Total L-AA 140.5 562 140.5 562 
Cornstarch 432.5 1557 432.5 1557 
Dyetrose 50 190 50 190 
Sucrose 200 800 200 800 
Cellulose 50 0 50 0 
Cornoil 80 720 80 720 
Salt Mix #200000 35 16.45 35 16.45 
Vitamin Mix #300050 10 38.7 10 38.7 
Choline Bitartrate 2 0 2 0 
Total 1000 3884.15 1000 3884.15 
% protein 14.5 14.5 
% carbohydrate 67.0 67.0 
% fat 18.5 18.5 
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Appendix 2: Chapter 3 Custom Amino Acid Diets 
  CTRL CysF LeuF 
  Diet # 511387 Diet # 510027  Diet # 511403 
L-Arginine 11.2   11.2   11.2   
Glycine 23.3   23.3   23.3   
L-Glutamic Acid 27   27   39.45   
L-Histidine 3.3   3.3   3.3   
L-Isoleucine 8.2   8.2   8.2   
L-Leucine 11.1   11.1   0   
L-Lysine-HCl 18   18   18   
L-Phenylalanine 11.6   11.6   11.6   
L-Threonine 8.2   8.2   8.2   
L-Tryptophan 1.8   1.8   1.8   
DL-Methionine 8.6   8.6   8.6   
L-Valine 8.2   8.2   8.2   
L-Cystine 3.9   0   3.9   
  gm/Kg kcal/gm gm/Kg kcal/gm gm/Kg kcal/gm 
Total L-AA 144.4 577.6 140.5 562 145.75 583 
Cornstarch 428.6 1543 432.5 1557 427.25 1538 
Dyetrose 50 190 50 190 50 190 
Sucrose 200 800 200 800 200 800 
Cellulose 50 0 50 0 50 0 
Cornoil 80 720 80 720 80 720 
Salt Mix #200000 35 16.45 35 16.45 35 16.45 
Vitamin Mix 
#300050 10 38.7 10 38.7 10 38.7 
Choline Bitartrate 2 0 2 0 2 0 
Total 1000 3886.21 1000 3884.15 1000 3886.75 
% protein 14.9 14.5 15.0 
% carbohydrate 66.6 67.0 66.5 
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Appendix 3: qPCR primers 
 


























Fwd CAG CGT CAT GGT CAG TCT GT 
Rev AGAAAACCGTGTGGCAGAGA 
Cox8b 
Fwd GAA CCA TGA AGC CAA CGA CT  

























Ifng Fwd  AACTGGCAAAAGGATGGTGAC 
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Rev  TTGCTGATGGCCTGATTGTC 
Il18 
Fwd  GACAGCCTGTGTTCGAGGAT  
Rev  CAGTCTGGTCTGGGGTTCAC  
Il6 
Fwd ACCAGAGGAAATTTTCAATAGGC  





Fwd  GCTAAGAAGGACCAGCCAGA  








Fwd GCGTACGGCAATGGCTTTAT  








Fwd  CAG CAC GGT GAA GCC ATT C 
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Appendix 4: MRM conditions for amino acids measurement 
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Appendix 5: CL316,243 activated gene set 
 
Zim1 Gm5617 Sort1 Serf1 Gpx7 
H19 Vash2 Sned1 Slc5a3 Gm19739 
Akr1cl Lypd1 Cxcl9 Mlst8 Col1a2 
Prss35 Klhdc9 Dlk1 Eln Csad 
Adam12 Cpz Pde3b Txndc16 Adgrl1 
Mest Igfals Chrna1os Fam171a2 Maged2 
Postn S100a4 Gstm7 Pparg Cpxm1 
Peg3 Col1a1 1600014C10Rik Gpt2 Tomm70a 
Cyp2f2 Cthrc1 Sfrp2 Hmgcs2 Lpl 
Car3 Tspan7 Mrps6 Tamm41 Pld3 
Prkar2b Ttyh3 Rrad Sox4 Col16a1 
Gdpd2 Mdga1 Dnm3os Selenoh Fgfrl1 
Thbs2 Hsd11b2 Vegfb Gdf11 Olfml2b 
Ly6h Mgmt Lyrm2 Marcks Slc7a8 
Polr3g Mfap2 Fdxr Col3a1 Igfbp4 
Adamts15 Atxn1 Sord Yipf2 Gas1 
H2afv Pla2g15 Epb41l1 Eef1b2 Bgn 
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Appendix 6: NAM gene signature 
 
Clec12a Card11 Add3 Edil3 Itgam Rcn3 
F13a1 Cav2 Akt3 Ehd4 Itgb7 Rgs18 
Ccl12 Ccl7 Aldh1a2 Eif2b2 Kdelc2 Rhoj 
Bmp2 Ccl9 Angptl4 Eng Lilra6 Rin3 
Cbr2 Cd83 Antxr1 Enpp1 Lrmp Ripply3 
Ccdc109b Cib1 Anxa1 Fam129a Lsp1 S100a6 
Ccr2 Clec4n Apold1 Fcna Ly6e S1pr1 
Cd209f Dennd2c Arl11 Fez2 Lyve1 Scarf1 
CD63 Ecm1 Asap1 Fgr Map4k4 Selm 
CD72 Fam69a atp8b4 Flna mmp14 Sept9 
Clec10a Fbxo4 Bzw2 Folr2 Mmp2 Serpinf1 
Crim1 Gmppb C4b Gas7 Mras Sesn1 
Egr1 Ifitm3 Capn1 Gbp4 Ms4a7 Sh3d19 
Fcrls Itga6 Cd200r4 Gbp8 Naaa Sharpin 
Gas6 Ldha Cd209b Glipr2 Nlrc3 Shcbp1 
Ier2 Marcksl1 cd93 Glrx Npl Skint3 
Ifi27l2a Mgl2 Cdk14 Gpr34 Nr1h3 Slc12a2 
Lipa Ms4a4a Cfh Gramd4 Nrp1 Slc13a3 
Pdlim1 Nedd9 Chst12 H2-aa Olfm1 Slc37a2 
Plbd1 Plxnb2 Cish Hba-a1 P2ry14 Slc9a3r2 
Pltp Pstpip1 Clec1b Hba-a2 Panx1 Slco3a1 
Rnase4 Rasgrp4 Cnn2 Hbb-bs Pdk3 Smagp 
Rtp4 Slc38a6 Col14a1 Hepacam2 Pea15a Stard8 
S100a4 Socs3 Cp Hes1 Pilra Steap3 
Tnfsf9 Spint1 Cpne8 Hivep2 Pla2g2d Tiam1 
Xdh Timd4 Csf2rb Hvcn1 Pla2g7 Timp2 
AB124611 Tlr2 Ctnnd2 Igfbp4 Pmp22 Tnip3 
Aldoc Vcam1 Dock5 Il1r2 Pxdc1 Tnni2 
Arhgef10l Ada E2f2 Il1rl1 Rab34 Trip6 
C130050O18Rik Adamts2 Ear2 Irf8 Rapgef2 Tssc4 
Sephs2 Sft2d2 Slc16a10 Slc25a24 Slc35c2 Slc39a11 
Stom Susd3 Tbc1d23 Tc2n Tex9 Tjp2 
Tradd Trim24 Trim47 Trmt10c Tsta3 Ttc28 
Abhd14b Pid1 Pkib Pnpo Pold4 Ppp1r12b 
Rab19 Rab32 Rab37 Ralgps2 Rarg Rassf4 
Sar1b Sash1 Scel Sdc3 Sdc4 Sema4a 
Ttyh2 Blnk Cst3 Fli1 Ifitm6 Mgst2 
Unc119 Bst1 Cxcr2 Flnb Il18 Mical1 
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Vps37b C2cd2l Cyp51 Fmo1 Il1f9 Mlkl 
Wwp1 Cadm1 Cyr61 Fnbp1l Il21r Mmd 
Abca5 Camk2d Cyth4 Foxp1 Impdh1 Mmp13 
Abcb4 Casp7 Dgat2 Frmd6 Ipo13 Mrc1 
Abcd2 Ccdc102a Dgkd Fut8 Itgax Msr1 
Abcg2 Ccdc91 Dhdh Galnt7 Kazn Nav1 
Abcg3 Ccl2 Dip2c Gars Kbtbd11 Nceh1 
Abi3 Ccl24 Dlc1 Gca Kctd12b Ncf4 
Abr Ccl6 Dnase1l3 Gde1 Kif11 Nckap5 
Acss1 Ccna2 Dpep2 Gem Kif23 Nfkbiz 
Adam28 Ccnd1 Dusp8 ggta1 Kitl Nid2 
Adgrl3 Cd163 Echdc1 Gimap6 Klhl5 Nlrp1c-ps 
Adora3 Cd164 Emilin2 Gpr165 Krt80 Nsdhl 
Aif1 Cd209a Emp3 Gpr55 Lag3 Nt5dc2 
Aifm1 Cd209g Epha2 Gpr84 Lat2 Nuak1 
Aldh18a1 Cd300a Ephx1 Gsto1 Ldlrap1 Nubp2 
Aldoa Cdk2ap2 Epn2 havcr2 Lgals9 Oas2 
Amica1 Cdr2 Eps8 Hdac10 Lifr Olfml3 
Anln Cetn2 Ermap Hes6 Lonrf1 Pacsin2 
Anxa2 Clec4a3 Esr1 Hk3 lpcat2 Paox 
Aprt Clmn Etv1 Hmgcs1 Lsm1 Paqr3 
Arhgap27 Clu Evl Hmmr Ltbp3 Pcdhga8 
Atp6v0e Cmah Fads1 Hps6 Lyl1 Pde1b 
Atp6v0e2 Colec12 Fam111a Hsd17b4 Mad2l1 Pde4d 
Bach2 Commd5 Fam117a Htra2 Man1a Pf4 
Bco2 Cpne5 Fam43a I830077J02Rik Map3k8 Pgf 
Bend6 Creg1 Fcgr4 Ier3 Marveld2 Phactr1 
Bin2 Csf2rb2 Fcrl1 Ifi30 Mef2c Phf11a 
Slfn5 Slfn8 Slfn9 Ssbp2 St3gal6 St5 
Tln2 Tmem14c Tmem245 Tmem254a Tmem254b Tmem9b 
Txndc16 Vnn3 Wdr46 Zfp125 Zfp36l1 Zfp599 
Prdm1 Prom1 Prr11 Pstpip2 Ptgs1 Ptpn22 
Rbpj Rell1 Retnla Rexo2 Rims3 Samd9l 
Sema6d Stat4 Tnfrsf11a Zmynd15   
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